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Abstract 
The work presented in this thesis focuses on the use of radical cyclisations to 
synthesise nitrogen heterocycles. Chapter 1 provides an introduction to radical 
cyclisations and the development of conditions over the past couple of decades. It 
also gives an introduction to atropisomerism, a phenomenon present in a number of 
cyclisation precursors, and how this has been exploited to achieve chirality transfer 
in the cyclisation of acrylanilides. 
Chapter 2 describes investigations into the effects of alkene substitution on the 
barrier to rotation about the N-alkenyl bond in enamides. A range of enamides were 
synthesised and their barriers to rotation were investigated by both 1H VT NMR and 
racemisation of an enriched atropisomer. Tetrasubstituted enamides were found to 
have significantly higher barriers to rotation, and in some cases it was possible to 
separate the two atropisomers at room temperature by chiral HPLC. 
Chapter 3 describes the results of 5-endo cyclisations of tetrasubstituted enamides. 
Dependant on the starting material, cyclisations were carried out mediated by both 
Bu3SnH and copper. Cyclisations of tetrasubstituted enamides proved to be more 
challenging than previous reported cyclisations of less hindered substrates with a 
number of by products produced.We have also examined the possibility of whether 
chirality transfer would be possible in the cyclisation of an enamide with a high 
barrier to rotation. 
In Chapter 4 studies into the cyclisations of 2-bromobenzyl enamides are presented. 
Initial cyclisations were carried out into the Bu3SnH mediated cyclisation of a 
trisubstituted enamide and the rate of both the 5-exo and 6-endo cyclisation was 
calculated. The cyclisation of tetrasubstituted 2-bromobenzyl enamides was then 
xi 
 
attempted, however it proved less successful. The hindered nature of the 
tetrasubstituted enamides was found to slow the rate of cyclisation significantly 
leading to the formation of other products. 
Chapter 5 describes studies into the synthesis of oxindoles via radical cyclisation. 
Reactions in methanol with CuBr and TPA at 50 
o
C gave three main products, a 
reduced compound, an eliminated compound and the target oxindole. Reactions 
repeated in toluene at 110 
o
C were much cleaner giving the oxindole product in high 
conversions.  
xii 
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1.0 Introduction 
Radical cyclisation reactions are useful processes in organic synthesis as they allow 
for the formation of a variety of carbo- and heterocyclic ring systems.
1–5
 They can 
offer high functional group tolerance and mild reaction conditions along with high 
levels of regio- and stereocontrol. In general, a radical cyclisation proceeds via three 
basic steps; generation of the radical , cyclisation of the radical, and then conversion 
of the cyclised radical to the product  (Scheme 1.1).  
 
Scheme 1.1: General steps of a radical cyclisation: a) - Generation of radical, b) - Cyclisation of 
radical, c) – Conversion of cyclised radical to product. 
The radical is predominantly generated from a halide (X),
5,6
 but can be derived from 
a range of different functionalities in the cyclisation precursor, such as thio- and 
selenoethers,
7
 aldehydes and ketones,
8
 and xanthates.
9
 The cyclisation step occurs 
via  the intramolecular addition of a radical to a multiple bond, most commonly a 
carbon-carbon multiple bond, however cyclisations onto carbon-oxygen
10,11
 and 
carbon-nitrogen
12,13
 bonds are known. The radical formed in the cyclisation step can 
be quenched in a number of ways, depending on the reaction conditions; it can be 
trapped by a radical scavenger, undergo a fragmentation reaction, or be converted in 
an electron transfer reaction to a cation or anion.  
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1.1 Traditional Organnostannane Mediated Radical Cyclisations 
Traditionally radical cyclisations were mediated by organostannane or organosilane 
reagents (e.g. Bu3SnH
1,14
 and (SiMe3)3SiH
15
) in the presence of radical initiators 
(e.g. AIBN) and for many years these were the only conditions used.  
 
Scheme 1.2: Bu3SnH mediated radical cyclisation. 
The cleavage of the relatively weak Sn-H and Si-H bonds with an initiator generates 
the corresponding tin and silicon centred radicals which abstract the halogen (X)  
from the σ carbon-halogen bond in the precursor 1 to form radical 2. Cyclisation of 
radical 2 onto a radical sink, such as an alkene, forms a third radical 3 which then is 
propagated by abstraction of a hydrogen atom from the organostannane or 
organosilane.  This furnishes the reduced product 4 and regenerates another reactive 
tin or silicon centered radical (the chain carrier) to continue the radical chain reaction 
(Scheme 1.2).  
These conditions have been employed in the cyclisation of a variety of substrates to 
give a range of cyclised products such as lactams,
16
 lactones,
17
 carbocycles,
18
 
indoles
19
 and oxindoles.
20
 Ishibashi has applied these conditions to the cyclisation of 
α-chloroacetamides and α,α-dichloroacetamides and found that the 
dichlorosubstrates underwent cyclisation much more readily.
21
 The cyclisation was 
then applied in the stereoselective synthesis of the natural products (±)-mesembranol 
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7 and (±)-elwesine.
16
 Cyclisation of enamide 5 led to the cyclised product 6 in 51% 
yield, which was then converted into the natural product 7 after two further steps, 
(Scheme 1.3). 
 
Scheme 1.3: Bu3SnH mediated cyclisation in the synthesis of (±)-mesembranol. Reagents and 
Conditions: a) Bu3SnH (2.1 eq.), AIBN (cat.), toluene, reflux, 4h. 
Ishibashi has used also Bu3SnH to carry out the traditionally ‘disfavoured’
22
 5-endo-
trig cyclisation  of N-vinylic α-chloroacetamides to give 5-membered lactams.23 
Treatment of enamide 8 with Bu3SnH in the presence of AIBN led to the 5-endo 
cyclisation product 10 in 63% yield along with the reduced non-cyclised compound 
11 as a minor product (Scheme 1.4). 
 
Scheme 1.4: Tin mediated cyclisation of N-vinylic α-chloroacetamides: Reagents and conditions: 
Bu3SnH (1.1 eq.), AIBN (cat.) toluene, reflux. 
The type and level of substitution on the radical centre can affect the regiochemical 
outcome of the cyclisation and under certain conditions the 4-exo cyclisation is 
favoured. The difference in the reaction pathways of enamides 11a-c can be 
explained in terms of electronic stability of the initial radicals and/or steric clashes in 
the cyclised radical intermediates 15 and 16 (Figure 1.1, Table 1). The authors 
suggest that enamide 11a proceeds via the more electronically stable benzyl radical 
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intermediate 15 to give exclusively the 4-exo product 12a. However when a larger R 
group is introduced (11b R=Me) steric clashing occurs between this R group and the 
neighbouring gem-dialkyl groups in 15, destabilising the radical and as a result both 
pathways are followed. Increasing the size of the R group even further (11c R=Ph) 
results in severe steric clashing in the benzyl radical 15, therefore the α-acylamino 
radical dominates leading to the 5-endo product 13c as the major product. Another 
possible explanation is that for 11b-c the 4-exo trig cyclisation has a greater degree 
of reversibility due to the methyl/phenyl group at the radical centre stabilising the 
initial radical, hence giving rise to greater percentages of the thermodynamic 
products 13b-c. 
 
Entry R-Group 4-exo / % 5-endo  / % Reduced / % 
1 H (11a) 50 0 32 
2 Me (11b) 42 35 19 
3 Ph (11c) 0 76 0 
Table 1.1: Ratios of 5-endo  and 4-exo products in cyclisation of enamides. Reagents and 
Conditions: Bu3SnH (1.1 eq.), AIBN (cat.) toluene, reflux. 
 
Figure 1.1: Radical intermediates in the cyclisation of enamides 11a-c. 
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1.1.1 Drawbacks of Organostannane Mediated Cyclisations 
Whilst these reductive conditions have proven successful in many applications 
including the synthesis of a number of natural products
24–27
 there are certain 
disadvantages that limit the usefulness of the process. The reductive nature of the 
reaction is a major drawback, the termination of the cyclised radical with a hydrogen 
atom results in the loss of two functional groups in the transformation of the starting 
material into the product. Organostannane reagents and their by-products are also 
particularly toxic and can be difficult to remove from the final product.
28
 This causes 
particular concern for the pharmaceutical industry, where acceptable levels of tin 
compounds in final products are very low, and it is generally very hard to achieve 
these low levels during purification.
29
 Other disadvantages of these procedures are 
the need for stoichiometric amounts of organostannane reagent and the relatively 
high cost of these reagents, issues which are magnified on a large scale making the 
process unattractive for industry. 
 
1.1.2 Overcoming the Issues in Organostannane Mediated Reactions. 
There have been attempts at overcoming these issues and Studer
30
 and Baguley
31
 
have both written reviews covering developments in the area. As well as modified 
work-up and purification procedures,
32–34
 a range of alternative tin hydrides have 
been developed to aid with the removal of any tin containing by-products from the 
reaction mixture. In particular solid-supported,
28,35–37
 PEG-bound,
38
 water soluble,
39
 
acid extractable
40
 and perfluorous tin hydrides
41
 have all shown significantly to 
improve the removal of any tin residues from reactions mixtures. 
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In 1979 Berge and Roberts reported that partitioning the concentrated reaction 
mixture between acetonitrile and pentane, followed by concentration of the 
acetonitrile extract could result in significantly reduced levels of tin compounds in 
the product.
32
 Another method developed by Jacobus involves conversion of the 
organotin residue into the insoluble organotin fluoride by washing the reaction 
mixture with aqueous potassium fluoride. The organotin fluoride can then be 
removed by filtration and the organic phase dried and concentrated to yield the 
product.
42
 More recently Harrowven has modified the method of Jacobus and 
Leibner, and has developed the use of a KF-silica stationary phase for column 
chromatography as a means of removing tin residues.
34
 Using the 
hydrodehalogenation of an aryl halide with tributyltin hydride as a reagent he has 
shown that simply concentrating the reaction mixture and eluting it through a 
stationary phase comprising of 10% w/w of KF and 90% w/w silica resulted in levels 
of tin below 30 parts per million. Solid supported tin reagents have also been 
developed to facilitate the removal of tin at the end of the reaction.
43–45
 
In the early 90’s Curran looked at addressing the issues relating to the reductive 
nature of tin reagents, and the need for stoichiometric amounts in reactions. By 
replacing Bu3SnH, with hexabutylditin, the possibility of reductive termination was 
removed and instead the reaction was found to be terminated by transfer of an iodine 
atom (an atom transfer radical cyclisation process, ATRC), either from the substrate 
17 or a Bu3SnI by-product (Scheme 1.5). This also allowed the loadings of tin 
reagent to be lowered sub-stoichiometric levels of 10 mol%.
17
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Scheme 1.5: A non-reductive, non-stoichiometric tin cyclisation. Reagents and conditions: 10 
mol% Bu3SnSnBu3, benzene, hν. 
The retention of functionality and the catalytic conditions achieved by Curran, along 
with the developments in purification techniques discussed earlier represent 
significant improvements in the area, however the toxicity and high cost of organotin 
reagents still remain major drawbacks. In order to address these issues research has 
focussed on the use of other metals such as copper,
5
 nickel
46,47
 and ruthenium
48–50
 to 
mediate the reaction and has led to the development of atom transfer radical 
cyclisations. 
 
1.2 Atom Transfer Radical Cyclisation 
In 1964 Murai et al showed that CuCl could catalyse the intermolecular addition of 
ethyltrichloroacetate across a double bond
51
 (Scheme 1.6a). In 1983 Nagashima et al  
then applied similar conditions to achieve the intramolecular addition, resulting in a 
copper mediated 5-exo-trig cyclisation of 22 (Scheme 1.6b).
52
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Scheme 1.6: Inter- and intramolecular addition of trichloroacetates across a double bond. 
Reagents and conditions: a) CuCl, EtOH, reflux, b) 30 mol% CuCl, MeCN, 140 
o
C. 
Nagashima proposed that the reaction proceeded via a catalytic redox mechanism 
where CuCl reacts with the substrate 22 to form the initial tertiary radical 24 and 
CuCl2. This radical can then cyclise into the double bond to form the more reactive 
primary radical 25 which then interacts with the CuCl2 generated in the first step to 
furnish the functionalised lactone 23 and regenerates the CuCl catalyst (Scheme 1.7).  
 
Scheme 1.7: Proposed catalytic redox mechanism.  
This CuCl mediated cyclisation has numerous advantages over the traditional tin 
mediated reaction. The redox mechanism allows for the product to be terminated by 
a halogen, hence retaining a degree of functionality in the product for further 
chemistry. The CuCl reagent is significantly cheaper, less toxic, easier to handle, and 
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easier to remove than the organotin reagents used in the traditional radical 
cyclisations. In addition to this, the reaction was also shown to proceed with sub-
stoichiometric amounts of CuCl making the reaction more industrially viable. As a 
result of this initial development a large amount of research into copper mediated 
atom transfer radical cyclisations (ATRC) has focussed upon extending the scope of 
the reaction to form γ-lactams and other ring sizes as well as γ-lactones.  The effect 
of solvent, temperature and ligands for copper have been examined in order to 
improve the efficiency of the reactions. The work up until early 2002 has been 
summarised in a comprehensive review by Clark.
5
 
 
1.2.1 Development of conditions for ATRC 
Nagashima was able to apply the conditions used in the synthesis of the γ-lactones to 
the synthesis of γ-lactams. There was no evidence of products arising from 6-endo 
cyclisation which might be expected in these reactions, with only the 5-exo product 
being observed. However high reaction temperatures and in some cases long reaction 
times were required in order to achieve synthetically useful yields, (Scheme 1.8).
53,54
 
 
Scheme 1.8: Nagashima’s ATRC to produce γ-lactams. Reagents and conditions: 30 mol% CuCl, 
MeCN, 140 
o
C. 
Cyclisation of both secondary and tertiary amides was possible, although cyclisation 
of the tertiary amide was more efficient (26b → 27b). The greater efficiency for the 
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cyclisation of the tertiary amide 26b can be explained by conformational analysis of 
the precursor. The amide bond characteristically has a high barrier to rotation, in the 
region of 16-22 kcal/mol,
55
 which leads to two possible conformations of the amide 
precursor, the anti conformer and the syn conformer, (Scheme 1.9). Only one of 
these comformers, the anti, is predisposed for cyclisation to occur, with the radical 
and the unsaturated carbon of the radical sink positioned so that orbital overlap is 
possible. The N-protecting group can affect the populations of these two conformers; 
when unprotected (R=H), the least sterically hindered syn conformer is preferred, 
however bulky or electron withdrawing groups can push the equilibrium towards the 
anti conformer and therefore favour cyclisation.
56
  
 
Scheme 1.9: Two conformers of amides arising from amide bond rotation. 
The existence of two conformers may also explain why high temperatures and long 
reaction times are sometimes needed.  In these cases high temperatures are required 
to ensure an appropriate concentration of the anti conformer is populated. The 
importance of the N-CO bond rotation and the population of the two conformers has 
also been noted by Curran in the cyclisation of N-allyl α-polyamides,17 and by Stork 
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and Ishibashi in the tin mediated cyclisation of N-allyl haloamides.
16,21,57
 Newcomb 
also reported supporting evidence for this using laser flash photolysis kinetic studies 
of N-CO bond rotation.
58
 
Nagashima used the same approach to synthesise bicyclic lactams, providing access 
to pyrrolidine alkaloid skeletons. Cyclisations of the precursor 29 at 110 
o
C in the 
presence of 30 mol% CuCl in acetonitrile led to the product 30, as a single 
diastereomer with a cis ring junction, in 91% yield (Scheme 1.10).
54
 
 
Scheme 1.10: CuCl mediated cyclisation to form a bicyclic ring system. Reagents and conditions: 
30 mol% CuCl, MeCN, 110 
o
C, 1 h. 
In order to try and lower reaction temperatures and improve the efficiency of the 
reaction different copper salts were screened and Cu2O, Cu(NO3)2.5H2O and 
Cu(CCPh) all were effective in mediating the cyclisation of the trichloroacetate 22, 
although CuCl still remained the most effective.
59
 Different solvents were also 
screened in the reaction of 22, however only MeCN and alcohols proved to be 
effective in mediating this cyclisation, and alcohols only gave low yields. The 
concentration of the reaction was also found to be crucial, with dilute conditions (4-8 
mL per 1 mmol of substrate) required for the efficient cyclisation; higher 
concentrations resulted in a decreasing yield due to intermolecular polymerisation.
59
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1.2.1.1 The effect of ligands on ATRC 
The use of copper ligands has been investigated and has proven to accelerate the rate 
of reactions and allow the cyclisation of less reactive substrates. The addition of 
2,2’-bipyridine (bipy) in a 1:1 ratio with CuCl to the reaction of 22 was found to 
accelerate the rate of reaction fourfold.
59
 The Cu(bipy)Cl system was most active in 
DCM, however other solvents such as DCE and THF were also successful.
60
 The 
more active catalyst system now allowed for cyclisations to be carried out at room 
temperature, with much shorter reaction times in comparison to the CuCl/MeCN 
system (Table 1.2).  
 
R group Conditions Temp  Time / h Yield / % 
Bn (26c) 30 mol % CuCl / MeCN 80
 o
C 18 68 
Bn (26c) 30 mol % Cu(bipy)Cl / DCM r.t. 1 98 
Ts (26d) 30 mol % CuCl / MeCN r.t. 24 97 
Ts (26d) 5 mol % Cu(bipy)Cl / DCM r.t. 0.2 91 
Boc (26e) 30 mol % CuCl / MeCN 80 
o
C 4 80 
Boc (26e) 30 mol % Cu(bipy)Cl / DCM r.t. 2 78 
Table 1.2: The effect of bipy on copper catalysed ATRC. 
Quayle has applied the Cu(bipy)Cl catalyst system to the target-orientated synthesis 
of γ-butyrolactones such as 31.61 This group of compounds have been shown to be 
useful intermediates in the synthesis of lignans such as lactol 32 (Figure 1.2).  
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Figure 1.2: Structures from Quayle’s target orientated synthesis. 
The cyclisation of 33 with CuCl and bipy proceeds to give the γ-butyrolactam 35 in 
89% yield with high levels of diastereoselectivity (dr > 95:5) in favour of the threo-
isomer.
61
 The stereochemical result may be rationalised in terms of an ‘allylic strain 
model’ shown below (Scheme 1.11). Cyclisation initially generates the planar 
benzylic radical 34 which adopts a conformation where the bulky aromatic group 
takes up an ‘outside’ orientation with respect to the lactone ring, minimising 
unfavourable steric interactions. Halogen abstraction from the Cu
II 
complex 
genereated in the first step then proceeds anti- to the bulky geminal 
dichloromethylene group, leading to the high level of stereoselectivity. 
 
Scheme 1.11: Stereo-control in Cu(bipy)Cl mediated cyclisation of 33. Reagents and Conditions: 
CuCl 5 mol%, bipy 5 mol%, DCE, 80 
o
C. 
In contrast, when ester 36 (3 mmol) was treated with Cu(bipy)Cl in DCE at reflux 
for 3.5 h the reaction was almost stereo-random, resulting in lactones 37T  and 37E in 
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a 3:2 ratio and 90% isolated yield (Scheme 1.12).
61
 On scaling up the reaction (46 
mmol) the thero-isomer 37T was the major product, suggesting that it is the initial 
product and that in the earlier experiments equilibration had occurred following 
cyclisation. This was confirmed when either isomer 37T or 37E were subjected 
separately to mild thermolysis in DCE at 80 ˚C  giving rise to a 3:2 equilibrium 
mixture of 37T  and 37E. The two isomers 37T  and 37E were then used in the 
synthesis of lactol 32. 
 
Scheme 1.12: Cu(bipy)Cl mediated cyclisation in the synthesis of lactol 32. Reagents and 
Conditions:  a) CuCl 5 mol%, bipy 5 mol%, DCE, 80 
o
C. 
Ghelfi used the Cu(bipy)Cl catalyst system in the synthesis of optically active 
Quercus lactones e.g. whisky lactone 41.
62
 These lactones are fragrant compounds 
found in different types of wood and responsible for the sensory characteristics of 
many alcoholic beverages.
63
 Ester 39 was synthesised from enantiomerically pure 
alcohol 38, and then treated with Cu(bipy)Cl to give the cyclised lactones trans-40 
and cis-40, which were dehalogenated to give the target compounds trans-41 and 
cis-41 with the trans isomer as the major product (Scheme 1.13).
62
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Scheme 1.13: ATRC in the synthesis of Quercus lactones. Reagents and Conditions: a) 
Cl2CHCOCl, DMAP, DCM, r.t., 2 h. b) Cu(bipy)Cl, 145 
o
C, MeCN. c) Bu3SnH, AIBN, 80 
o
C, 
toluene. 
Following the discovery of bipy as a ligand to accelerate ATRC reactions, a number 
of other nitrogen containing ligands were investigated and shown to improve the 
efficiency of the copper mediated reactions further. It is thought that ligands either 
help to solubilise the CuCl, alter the redox potential of the catalyst system, or both.
5
  
Pyridine imine ligands (NMPI’s) (Figure 1.3) are easily prepared by the reaction of 
commercially available amines with pyridine carboxaldehydes in the presence of 
MgSO4, and as a result a wide range of catalysts with different solubilities and steric 
and electronic properties have been synthesised.
64,65
  
 
Figure 1.3 General structure for NMPI ligands. 
Chapter 1: Introduction 
 
16 
 
It was found that bulky N-alkyl substituents (R) retarded the rate of cyclisation, 
whereas 42a (R= n-pentyl) with the less bulky substituent proved to be active 
enough to catalyse the cyclisation of mono-halosubstrates such as 43 at room 
temperature.  
 
Scheme 1.14: Cyclisation of mono-holosubstrate with NMPI ligand. Reagents and conditions: 30 
mol% CuBr, 30mol % 42a, DCM, r.t., 24 h.  
A range of electronically modified ligands, changing X in structure 42, were also 
screened and it was found that an electron withdrawing group (X= NO2) caused a 
decrease in the rate of cyclisation, whereas a mildly inductive electron donating 
group (X= Me) showed a slight increase in the rate of cyclisation.
65
 
Another bidentate ligand that was shown to be useful in catalysing cyclisation 
reactions is N,N,N’,N’-tetramethylethylenediamine (TMEDA) 46 which proved to 
give a more reactive catalyst system (Cu(TMEDA)2Cl) than either the bipy or NMPI 
ligands, improving yields as well as allowing for lower catalyst loadings in the 
reactions to give -lactams (e.g. 47).66 TMEDA also has the advantage of being 
commercially available and relatively inexpensive compared to the bipy ligand 
(TMEDA - 100 mL for £15.30, bipy - 100 g for £85.20, Sigma Aldrich, 25/07/13). 
The TMEDA complex was found to mediate the cyclisation of 45 to 47 as a single 
diastereomer in an 88% yield (Scheme 1.15), whereas the CuCl-bipy system failed to 
achieve any cyclisation product.
66
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Scheme 1.15: Cu(TMEDA)2Cl mediated cyclisation. Reagents and conditions: 10 mol% CuCl, 10 
mol% TMEDA, MeCN, 60 
o
C, 20 h. 
Ghelfi and Parsons investigated what effect the nitrogen protecting group had on the 
Cu(TMEDA)Cl mediated cyclisations.
67
  Benzyl protecting groups proved to be the 
most effective with yields of 99%, however bulkier naphthyl or benzhydril 
protecting groups resulted in lower yields (Table 1.3, entry 1-6). The N-
dimethylamino group has also been used giving the desired product in 91% yield 
(Table 1.3, entry 7) with an excellent yield being achieved when EtOAc was used as 
an alternative solvent (Table 1.3, entry 8).
68
 This protecting group has the advantage 
over the benzyl group of being easier to remove due to the weaker N-N bond 
compared to the N-C bond. 
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Entry R group Solvent Temp / 
o
C Conversion / % Yield / % 
1 (48a) 
 
MeCN 25 
 
 100 99 
2 (48a) MeCN 60 100 99 
3 (48b) 
 
MeCN 25 31 24 
4 (48b) MeCN 60 68 58 
5 (48c) 
 
MeCN 25 83 74 
6 (48c) MeCN 60 94 78 
7 (48d) 
 
MeCN 60 94 91 
8 (48d) EtOAc 60 99 97 
Table 1.3: The effect of the N-protecting group on Cu(TMEDA)Cl mediated cyclisation. 
Reagents and Conditions: CuCl 10 mol%, TMEDA 20 mol%, 20h. 
Ghelfi also showed the cyclisation to be successful with a range of substitution on 
the allylic group (Table 1.4). In general the reaction proceeded with excellent yields, 
the poor yield upon cyclisation of 48g was attributed to the poor stability of 49g 
under the reaction conditions. The C-4 substituent was found to have similar steric 
interactions with the Me and the Cl at the C-3 position, resulting in limited 
preference for the cis or trans product. It was also found that a C-5 substituent forces 
the C-4 substituent onto the opposite face of the ring (Table 1.4, entries 6 and 7). 
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Entry R
1
 R
2
 R
3
 R
4
 Conversion / 
% 
Yield / 
% 
Cis:Trans 
1 (48a) H H H H 100 99 66:34 
2 (48e) H H Me Me 100 99 50:50 
3 (48f) H Me H H 100 99 31:69 
4 (48g) H Cl H H 22 0 N/A 
5 (48h) H H H Cl 100 100 80:20 
6 (48i) Me H H H 100 98 1:7:22:70
a
 
7 (48j) Ph H H H 100 98 2:5:26:67
a
 
 
Table 1.4: Varying the allylic substitution in Cu(TMEDA)Cl mediated cyclisations. Reagents and 
Conditions: CuCl 10 mol%, TMEDA 20 mol%, 60 
o
C, MeCN, 20h. 
a
Ratio % t-4, t -5:c-4, c -5: t-4, c -
5: c-4, t -5 taking r-3-Cl. 
Both the NMPI and TMEDA systems were found to have an optimum ratio of ligand 
to copper of 2:1,
64,66
 suggesting two bidentate ligands molecules were required to 
form the active catalyst complex. As a result alternative polydentate ligands such 
tridentate N,N,N’,N’,N’’-pentamethyldiethylenetriamine (PMDETA) 50,69 and 
tetradentate N,N,N’,N’,N’’,N’’-hexamethyltriethylenetetramine (Me6-Tren) 51,
70–72
 
and tripyridylamine (TPA) 52,
73–75
 ligands have been explored. All form active 
complexes with a 1:1 copper/ligand ratio. 
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Figure 1.4: Multi-dentate ligands. 
Ghelfi used PMDETA to carry out the Ueno-Stork ATRC of dichlorohemiacetal 
acetate 53 in a one pot, multi-step reaction. The cyclic product 54 was subsequently 
oxidised to the lactone product 55.
69
 
 
Scheme 1.16: Cu(PMDETA)Cl mediated Ueno-Stork cyclisation. Reagents and conditions: a) 10 
mol% Cu(PMDETA)Cl, MeCN, 80 
o
C, 18 h. b) i) H2SO4/H2O, 80 
o
C, 6-24 h, ii) K2Cr2O7, H2SO4, 
acetone/H2O, 25 
o
C, 2-4 h. 
The tetradenate ligand Me6-Tren when used as a 1:1 ratio with copper halide was 
found to be a far more active complex than either bipy or TMEDA in the cyclisation 
of 56. When dichloro- compound 56 was treated with 30 mol% Cu(Me6-Tren)Cl at 
room temperature the cyclised product 47 was obtained in a 90% yield after 2 h, 
whereas when NMPI ligand 42a was used the best conversion obtained was 15 % in 
72 h (Scheme 1.17A).
72
 The more active nature of the Cu(Me6-Tren)Cl complex 
allowed catalyst loadings to be lowered to 5 mol% and the cyclisation was still 
complete within 24 h.
76
 Cyclisation of a number of monohalo-substrates was also 
possible using the Cu(Me6-Tren)Cl catalyst system at room temperature (Scheme 
1.17B).
76
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Scheme 1.17: Cu(Me6-Tren)CL mediated cyclisations. Reagents and Conditions: a) 30 mol% 
Cu(Me6-Tren)Cl, DCM (0.12M), r.t., 2h, b) 30 mol% Cu(Me6-Tren)Cl, DCM (0.12M), r.t. 
TPA has also been shown to form a significantly more active catalyst system than 
the bidentate ligands. As with the Me6-Tren ligand it effectively catalyses the 
cyclisation of  the relatively deactivated monohalo-substrates (Scheme 1.18).
73
 
 
Scheme 1.18: Cu(TPA)Br mediated cyclisation of monobromoacetamide. Reagents and 
conditions: 30 mol% Cu(TPA)Cl, DCM, r.t., 2h. 
 
1.2.1.2 The use of additives in ATRC 
Even with these more activated catalysts, in order to achieve high yields in short 
reaction times high catalyst loadings are still often required, particularly with the less 
activated substrates. Clark investigated the addition of additives to the reaction to 
reduce any build-up of inactive CuBr2 back to active CuBr. AIBN was chosen as a 
potential additive as the by-products should be volatile and therefore facilitate the 
work-up. It has also been used in combination with Cu(TPA)Br with promising 
results in intermolecular atom transfer radical addition reactions.
77
 It was found that 
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the addition of 10 mol% of AIBN allowed loadings of Cu(TPA)Br to be lowered to 1 
mol%, with the cyclisation of 60 proceeding with 100% conversion, and 84% yield 
at room temperature.
73
 
 
Scheme 1.19: Cu(TPA)Br mediated reaction with AIBN as an additive. Reagents and conditions: 
1 mol% Cu(TPA)Br, 10 mol% AIBN, DCM, r.t. 
When the reaction was trialled with only AIBN and no Cu(TPA)Br, no cyclisation 
occurred at all showing that the AIBN was not initiating the reaction itself. The 
reaction was also carried out with CuBr2 as opposed to CuBr and the reaction 
proceeded with 97% yield showing that under these conditions either CuBr or CuBr2 
can be used.
73
 This is an example of the ‘initiators for continuous activator 
regeneration’ (ICAR) protocol for regenerating the active catalyst species from the 
deactivated species.
78
 
Another common technique employed  in atom transfer radical polymerisation 
(ATRP) and atom transfer radical addition (ATRA) is the ‘activators regenerated by 
electron transfer’  (ARGET) process.78,79 Ghelfi has applied this approach to ATRC, 
exploiting the reducing nature of ascorbic acid to lower catalyst loading levels to 2-4 
mol%.
80
 It was found that Na2CO3 also had to be added in order to quench the HCl 
produced in the catalyst regeneration step. Thus, cyclisation of 48 reached 100% 
conversion in two hours at room temperature when treated with 4 mol% 
Cu(PMDETA)Cl, 5 mol% ascorbic acid and 5.5 mol% Na2CO3 (Scheme 1.20), 
whereas when a standard redox catalyst was employed in MeCN the reaction took 20 
h to reach completion.
66
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Scheme 1.20: ARGET-ATRC. Reagents and conditions: 4 mol% Cu(PMDETA)Cl, 5 mol% 
ascorbic acid, 5.5 mol% Na2CO3, EtOH, r.t., 2h. 
The reaction also had the advantage that it worked in ethanol, a safe solvent, 
obtainable from renewable sources, and that only small amounts of solvent were 
required (2 mmol of substrate/mL ethanol). The reaction was also tested using 
TMEDA as the ligand however this resulted in only 53% conversion, indicating that 
the choice of ligand was important.
80
  
Whilst the ARGET-ATRC conditions of Ghelfi were shown to be effective for the 
cyclisation of both dichloro- and trichloroacetamides, they were not applied to the 
cyclisation of monohalo-substrates. Clark however, screened a number of reagents 
common in ARGET-ATRP reactions to find conditions to carry out the cyclisation 
of the monobromo-substrate 60.
81
 The reaction was trialled with phenols,
82
 ascorbic 
acid,
80,83
 glucose,
84
 hydrazine,
78
 as well as the common reductant NaBH4, and these 
reagents were compared to the ICAR reagent AIBN. 
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Entry Additive Solvent Conversion Yield 
1 C6H5OH MeOH 10 
a 
2 C6H5OH DCM 91 83 
3 Ascorbic acid MeOH 55 9 
4 Ascorbic acid DCM 19 18 
5 
6 
7 
AIBN 
AIBN 
NH2NH2 
MeOH 
DCM 
MeOH 
50 
100 
10 
43 
84 
11 
8 
9 
10 
11 
12 
13 
Glucose 
NaBH4 
NaBH4
c 
KBH4
c 
KBH4 
KBH4
d 
MeOH 
MeOH 
MeOH 
MeOH 
THF 
MeOH 
23 
100 
67 
100 
0 
0 
17 
82
b 
52 
74 
0 
0 
Table 1.5: ARGET reagents for cyclisation of monobromosubsrtate 60. Regents and Conditions: 
1 mol% Cu(TPA)Br, 10 mol% additive, 50 
o
C, 5h, 0.12M. 
a
 Not measured as conversion too low. 
b
 
Reaction time 10 mins at r.t.
 c
 5 mol% of additive used. 
d
 No Cu(TPA)Br added. 
Of the common ARGET reagents screened in methanol only ascorbic acid proved to 
be more effective than the ICAR reagent AIBN (Table 1.5, entries 3 and 5) and in 
DCM only phenol gave comparative results (Table 1.5, entries 2 and 6). However 
NaBH4 proved to be very effective giving 100% conversion in 10 mins at room 
temperature (Table 1.5, entry 9). This result led to further borohydride reducing 
agents being screened, of which KBH4 was the most effective, with loadings of 5 
mol% of borohydride still giving 100% conversion (Table 1.5, entry 11). The solvent 
choice proved to be important, with no reaction observed in anhydrous THF (Table 
1.5, entry 12). Hydride sources have been shown to mediate 5-exo trig cyclisations 
of aryl halides in the presence of an initiator,
85,86
 so a control reaction was carried out 
with the addition of no Cu(TPA)Br to see if the borohydride was mediating the 
cyclisation itself, however no reaction was observed (Table 1.5, entry 13). 
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It is known that Cu(TPA)Br disproportionates to give Cu
0
 metal and 
[Cu
II
(TPA)Br][Br] in polar solvents such as MeOH and DMSO,
87
 and therefore 
Clark investigated the use of Cu
II
 salts as precatalysts for the reaction following an 
‘activators generated by electron transfer’ or AGET method.81 This approach uses 
the [Cu
II
(L)X]X species and a reductant at the start of the reaction, rather than the 
oxidatively less stable Cu
I
(L)X species.
88
 
 
Entry Cu Source (mol%) KBH4 mol% Conversion Yield 
1 CuBr (1) 10 100 68 
2 CuBr (0.1) 5 23 18 
3 CuBr2 (1) 10 100 84 
4 CuBr2 (0.1) 5 0 0 
5 
6 
7 
Cu(OTf)2 (0.1) 
CuSO4.5H2O (0.1) 
Cu(acac)2 (0.1) 
5 
5 
5 
100 
100 
100 
85 
97 
83 
8 
9 
Cu(ClO4)2.6H2O(0.1) 
CuSO4.5H2O (0.05) 
5 
2.5 
100 
40 
85 
35 
Table 1.6: AGET cyclisation of monobromosubsrtate 60. Regents and Conditions: Copper source, 
KBH4, r.t., 10 min, MeOH, 0.12M. 
Four Cu
II
 salts, Cu(OTf)2, CuSO4.5H2O, Cu(acac)2 and Cu(ClO4)2.6H2O were all 
found to be superior to CuBr and CuBr2, with loadings as low as 0.1 mol% of Cu and 
5 mol% of KBH4 giving 100% conversion within 10 mins (Table 1.6). It was 
possible to drop the loadings even lower to 0.05 mol% Cu and 2.5 mol% KBH4 and 
still obtain reasonable activity (Table 1.6, entry 9).
81
 CuSO4.5H2O was chosen as the 
ideal copper source due to its low cost (£36.50 for 500 g, Sigma Aldrich, 25/07/13). 
These reactions did not require anhydrous salts and it was not necessary to exclude 
moisture from the reactions. 
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1.2.1.3 The use of copper-carbene complexes in ATRC 
Stable Cu
I
-NHC complexes have been shown to act as catalysts in hydrosilylation,
89
 
C-H activation
90
 and Huisgen dipolar cycloaddition (‘click’) reactions91 and Quayle 
has investigated their use in ATRC reactions.
92
 Exposure of ester 63 and amides 26b 
and 65 to ligand 62 in both toluene and DCE resulted in the desired cyclised 
products 64, 27b and 66 in low yields, <5%, 22% and 38% respectively. However 
when the reactions were carried out in a microwave reactor the yields were much 
improved (Scheme 1.21).
92
 Irradiation in DCE at 110 
o
C proved to be the optimal 
conditions for these reactions, with lower temperatures resulting in slower reactions, 
whilst higher temperatures led to reduced yields. It was possible to lower catalyst 
loadings to 1 mol% without greatly affecting the yield, although longer reactions 
times were required; cyclisation of 65 with only 1 mol% of catalyst led to the 
product 66 in a 63% yield after 17 h compared to 82% in 3 h with 5 mol% of 
catalyst.
92
 Examination of the crude NMR from the reaction of amide 26b showed 
that the carbene complex 62 was still present and had not undergone significant 
decomposition during the reaction suggesting that recycling of the catalyst is a 
possibility.
92
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Scheme 1.21: Carbene mediated ATRC. Reagents and conditions: 5 mol% 62, DCE, μW, 110 oC, 3 
h. 
a
 1 mol% 62, 17 h. 
1.2.1.3 The use of solid supported copper catalysts. 
A range of solid supported copper catalysts have also been developed
93–95
 allowing 
easy separation of the catalyst from the cyclised product and re-use of the catalyst. 
Clark immobilized amine and pyridine based ligands on silica, polystyrene and 
JandaJel, which then formed the active catalyst complex when stirred with the 
relevant copper salt under an inert atmosphere.
93,94
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Figure 1.5: Solid supported ligands for ATRC. 
Cyclisations of both activated trichloroacetamides such as 26d and relatively 
deactivated monobromoacetamide 43 are both successful with the heterogeneous 
catalysts although they were found to be slower than the homogenous equivalents.
94
 
The trichloro- compounds undergo facile cyclisation at room temperature within 1 
hour, whereas the less activated monobromo- compounds require higher 
temperatures (80 
o
C) and longer reactions times (24 h) (Scheme 1.22).  
 
Scheme 1.22: Solid-supported ATRC. Reagents and Conditions: a) 30 mol% ligand, 30 mol% 
CuCl, DCE, r.t. b) 30 mol% ligand, 30 mol% CuBr, DCE. 
Nagashima has investigated the use of a Cu(bipy)Cl complex immobilised in a 
polysiloxane gel ([Cu/bipy]@Si) as a reusable catalyst system in ATRC reactions. 
The gel proved to be more stable than the standard Cu(bipy)Cl complex in solution 
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and can be stored under nitrogen for over a month and handled under aerobic 
conditions. Again, cyclisations of both trichloro- and monobromoacetamides were 
successful giving quantitative yields. Upon recycling of the catalyst the same yield 
was obtainable, although longer reaction times were required (Scheme 1.23).
95
  
 
Scheme 1.23: Polysiloxane Gel Encapsulated Cu(bipy)X mediated ATRC. Reagents and 
Conditions: a) [Cu/bipy]@Si 0.45 mol%, DCM, r.t., 4 h. b) [Cu/bipy]@Si 0.45 mol%, DCM, r.t., 16 
h. 
In summary, these copper mediated 5-exo trig ATRC reactions have undergone 
significant improvements since their first discovery in 1983 and now exhibit a 
substantial range of advantages over the traditional tin mediated cyclisations. It is 
now possible to carry out cyclisations on relatively unactivated monohalosubstrates 
(e.g. 60) with low catalyst loadings (e.g. 0.05 mol%), achieving high yields at low 
temperatures (RT) in short reactions times (<20 mins). The reactions can also be 
mediated by relatively non-toxic and cheap reagents in green solvents such as 
ethanol, and generally just require filtering through a silica plug to remove the 
copper residues to work-up the reactions. It is possible to recycle the catalysts if 
solid supported variants are used.
93–95
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1.2.2 Synthesis of other ring sizes by ATRC 
ATRC has also been applied to the synthesis of larger ring sizes. Clark and Verhlac 
have  shown that copper mediated ATRC can be used to synthesise δ-lactams via 6-
exo trig cyclisations.
76
 The cyclisation of 75a (R = Bn) was carried out at both 25 
o
C 
and 80 
o
C with three different ligands; bipy, PMDETA and TPA. All three ligands 
were found to be effective and gave similar results, with only the exo product being 
observed in all cases. Although reasonable yields were achieved at 25 
o
C (Table 1.7 
entries 1-3), significantly better results were achieved upon heating the reaction to 80 
o
C with higher yields in much shorter reaction times (Table 1.7 entries 4-5). It was 
also found that when a bulky t-butyl N-protecting group (75b) was used the reaction 
was not impeded and still gave high yields in reasonable reaction times (Table 1.7 
entries 6-8). 
 
Entry R Group Ligand Time / h Temp / 
o
C Yield 
1 Bn (75a) Bipy 72 25 60 
2 Bn (75a) PMDETA 72 25 30 
3 Bn (75a) TPA 72 25 40 
4 Bn (75a) PMDETA 2 80 92 
5 
6 
7 
Bn (75a) 
t-Bu (75b) 
t-Bu (75b) 
TPA 
Bipy 
PMDETA 
2 
18 
18 
80 
80 
80 
90 
99 
98 
8 t-Bu (75b) TPA 18 80 96 
Table 1.7: Synthesis of δ-lactams via 6-exo cyclisation. Regents and Conditions: CuCl 30 mol%, 
ligand (30 mol%), DCE. 
Verlhac has also used ATRC to carry out macrolactonisation of trichloroacetates via 
8-, 9- and 10-endo trig cyclisations.
75,96
 The use of the highly active Cu(TPA)Br 
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complex allowed for the cyclisations of trichloroacetates with 3-10 mol% of catalyst, 
in DCE at reflux giving yields between 53 and 90% (Scheme 1.24).  
 
Scheme 1.24: Macrocyclisation using copper mediated ATRC. Reagents and conditions: 
Cu(TPA)Br 10mol%, DCE, 0.1M, reflux. 
a
3 mol% of Cu(TPA)Br used. 
Investigations into the synthesis of medium-sized benzene ring fused lactones have 
been carried out by both Ram
97
 and Quayle
98
 and both have observed the production 
of a benzannulated product via a lactone intermediate formed in an 8-endo trig 
cyclisation. Ram treated trichloroacetate 79 with 1 equivalent of the Cu(bipy)Cl 
catalyst system resulting in the benzannulated compound 80, however the yields 
were poor and the reaction was complicated by the formation of the biaryl 
compounds 81 and the reduced compounds 82 (Scheme 1.25).
97
  
 
Scheme 1.25: Cu(bipy)Cl mediated benzannulation reaction. Reagents and Conditions: 
Cu(bipy)Cl (1 eq.), benzene, reflux. 
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Quayle has successfully synthesised of a number of benzannulated products using 
copper complexes of ligands 84 and 85.
92,98
 Initially the cyclisation of ester 79 with 5 
mol% Cu(85)Cl in toluene afforded lactone 83 in 95% conversion in 48 h via an 8-
endo trig cyclisation along with the benzannulated 80 as a minor by-product. 
Repeating the reaction for 120 h led to complete consumption of the ester 79 and 
lactone 83 with the benzannulated product 80 as the major product, however after 
column chromatography this was only obtained in a 23% yield. When ester 79 was 
treated with the same catalyst system in DCE under microwave irradiation at 200 
o
C 
the benzannulated product 80 was obtained in a greatly improved 84% yield in a 
much reduced reaction time of only two hours (Scheme 1.26A).
98
 The copper-
carbene complex 84 was also shown to mediate the benzannulation reaction, 
providing similar, if not better, yields (Scheme 1.26B).
92
  
 
Scheme 1.26: Quayle’s Benzannulation via an 8-endo trig  ATRC intermediate. Reagents and 
Conditions: a) Cu(85)Cl 5 mol%, toluene, reflux, 120 h. b) Cu(85)Cl 5mol%, DCE, 200 
oC, μW, 2 h. 
c) Cu(84)Cl 5 mol%, DCE, 200 
oC, μW, 2 h. 
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1.2.3 Tandem ATRC 
Tandem atom transfer cyclisations have also been shown be useful in the synthesis 
of polycyclic systems. Quayle has applied a 5-exo cyclisation followed by a 6-exo 
cyclisation to the synthesis of a 6,5-bicyclic ring system 91
99
 as the core for the 
Eunicellin 88 series of natural products.
100,101
 The addition of 89 to a preformed 
solution of Cu(bipy)Cl 5 mol% in DCE followed by heating to 90 
o
C for 3.5 hours 
led to the unstable trichloroacetates 90a and 90b, which upon purification by column 
chromatography led to 91a and 91b in a 2:1 ratio after elimination of HCl (Scheme 
1.27).
99
 The stereostructure was assigned based upon a single crystal X-ray that was 
obtained of 90a. The X-ray structure showed that the cyclohexane ring adopts a chair 
conformation with the C4-Cl substituent axially disposed and the bulky 
chloroisopropyl group at C7 in an equatorial position. The lactone was shown to be 
cis-fused with the C7a-Cl axially disposed with respect to the cyclohexane ring. 
NOE measurements were carried out on both 91a and 91b which suggest that this is 
also the conformation of the eliminated products in solution. 
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Scheme 1.27: Tandem ARTC in the synthesis towards Eunicellins. Reagents and Conditions: i) 
CuCl 5 mol%, bipy 5 mol%, DCE, 90 
o
C, 3.5 h. ii) SiO2. 
Stevens has also applied a tandem cyclisation approach to the synthesis benzospiro-
indolizidinepyrrollidione 93, as a racemic mixture, via sequential 5-exo and 6-endo 
cyclisations.
102
 TMEDA was used as the ligand and it was found that a 2:1 ratio of 
ligand to CuCl was required in order to obtain the best yield. 
 
Scheme 1.28 Tandem cyclisation in the synthesis of benzospiro-indolizidinepyrrollidones. 
Reagents and Conditions: CuCl 40 mol%, TMEDA 80 mol%, MeCN, reflux, 21 h. 
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1.2.4 5-Endo Cyclisations 
The ligand accelerated conditions have been shown to facilitate 4-exo and the 
traditionally disfavoured
22
 5-endo cyclisations of enamides.
71,103,104
 For enamides 
there are generally two competing reaction pathways; the 4-exo pathway is generally 
quicker, but reversible, and results in the kinetic product, whereas the 5-endo 
pathway leads to the less strained thermodynamic product. 
Interestingly, when cyclising enamides under normal ATRC conditions, the expected 
atom transfer products were not obtained, instead unsaturated cyclisation products 
were formed. Treatment of trichloroacetate 94 with Cu(bipy)Cl (50 mol%) in 
refluxing toluene resulted in the diene 95 in 90% yield.
104
 (Scheme 1.29A) while 
cyclisation of the monobromo-substrate 96 with Cu(Me6-Tren)Br (30 mol%) in 
DCM furnished two alkene products 97 and 98 in a 1:1 ratio in 82% combined yield 
(Scheme 1.29B).
71
  
 
Scheme 1.29: Copper Mediated 5-endo Cyclisations.  Reagents and Conditions: a) 50 mol% 
Cu(bipy)Cl, toluene, reflux. b) 30 mol% Cu(Me6-Tren)Br, DCM, r.t.  
Mechanistically it has been postulated that the reactions proceed via an initial 5-endo 
cyclisation to give the tertiary radical 100, which then undergoes a Cu(II) mediated 
oxidation via a radical-polar crossover reaction to give the corresponding N-
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acyliminium ion 101, which, upon elimination of a proton furnishes the alkene 
products 97 and 98. Further elimination of HCl from 97b or 98b can lead to the 
diene 95 (Scheme 1.30). 
 
Scheme 1.30: 5-endo Radical Cyclisation via an N-Acyliminium Ion. 
Ghelfi has used both Cu(TMEDA)Cl and Cu(bipy)Cl to catalyse 5-endo cyclisations 
but did not observe the eliminated products that Clark observed, instead the 5-endo 
and 4-exo atom transfer products were observed.
105
 Treatment of trichloroenamide 
102 with Cu(bipy)Cl in toluene at reflux led to complete conversion to the β-lactam 
103 and γ-lactam 104, (Scheme 1.31A). The crude ratio of 4-exo to 5-endo products 
varied (103 : 104 = 1 : 2.6-9.6), but the 5-endo product was always found to be the 
major component in the crude mixture. Upon purification on silica gel the hydroxy-
γ-lactam 106 and methoxy-γ-lactam 105 were formed from the 5-endo product 104. 
In contrast when the reaction was carried out in acetonitrile rather than toluene only 
the β-lactam product 103 was observed with no evidence for the γ-lactam product 
104, (Scheme 1.31B).
105
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Scheme 1.31: 5-endo vs. 4-exo cyclisations. Reagents and Conditions: a) Cu(bipy)Cl 50 mol%, 
toluene, reflux. b) MeOH, SiO2. c) Cu(bipy)Cl or Cu(TMEDA)Cl 50 mol%, acetonitrile, reflux.  
This change in regioselectivity is thought to be due to a reversible mechanism where 
the β-lactam 103 is the kinetic product and γ-lactam 104 is the thermodynamic 
product, (Scheme 1.32).
105
 4-Exo cyclisation of 107 to give 108 is therefore expected 
to be quicker than 5-endo cyclisation to give 109. The Cu complexes used are readily 
soluble in acetonitrile, hence formation of radical 108 is expected to be rapidly 
followed by atom transfer from the CuCl2 species to give β-lactam 103. However, 
solubility of CuCl2 species in toluene is low resulting in a much slower rate of 
trapping of the radical 108 and providing it with a longer ‘life time’, allowing for 
equilibration to the more stable stable radical 109 to occur. Trapping of this radical 
resulted in the γ-lactam 104 as the major product. 
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Scheme 1.32: Kinetic and thermodynamic pathways in cyclisation of enamides. 
The more active Cu(TPA)Cl complex has been shown to mediate the cyclisation of 
the less reactive secondary monohalosubstrates.
106
 The reaction of enamide 110 with 
1 equivalent of Cu(TPA)Br in refluxing toluene gave the α,β-unsaturated lactam 111 
in 86% yield (Scheme 1.33). Interestingly if DCE was used as the solvent the diene 
112 was formed exclusively in a 70% yield.  
 
Scheme 1.33: Copper mediated 5-endo cyclisations of secondary monohalosubstrates. Reagents 
and Conditions: a) 1 eq. Cu(TPA)Br, toluene, 110 
o
C, 2h. b) 1 eq. Cu(TPA)Br, DCE, 80 
o
C, 2h. 
It is postulated that the diene 112 is formed by further oxidation of the monoene 111, 
as occurs when 113 is transformed to 114 by heating with 1 eq. of Cu(TPA)Br 
(Scheme 1.34).  
 
Scheme 1.34: Conversion of monoene 113 into diene 114 by Cu(TPA)Br. Reagents and 
Conditions:  1eq. Cu(TPA)Br, DCE, 80 
o
C, 2h. 
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Attempts have been made to trap out the postulated N-acyliminium ion, however 
there has only been limited success. The cyclisation of enamide 115 in the presence 
of MeOH led to the formation of lactam 116, albeit in a low 30% yield.
5
  
 
Scheme 1.35: Trapping acyliminium ion with methanol. Reagents and Conditions: 30 mol% CuBr, 
30 mol% 42a, 10 eq. MeOH, DCM. 
Clark has applied his CuSO4/KBH4 conditions to the 5-endo cyclisations of 
enamides and has investigated the possibility of reductively trapping the 
acyliminium ion in situ with the borohydride reagent, or by the nucleophilic 
solvent.
81
  As with the 5-exo cyclisations, the 5-endo cyclisations were effective with 
low catalyst loadings. Cyclisation of 117 led to four different products; the reduced 
compound 119, the two oxidatively terminated products 120 and 121, and the 
precyclised reduced product 118. The reduced compound 119 may be formed by 
either trapping of the acyliminium ion 124 by the borohydride, or via direct 
reduction of the intermediate radical 123.  
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Scheme 1.36: CuSO4/KBH4 mediated 5-endo cyclisation. Reagents and Condition: CuSO4.5H2O, 
KBH4, MeOH, r.t., 30 min. 
Cyclisation of 117 with 1 mol% CuSO4 and 100 mol% KBH4 in MeOH led to the 
reduced cyclised product 119 in 11% yield, and the oxidatively terminated products 
120 and 121 in 6% and 69% yields respectively. Increasing the amount of KBH4 to 
10 equivalents in a hope to competitively trap the acyliminium ion reductively to 
give 119 was only partially successful with an increased yield of 32%, however a 
significant amount (30%) of the precyclised reduced product 118 was then observed. 
Unfortunately it was not possible to find conditions that led to the reduced cyclised 
product 119 in high yield.
81
 
 
1.2.5 ATRC mediated by other metals. 
As many transition metals have multiple easily accessible oxidation states they make 
ideal candidates for mediating redox initiated ATRC reactions. In recent years 
notable methods using metals other than copper, such as ruthenium,
48–50,107
 zinc
108
 
and titanium
109
 have been developed.  
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1.3 Atropisomersism 
Enamides such as 96a have been shown to exhibit atropisomerism.
110,111
 
Atropisomerism is a phenomenon where chirality occurs due to restricted rotation 
about a single bond.
112
 Atropisomers do not necessarily contain a stereogenic centre, 
instead chirality arises due to two possible spatial arrangements about the given bond 
axis, leading to the two enantiomers. Figure 6 shows an atropisomeric biaryl 
compound which has a chiral axis about the aryl-aryl bond, and the corresponding 
space-filling model which illustrates how rotation about the bond is hindered due to 
steric clashing of the bulky R
1
 and R2 groups with the R
3
 and R
4
 groups.  
 
 
Figure 6: Depiction of Atropisomerism showing space-filling models.
113
 
Atropisomers are identified by the Cahn-Ingold-Prelog using M  and P descriptors 
rather than the R and S used for stereoisomers.
114
 Racemisation of atropisomers 
occurs thermally with no need for breaking and forming any bonds. The only energy 
required for racemisation to occur is that to overcome the barrier to rotation and 
rotate a single bond through 180 ˚. As racemisation occurs through bond rotation, 
which is time dependent, half-lives for atropisomers can vary greatly from a matter of 
minutes to years, depending on the degree of steric hindrance, temperature, and 
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solvent. In favourable cases, where the barrier to rotation is high enough the two 
atropisomers can be separated at room temperature. 
 
The first stable atropisomers 125 were isolated in 1922 by Christie and Kenner,
115
 
and were resolved by co-crystallisation with brucine 126, a chiral amine alkaloid. 
The two salts were obtained in approximately equal yields through fractional 
crystallisation and had distinctly different solubilities, crystalline forms, melting 
points and [D

 
Figure 1.7: First isolated atropisomers. 
Following the discovery of atropisomerism, it has been identified in a large variety of 
molecules, both natural and synthetic. 
Figure 1.8: Atropisomeric natural products. 
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1.3.1 Atropisomerism in natural products 
The natural products vancomycin 127,
116
 gossypol 128
117
 and naphthylisoquinolines 
129
118
 all exhibit atropisomerism. Vancomycin 127,
116
 often referred to as one of our 
‘last defence’ antibiotics, is a very interesting molecule with many naturally 
occurring points of chirality in both the sugars and the heptapeptide chain. It also has 
two atropisomeric chiral planes formed from the bisaryl ethers with a chiral axis 
about the aryl-aryl bond. Gossypol 128 is a toxic yellow pigment from cotton plants 
which exhibits anti-cancer properties with the two different atropisomers showing 
different mechanisms for anti-cancer activity.
117
 The two atropisomers naturally 
occur in a range of ratios from 30% ee (-) to 90% ee (+).
117
 Naphthylisoquinolines 
129 are part of  some plants self-defence mechanism and exhibit anti-malarial 
properties.
118
 They have a chiral axis about the bond between the naphthyl and the 
tetrahydroisoquinoline component. 
These three natural products all have the chiral axis occurring about an aryl-aryl bond 
and this type of atropisomerism has been the most widely exploited synthetically. 
The factors controlling the rate of racemisation of biaryls have been extensively 
studied and are summarized in a review by Adams.
119
 It was evident from these 
studies that in order for a biaryl compound to exist as two stable enantiomers 3 of the 
4 ortho substituents had to be bigger than a hydrogen atom.
119
 Even with this 
condition satisfied compounds with small substituents such as a fluorine or a 
methoxy group might still not be resolvable and Sternhell has quantified these rules 
in terms of steric interference vaules.
120
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1.3.2 Atropisomerism in synthetic compounds 
Many axially chiral biaryl compounds have been synthesised and are used as ligands 
in asymmetric synthesis,
121–123
 one of the most notable being 2,2'-
bis(diphenylphosphino)-1,1'-binaphthyl 130 (BINAP).
124
 BINAP has two 
diphenylphosphinonaphthyl groups linked at the 1- and 1’- positions and it is about 
this bond where the restricted rotation occurs giving rise to the chiral axis.  
 
Figure 1.9: BINAP  
It is commonly complexed with ruthenium,
125,126
 rhodium
127,128
 or palladium
129,130
 
for use in enantioselective synthesis, such as the synthesis of menthol where BINAP 
is used to synthesis one of the chiral intermediates on an industrial scale in 96-99% 
ee.
131
 BINAP itself is synthesised from 1,1-binaphthol another chiral ligand which is 
prepared from an asymmetric coupling of 2-naphthol using copper (II) chloride and 
amphetamine.   
A number of methods have been developed for the asymmetric synthesis of 
binaphthyl compounds. These involve both the synthesis of a racemic mixture 
followed by resolution of that mixture,
132
 or the preparation of single atropisomers 
via an asymmetric synthesis.
133,134
 
More recently this phenomenon has been recognised in alternative synthetic systems 
such as benzamides 131,
135,136
 benzanilides 132,
137
 anilides 133
136,138
 and enamides 
134.
110
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Figure 1.10: Atropisomerism in alternative synthetic systems 
1.3.3 Measuring the barrier to rotation in atropisomers 
The half-life of atropisomers can be calculated based upon the barrier to rotation 
about the bond with restricted rotation and can range from milliseconds to years. A 
number of different methods can be used to investigate the barrier to rotation in 
atropisomers. Clayden applied three different methods to analyse the barrier to 
rotation in tertiary amides 135; variable temperature NMR spectroscopy, resolution 
by chiral HPLC followed by analysis of subsequent racemisation and 
chromatographic separation of diastereomers on silica followed by analysis of 
subsequent epimerisation.
139
  
 
Figure 1.11: General structures of tertiary amides investigated by Clayden. 
VT NMR analysis proved to be most effective for calculating the barriers to rotation 
of amides with only one ortho substituent (135, 136a R
3
 = H) as the barrier to 
rotation in these compounds was significantly lower than the 2,6-disubstituent 
compounds 136 where the chromatography methods were more applicable.
139
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Tertiary aromatic amides with only one ortho substituent, 135 and 136a, were found 
to be chiral on the NMR timescale, but racemised quickly with a half life of <2s at 
20 
o
C. Those with two ortho substituents, 136, can in general be separated into the 
two atropisomers unless either R
3 
or R
4
 is a freely rotating trigonal substituent or 
silyl group.  For the 2-substituted tertiary 1-naphthamides 137 the barrier to rotation 
is largely influenced by the size of the R
3 
substituent. With the peri-substituent 
naphthamides 138 even when the R
3
 substituent was a hydrogen atom or the trigonal 
CHO group the atropisomers could be separated. 
139
 
Similar techniques have also been employed by Lunazzi in the analysis of highly 
hindered naphthyl phenyls,
140
 naphthyl sulfones,
141
 naphthyl sulfoxides,
142
 naphthyl 
imines
143
 and naphthyl ketones.
144
 Dynamic NMR has also been used to calculate the 
barrier to rotation in enamides.
110,111
 NMR analysis of N-benzylated enamides such 
as 96a show the benzyl protons to be diastereotopic at low temperatures, appearing 
as two mutually coupled doublets due to slow rotation about the N-alkenyl bond. 
Upon heating the doublets coalesce to form one singlet as the rate of rotation about 
the N-alkenyl increases (Figure 1.12). Use of the WINDNMR 7.1 line shape analysis 
programme
145
 allowed the rotational rate constant, krot, to be calculated for each 
temperature, and an Eyring plot then allowed rate of rotation at 298 K, k298, to be 
calculated, which when factored into the Arrhenius equation allowed the barrier to 
rotation about the N-alkenyl bond to be calculated. 
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Figure 1.12: VT NMR of Enamide 96a (x = impurity) 
 
1.4 Atropisomerism in Radical Cyclisations 
Atropisomerism can have important consequences in the cyclisation of anilides.  
Work by Curran has looked at the atropisomerism of anilides where there are two 
rotational elements that must be considered. (E)-89 and (Z)-89  rotamers occur due to 
the amide rotation about the N-CO bond as well as (M)-89 and (P)-89 isomers due to 
the restricted rotation around the N-aryl bond.
146,147
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Figure 1.13: Rotamers of radical precursors 
Curran has shown that ortho substitution of the anilide (X ≠ H) is necessary in order 
to increase the barrier to rotation around the N-aryl bond to a level where 
atropisomerism can be observed in variable temperature proton NMR, and if the 
substituent at this position is sufficiently bulky (e.g. X = I) the atropisomers can be 
resolved by methods such as chiral HPLC.
148,149
 The magnitude of the barrier to 
rotation was found to vary depending on the level of substitution in the anilides 
around the aromatic ring, at X, and at the α- position of the carbonyl. Curran found 
that when X = I a barrier to rotation large enough to allow resolution at room 
temperature could be achieved. 
 
1.4.1 Chirality Transfer in Radical Cyclisations 
Curran then investigated whether chirality transfer was possible during the radical 
cyclisation of acrylanilides designed for 5-exo trig cyclisations.
150
 Chirality transfer 
in 5-exo trig cyclisations had previously been attempted by having a chiral inducing 
group elsewhere in the molecule (Scheme 1.37).
151
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Scheme 1.37: Attempted chirality transfer using a chiral inducing group. Reagents and 
Conditions: Bu3SnH, AIBN, toluene, reflux. 
 
When cyclisation of (S)-acrylanilide 140 was attempted a 1:1 mixture of 
diastereomers 142 was obtained and it was unclear why the reaction was so 
unselective. Curran noticed that acrylanilide 140 contained an axis of chirality, 
caused by slow rotation about the N-aryl bond, as well as the chiral group and was 
consequently a 1:1 mixture of diastereomers itself, leading to a 1:1 mixture of 
diastereomeric radical intermediates and hence the unselective cyclised 
diastereomeric products 142. He then synthesised acrylanilide 143 and the 
diastereomers were resolved by chiral HPLC giving a 91/9 mixture of M,S-143 / P,S 
143 which under the cyclisation conditions showed chirality transfer giving a 95/5 
mixture of diastereomers R,S-144 / S,S-144.
150
  
 
Scheme 1.38: Cyclisation of resolved diastereotopic acryanilides showing chirality transfer. 
Reagents and Conditions: Bu3SnH, Et3B/O2, DCM, -78 
o
C. 
 
 
Chapter 1: Introduction 
 
50 
 
Curran then looked at whether chirality transfer from acrylanilides could be achieved 
without the need for a chiral auxiliary group elsewhere in the molecule. Anilide 145 
was synthesised and found to have a barrier to rotation of ~29 kcal mol
-1
, allowing 
for the separation of atropisomers by chiral HPLC. Radical cyclisation of one 
atropisomer using Bu3SnH then afforded the cyclised product 146 with ~90% 
chirality transfer (Scheme 1.39).
150 
 
Scheme 1.39: Chirality transfer in the 5-exo cyclisation of acrylanilides.  Reagents and 
conditions: Bu3SnH, Et3B, O2, 20 
o
C, benzene. 
One important consideration when investigating chirality transfer during cyclisation 
reactions of molecules such as 147 is to keep in mind that the radical intermediate 
148 formed is much more configurationally labile around the N-aryl bond than the 
starting material 147 as the loss of the bulky iodine atom from 147 will lead to a 
much lower barrier to rotation. In order for the chirality of the starting material to be 
transferred to the product the rate of cyclisation kc must be greater than the rate of 
rotation krot of the radical intermediate under the reaction conditions (Scheme 1.40).  
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Scheme 1.40: Competing bond rotation and cyclisation of the radical. 
This success in chirality transfer with atropisomeric anilides 145 and the presence of 
atropisomerism in related enamides such as 96a suggests that chirality transfer may 
be possible in the cyclisation of enamides. Comprehensive mechanistic studies by 
Newcomb
58
 and Chatgilialoglu
152
 have shown that rates of cyclisation can be 
measured for enamides and their 5-endo cyclisations. Whereas the rates of 5-exo 
cyclisations of aryl radicals 148 have been calculated to be ~ 3 × 10
9
 s
-1
,
148
 studies 
show the rate of 5-endo cyclisations of enamide radicals  e.g. 151 derived from 
enamide 150 to be in the order of 10
4
 slower.
153
 This suggests chirality transfer in 5-
endo trig cyclisations of enamides 150 would be more difficult to achieve than in the 
related 5-exo trig cyclisations of 148 as the barrier to rotation (M)-151 → (P)-151 
will have to be significantly higher in order to prevent racemisation of the radical 
intermediate prior to cyclisation (Scheme 1.41). 
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Scheme 1.41: Competing bond rotation and cyclisation of enamides.  
1.5 Summary 
Over the past couple of decades there have been significant improvements in the 
conditions for radical cyclisations. The development of copper mediated atom 
transfer radical cyclisation as a less toxic, non-reductive alternative to the traditional 
tin mediated cyclisations has grown in importance. The use of ligands for copper 
(see section 1.2.1.1) has allowed catalyst loadings to be reduced as low as 1 mol% 
and has facilitated the cyclisation of less activated substrates, notably the 5-endo 
cyclisations of enamides (see section 1.2.4). These enamide substrates exhibit 
atropisomerism, a phenomenon exploited in anilides to achieve chirality transfer 
upon cyclisation (Scheme 1.48). Herein we report investigations into the effect of the 
substitution at the alkene on the barrier to rotation in enamides and the results of 
cyclisations of atropisomeric enamides with high barriers to rotations. We also report 
the results when copper mediated cyclisation conditions were applied to the 
synthesis of oxindoles via the cyclisation of anilides.
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2.0 Investigations into the Barrier to Rotation in Enamides. 
 
2.1 Introduction   
Atropisomerism in enamides has been observed due to restricted rotation about the 
N-alkenyl bond and can result in the existence of two distinct isomers.
110,111
 Anilides, 
which also exhibit atropisomerism, can be separated by chiral HPLC when the barrier 
to rotation is high enough, and have been shown to undergo 5-exo cyclisation of a 
single atropisomer with 90% chirality transfer.
150
 Thus if enamides 150 with a high 
enough barrier to rotation could be synthesised, the atropisomers could be separated, 
and chirality transfer may be possible in the cyclisation of enamides 150 → 152.   
 
Scheme 2.1: Possible chirality transfer in the cyclisation of enamides. 
The possibility of chirality transfer depends on the rate of cyclisation 151-M→152-R 
being faster than the rate of rotation of the radical 151-M→151-P. Therefore in order 
to better contemplate the prospect of chirality transfer in enamides, a better 
understanding of the rotation dynamics about the N-alkenyl bond was required.  
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2.1.1 Investigations into the Barriers to Rotation in Enamides 
N-benzyl enamides 153 have proven to be ideal compounds for calculating barriers to 
rotation using variable temperature (VT) NMR.
110,111,154
 When the N-alkenyl bond is 
rotating freely the two methylene protons H
A
 and H
B
 are equivalent and appear in the 
proton NMR as a singlet, however when the rotation about the C-N is slow the 
protons become diastereotopic and appear as two mutually coupled doublets in the 
proton NMR due to the orthogonal nature of the amide and alkene functional groups.  
 
Figure 2.1: N-benzyl enamides. 
Ahlbrecht and co-workers measured the barrier to rotation of simple N-benzyl 
enamides.
154
 Δυ, the shift distance in Hz between HA and HB, which is dependent on 
temperature, was measured and extrapolated to the coalescence temperature, Tc, by 
linear regression, and ΔG‡ was calculated for Tc using Equation 2.1. 
 
k = π(Δυ2 + 6JAB
2
)
0.5
 /  2 
Equation 2.1 
It was found that the effect of the R
1
 substituent was mainly electronic in nature, 
however the effects of the R
2
, R
3
, and R
4
 substituents were rationalised by non-
bonding interactions between the substituents. The barriers of rotation were found to 
vary from <7.4 kcal/mol to >24.1 kcal/mol and compounds 154 and 155 were found 
to have high enough barriers to rotation to allow separation of the atropisomers.
154
 
Chapter 2: Investigations into the Barrier to Rotation in Enamides 
 
55 
 
Separation via diastereotopic salts was not successful due to the basicity of the 
compounds, instead low pressure liquid chromatography on microcrystalline, 
swollen triacetylcellulose with ethanol/H2O as the eluent yielded enriched samples of 
the atropisomers. More precise barriers to rotation were then obtained monitoring 
thermal racemisations by polarimetry, giving results in good agreement with those 
obtained by NMR analysis.
154
 
 
Figure 2.2: Atropisomeric enamides separated by Ahlbrecht. 
a
Calculated from NMR. 
b
Calculated 
by thermal racemisation. 
Curran examined halo-enamides 156 – 158 as 5-endo-trig radical cyclisation 
precursors and found that they existed as a single amide rotamer in solution and 
exhibited atropisomerism.
153
 The 
1
H NMR showed only a single resonance for each 
different proton or group of protons, suggesting either the existence of one single 
amide rotamer or two amides rotamers in rapid equilibrium on the NMR timescale. α-
Haloamides have amide rotation barriers typical of other amides,
155
 therefore the 
barriers to rotation about the N-CO bond in 156 - 158 are likely to be in the range of 
15-17 kcal/mol,
156
 meaning the latter explanation is unlikely as processes with 
barriers of that height are typically slow on the NMR timescale. The diastereotopic 
methylene protons exhibited sharp, well resolved doublets suggesting that the 
compounds where axially chiral in solution. X-ray crystal structures of 157 and 158 
showed the existence of the E-amide rotamer in the crystal and showed the 
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compounds to be non-planar. In compound 157 the plane of the amide and the alkene 
were found to be almost orthogonal with a dihedral angle of 74
o
.
153
  
 
Figure 2.3: Atropisomeric enamides studied by Curran. 
2.1.1.1 Previous Investigations within the Clark Group 
To gain further understanding of the rotation dynamics of enamides the Clark group 
have synthesised a series of compounds to further investigate what effect the acyl 
group and a cycloalkene group have on the magnitude of the barrier to rotation. As 
with Alhbrecht, Clark also synthesised N-benzyl enamides to allow the barrier to 
rotation to be calculated via VT NMR, however instead of using the method 
employed by Ahlbrecht, Clark used line shape analysis to calculate the barrier to 
rotation. Line shape analysis of the VT NMR spectra using the  WINDNMR
145
 
software allowed values for krot to be determined at each temperature, which when 
factored into the Arrhenius equation (Equation 2.2) allowed determination of ΔG‡ at 
each temperature. Eyring plots of 1/T against ln(k/T) where then produced allowing 
access to values for krot 298,  ΔG298
‡
,  ΔS‡, and  ΔH‡,  for the bond rotation using 
equations 2.3 - 2.6.  
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Equation 2.6 
Clark first investigated the nature of the cycloalkenyl group and a range of cyclic 
enamides with varying sized rings were synthesised. The size of the cycloalkenyl 
group was found to have little effect on the barrier to rotation (compare 96a and 159, 
G‡298 = 0.2 kcal mol
-1
). When the enamide was substituted at the β'- position, 
particularly if it is sp
2
 hybridised (resembling an anilide), the barrier to rotation was 
seen to increase significantly (compare 96a and 160, G‡298 = 4.7 kcal mol
-1
).
110 
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Figure 2.4:  Enamides synthesised while investigating the nature of the alkenyl group (barriers 
measured in toluene). 
Clark then investigated the effect of the acyl group on the barrier to rotation.
111
 
Sequential addition of a methyl group to the acyl group was also found to increase 
the barrier to rotation by 0.8-1.3 kcal mol
-1
 (compare 96a, 161 and 162). In order to 
estimate barriers to rotation for radicals derived from these bromides, radical models 
were synthesised with the halogen replaced by a hydrogen atom (e.g. enamide 163 as 
a model for radical 96a). Using these ‘radical models’ the barrier to rotation was 
found to decrease by 1-2 kcal mol
-1
 compared to the bromo derived radical precursors 
(compare 99a and 163), equating to a 5-26 fold increase in the rate of rotation around 
the N-alkenyl bond.
111
 
 
Figure 2.5. The effect of the acyl group on the barrier to rotation (barriers measured in 
toluene). 
Clark also calculated the barriers to rotation for enamides 156 – 158 to investigate 
the effect of the halogen atom itself.
110
 The enamides were found to have similar 
rotation dynamics with barriers to rotation varying between 11.7-12.1 kcal mol
-1
. 
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Figure 2.6: The effect of the halogen atom on the barrier to rotation (barriers measured in 
chloroform). 
The barrier to rotation of enamide 157 was measured in different solvents to assess 
any solvent effects.
110
 Only minor differences in the barrier to rotation were 
observed; in d4-methanol the barrier was measured at 11.6 kcal mol
-1
, and in d8-
toluene the barrier was calculated to be 11.1 kcal mol
-1
. d8-Toluene was considered 
the best choice of solvent as it allowed for the VT NMR to be run over a larger 
temperature range. 
Finally tetrasubstitued enamides, substituted at both the β and β''-positions were 
prepared. These compounds had barrier to rotations too high to calculate via VT 
NMR, however the compounds were resolvable by chiral HPLC, allowing the barrier 
to rotation to be calculated by monitoring the rate of racemisation at 80 ˚C (>25 kcal 
mol
-1
).
157
 
 
Figure 2.8. Tetrasubstitued enamides. 
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2.1.2 Previous Routes for Synthesis of Enamides. 
There were two main methods employed by Clark for the synthesis of enamides 156-
165. The first route (route A) starts with a ketone 166, which is reacted with 
benzylamine under Dean-Stark conditions to give an imine 167, before treatment 
with a base and acid halide to give the desired enamide 168. The second route (route 
B) starts with the same ketone 166, but instead involves reacting it with 
hydroxylamine in the presence of sodium acetate to give the oxime 169, which then 
undergoes an iron mediated acylation reaction to give the enamide 170, before 
benzylation with benzyl bromide in the presence of sodium hydride to give the final 
enamide 168. The oxime route proved to be more successful with the more 
substituted enamides where the imine route failed to give any of the desired 
product.
157
 
 
Scheme 2.2: The two routes previously used to synthesis enamides. Reagents and conditions: a) 1 
eq. benzylamine, toluene, reflux.; b) 1 eq. 2-chloroacetylchloride, 1 eq. N,N-diethylaniline, toluene, 0 
o
C.; c) 1.2 eq. NaOAc, 1.2 eq. NH2OH.HCl, MeOH, reflux.; d) 3 eq. 2-chloroacetic acid, 3 eq. 2-
chloroacetic anhydride, 2 eq. Fe(O), toluene, 70 
o
C.; e) 5 eq. NaH, 1.05 eq. BnBr, THF, reflux. 
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2.2 Results and Discussion 
2.2.1 Investigations into the Substitution Level at the Alkene 
Previous investigations had shown that enamides with tetrasubstituted alkenyl groups 
164-165 had significantly higher barriers to rotation than related enamides with 
lower substitution at the alkene. However we did not have a complete picture of the 
effect of the substitution level at the alkene on the barrier to rotation. Therefore 
initial investigations looked at the synthesis of a series of compounds (171 - 176) 
with varying levels of substitution at the alkene. 
 
Figure 2.9. Compounds synthesised to investigate the effect of substitution at the alkene. 
Compounds 171 and 172 were synthesied via the imine route (A, Scheme 2.2) where 
the appropriate ketone was reacted with benzylamine followed by acylation with 
acetyl chloride with Et3N as a base (Scheme 2.3).  Whereas compounds 173-176 
were synthesised via the oxime route (B, Scheme 2.2) which was then subjected to 
an Fe(0) mediated rearrangement to give the secondary enamide, followed by anion 
formation with NaH and alkylation with benzyl bromide (Scheme 2.4).  
 
Scheme 2.3. Synthesis of compounds 171 and 172 via the imine. Reagents and conditions: a) 1.0 
eq. benzylamine, toluene, reflux, b) 1.1 eq. acetyl chloride, 1.2 eq. Et3N, toluene, 0 
o
C – r.t. 
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Scheme 2.4. Synthesis of compounds 173 - 176 via the oxime. Reagents and conditions: a) 1.2 eq. 
NH2OH.HCl, 1.2 eq. NaOAc, MeOH, reflux, b) 2eq. Fe(0), 3eq. AcOH, 3eq. Ac2O, toluene, 85 
o
C, c) 
5eq. NaH, 1.1 eq benzyl bromide, THF, 0 
o
C – reflux. d Further compound was obtained as a mixture 
with 175. 
e
 Only obtained as a mixture with 174, (2:1 ratio of 175 : 174).  
These compounds were all analysed by 500 MHz 
1
H VT NMR and from the data it is 
clear that mono- and disubstituted enamides 171 and 172 have relatively low barriers 
to rotation. On cooling 171 the benzylic CH2 singlet begins to broaden as expected, 
but even at -94 
o
C decoalescence is not observed and therefore the barrier to rotation 
can not be calculated. Based on other results (see Table 2.1) we can say that these 
barriers to rotation are <7.6 kcal mol
-1
.  Two amide rotamers of enamide 171 were 
observed at room temperature, whereas normally N-alkyl enamides exhibit only a 
single E-amide rotamer in solution. 
 
 
Figure 2.10. 400 MHz 
1
H NMR of enamide 171 showing the two different rotamers. 
Ha 
Major 
rotamer 
Minor 
rotamer 
Benzyl 
protons 
Minor  
rotamer 
 
Major 
rotamer 
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The 
1
H NMR showed two sets of peaks which upon heating (298K→373K) 
broadened and coalescenced to give a single set of peaks. This is consistent with a 
slow rotation around the amide bond and a fast rotation around the N-alkenyl bond at 
298K, with rapid rotation around the amide bond and the N-alkenyl bond at 373K. 
 
Figure 2.11. Theoretical analysis of enamide 171 showing the four different possible 
conformations. 
Theoretical analysis of enamide 171 using B3LYP 6-31(G)d indicated that three out 
of the four possible conformations were planar, with the (E)-anti and (Z)-anti 
conformations predominating at equilibrium. Experimentally two conformations 
were seen in the 
1
H NMR at 298K in a 2:1 ratio: in good agreement with theory. The 
major isomer was assigned as (E)-anti-171 and the minor isomer as (Z)-anti-171 
based upon the 
1H NMR chemical shift and NOE data. The α-enamide proton 
resonates at 6.80 ppm in the major conformer and 7.50 ppm in the minor conformer. 
This data is in good agreement with that reported for related compound 177.
73
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Enamides 174 and 175 were both synthesised simultaneously from the same starting 
material, 2-butanone oxime. Purification after the final step yielded pure enamide 
174, however enamide 175 could not be obtained free of 174 and remained a mixture 
of the two isomers (2:1 ratio of 175 : 174). The 
1
H NMR of the mixture clearly 
showed the compounds had distinctly different barriers to rotation (Figure 2.12), with 
the benzyl protons for one compound appearing as a singlet and for the other 
compound as two doublets. 
 
Figure 2.12. 400 MHz 
1
H NMR of enamide 174 and 175 showing the two different isomers. 
NOe experiments were used to assign the two isomers. The compound with the 
highest barrier to rotation was identified as enamide 174 and the lowest barrier to 
rotation was identified as enamide 175 (Figure 2.13) as expected. In compound 174 
the methyl group is pointing towards the acyl group and therefore is likely to 
increase the barrier to rotation, whereas in 175 the methyl group is pointing away 
from the acyl group and less likely to result in an increase in the barrier to rotation.   
  
Impurity 
Minor CH 
Major CH 
Major 
Benzyl 
Minor 
Benzyl 
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Figure 2.13. NOE results of enamide 174 and 175 showing % enhancement. 
Unlike the mono 171 and disubstituted 172 enamides it was possible to use 400 MHz 
1
H VT NMR and line shape analysis to calculate the barriers to rotation for the tri-
substituted enamides 174 and 175 and they were determined to be 16.3 kcal mol
-1 
and 9.4 kcal mol
-1 
respectively (Table 2.1). However for enamide 174 coalesence 
was only just observed at 368K, close to the maximum temperature obtainable of 
373K for the solvent used (d8-toluene) and as a result this value may be less accurate 
than that for 175. 
 
Figure 2.14: 500 MHz 
1
H NMR VT NMR of 174 between 298K and 372K 
Line shape analysis of the NMR’s allowed krot to be calculated for each temperature. 
These values were then factored into the Arrhenius equation (Equation 2.2) allowing 
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the calculation of ΔG‡ at each temperature. Eyring plots where then produced 
allowing access to values for krot 298 and ΔG298
‡
 for the bond rotation using equations 
2.3 and 2.4, (see Table 2.1).  
 
The tetrasubstituted enamide 176 showed two clearly resolved doublets for the 
benzyl protons at room temperature which upon heating to 373K broadened but did 
not reach the point of coalescence. This meant the barrier to rotation was too high to 
be calculated by 500 MHz 
1
H VT NMR. As enamide 160 had previously had its 
barrier to rotation calculated by 500 MHz 
1
H VT NMR as 18.0 kcalmol
-1 
we know 
the barrier to rotation of enamide 176 must be >18.0 kcalmol
-1
. 
 
Figure 2.15: 400 MHz 
1
H VT  NMR of 176 at 298K (CDCl3) and 373K (toluene). 
  
298 K 
373 K 
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Substrate Level of substitution ΔG‡298 (kcal mol-
1
) 
171 Mono- <7.6
a 
172 Di- <7.6
a
 
173 Tri- <7.6
a
 
174 Tri- 16.3 
175 Tri- 9.4 
176 Tetra- >18.6
b
 
Table 2.1. Barriers of rotation for enamides 171-176. 
a
 Too low to measure by 500 MHz 
1
H VT 
NMR, 
b
 Too high to measure by 500 MHz 
1
H VT NMR,.    
These results show not only that the level of substitution at the alkene is important 
but also that the stereochemistry at the alkene can greatly affect the barrier to 
rotation. This can been seen particularly well when comparing 174 and 175; when 
the methyl group is cis to the nitrogen (174) the barrier to rotation is ~7 kcal mol
-1
 
higher than when it is trans to the nitrogen (compound 175). As we were particularly 
interested in atropisomeric enamides that could be resolved and potentially used in 
asymmetric radical reactions (Scheme 2.5) we next focussed our efforts on the 
synthesis of radical models of tetrasubstituted enamides. 
 
2.2.2 Synthesis of Radical Models for Tetra-Substituted Enamides. 
In order for chirality transfer to occur in a 5-endo trig radical cyclisation (179 → 
180) the barrier to rotation of the radical 179 (produced from homolysis of halide 
178) must also be high so that krot is slower than kc otherwise the single atropisomer 
of the enamide radical 179 could racemise prior to cyclisation.  
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Scheme 2.5: Potential chirality transfer in enamides. 
Therefore we prepared a range of N-acetyl tetrasubstituted enamides where the 
halogen atom had been replaced with hydrogen atom as models for the radical 
intermediates (195 – 201), Figure 2.18. These enamides were all synthesised via the 
‘oxime route’. 
 
2.2.2.1 Synthesis of Oximes 
Firstly the oximes were all synthesised from the corresponding ketone. In the 
majority of cases a mixture of E and Z isomers were produced.  
 
Scheme 2.6: Synthesis of oximes from ketones. Reagents and conditions: a) 1.2 eq. NaOAc, 1.2 eq. 
NH2OH.HCl, MeOH, reflux. 
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Figure 2.16: Oximes synthesised, showing yield and ratio of isomers. 
a
Only one isomer possible. 
b
Only one isomer observed.  
Roberts et. al. studied the formation and conformation of oximes.
158
 They found 
those with a quaternary α-carbon gave only a single isomer with the OH group anti 
to the quaternary carbon.  This was rationalised due to steric reasons. Similar results 
were found in our work as oxime 183 was isolated as only a single isomer, that was 
assigned as the anti isomer, based upon the literature precedent. Oximes 181, 184 
and 186 containing an sp
2 
hybridised carbon at the α-position gave rise to a mixture 
of isomers due to the lower steric demand of the carbon atom.  Roberts determined 
that for mixtures the major isomer was that where the OH group was anti to the most 
substituted carbon. We have therefore tentatively assigned the major isomers of our 
oximes as the anti isomers, however as the conformation of this bond does not affect 
our subsequent synthesis and is lost in the following reaction this has not been 
confirmed. 
 
2.2.2.2 Acylation of the Oximes 
Oximes 181-187 were then all subjected to acylation by acetic anhydride and acetic 
acid in the presence of iron powder to give the enamides 188 - 194.  
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Scheme 2.7: Synthesis of enamides from oximes. Reagents and conditions: 3 eq. acetic anhydride, 3 
eq. acetic acid, 2 eq. Fe(O), toluene, 70 
o
C. 
In all cases the desired enamide 188-194 was isolated in low to moderate yields (14-
69%). Enough material was gained for the purpose of our subsequent investigations 
and so the reactions were not optimised further. Acylation of oxime 186 resulted in 
two products, the desired enamide 193 (50%) and the diacylated product 193a 
(10%).  This minor diacylated by-product was not detected in the acylation of any of 
the other oximes.  
 
Figure 2.17: Enamides synthesised from oximes. 
 
2.2.2.3 Benzylation of Enamides to give Radical Models 
The enamides 188 - 194 were then deprotonated using sodium hydride before the 
addition of benzyl bromide to give the desired enamides 195 - 201 in 61 – 86% with 
one unexpected result (compound 198). 
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Scheme 2.8: Benzylation of enamides. Reagents and conditions: 1.05 eq BnBr, 5 eq. NaH, THF, 
reflux. 
 
Figure 2.18: Enamides synthesised as radical models. 
Enamide 192 formed a tri-benzylated product 198 with two benzyl groups adding on 
to the benzylic position of the indene ring. These protons, like those in 
cyclopentadiene, have an unusually high acidity as the loss of one of these protons 
would lead to a stable aromatic anion, which can then react further with the benzyl 
bromide to give the per-benzylated product.  
 
Scheme 2.9: Deprotonation of enamide 192. 
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2.2.3 Analysis of Barriers to Rotation in Enamides 195 - 201 
In the 400 MHz 
1
H NMR of all the enamides 195 - 201 the benzyl protons appear as 
two clearly resolved doublets showing their diastereotopicity, indicating the chiral 
environment resulting from an axis of chirality around the N-C=C bond with a high 
barrier to rotation. 
 
Figure 2.19: 400 MHz 
1
H NMR of enamide 195. 
It was not possible to measure the barrier to rotation using VT NMR as coalescence 
of the benzyl doublets was not observed within the temperature ranges possible on 
the NMR machine (183 K – 373 K). This high barrier to rotation observed for 
enamides 195 – 201 suggests that the analogous radical intermediates (with the 
radical at the acyl methyl carbon) would also have a high barrier to rotation and 
could lead to chirality transfer during cyclisation. 
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2.2.3.1 Barrier to Rotation Calculation by Chiral HPLC 
Chiral HPLC is another method which can be used to measure the barrier to rotation 
of atropisomers by separating the two atropisomers and then measuring the rate of 
racemisation. This method has been used to calculate the barrier to rotation in other 
tetrasubstituted enamides (164 and 165).
157
  
 
Figure 2.20. Compounds separated on chiral HPLC. 
Separation of the synthesised enamides 195 – 201 was attempted on a number of in 
house chiral columns (Chiralcel OD, OD-H, AD, AD-H, OB, IA) with limited 
success. Separation was only achieved with enamide 198 where the two atropisomers 
were almost fully resolved (Figure 2.21), however separation was not observed with 
the other enamides. 
 
Figure 2.21. Chiral HPLC trace of compound 198. 
A selection of the enamides (Figure 2.22) were then sent to our collaborators, Curran 
and co-workers, in Pittsburg, America for attempted separation on a Whelk-O 
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column, the type used previously for the separation of enamide atropisomers such as 
enamide 164 and 165. 
 
Figure 2.22: Enamides sent to Curran for attempted Separation by Chiral HPLC. 
Enamide 200 had been synthesised previously in the group and separated by Curran 
allowing calculation of the barrier to rotation, 25.7 kcal mol
-1
, by monitoring the rate 
of racemisation.
157
 Unfortunately separation of compounds 195, 196 and 201 on the 
Whelk-O was unsuccessful; it was not clear whether this was due to equilibration 
due to a low barrier to rotation (atropisomers interconverting too quickly) or a poor 
resolution on the column for these structures. 
           
Figure 2.23: HPLC chromatograms of enamides showing no separation. 
However separation was achieved with enamides 197 and 198. Enamide 198 gave 
similar results to those achieved on in-house columns giving partial separation of the 
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two atropisomers. As complete separation was not a achieved an, accurate barrier to 
rotation was not calculated, however enriched fractions took several hours to 
racemise in iPrOH at room temperature suggesting a barrier to rotation >24 kcal mol
-
1
. Better separation was possible with enamide 197. Separation yielded one 
atropisomer with >97:3 er which underwent racemisation at 82 
o
C in iPrOH. From 
this data the barrier to rotation was calculated to be 31 kcal mol
-1 
resulting
 
in a half 
life of 128 years at 298K or 10.6 days at 353K (a typical temperature to mediate a 
radical cyclisation reaction). 
       
Figure 2.24: HPLC chromatograms of enamides 197 and 198. 
 
Scheme 2.10: Racemisation of enamide 197. Reagents and Conditions: iPrOH, 82 
o
C. 
 
2.2.3.2 Comparison of Barriers to Rotation in ‘Radical Models’. 
Comparing the results for the barriers to rotation calculated for the radical models 
195-200, as well as values previously reported provides some interesting 
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observations. Although we did not observe coalescence in the 400 MHz 
1
H VT 
NMR of enamide 201, and were therefore unable to obtain a value for the barrier to 
rotation, Ahlbrecht had previously calculated the barrier using his extrapolation 
method to be 21.3 kcalmol
-1
.  This is 6.2 kcalmol
-1
 lower than the value obtained for 
the restricted conformational analogue 164 (Figure 2.25). This relatively low value 
for 201 suggests a co-operative gearing of the phenyl substituent in the position 
during the key rotation around the N-alkenyl bond in 201. This could also explain 
why we were unable to calculate the barrier to rotation for 195 as again the phenyl 
substituent can undergo a co-operative gearing process during the rotation about the 
N-alkenyl bond. The higher value obtained for enamide 200 compared to 201 
suggests that the isopropyl group is less able to partake in this process.  A increase of 
almost 10 kcal mol
-1
 occurs due to the addition of a ’-methyl substituent between 
enamides 203 and 164, therefore it is not surprising that we were unable to calculate 
a barrier to rotation for enamide 196 which only has substitution in the ’-position. 
However enamide 197, which gave the highest barrier to rotation of 31 kcalmol
-1
, 
has substituents at both the ’- and ’’-positions that are conformationally restricted 
and unable to undergo any co-operative gearing to aid rotation about the N-alkenyl 
bond. 
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Figure 2.25: Comparsion of barriers to rotation. 
a
Calculated previously within the group,
157
 
b
Calculated by Ahlbrecht.
154
 
c
Unable to calculate barrier to rotation by either 
1
H VT NMR or chiral 
HPLC. 
2.2.4 Synthesis of halogenated analogues for cyclisations. 
From the work on ‘radical models’ we knew we could achieve high barriers to 
rotation so we next began synthesising halogenated analogues of the ‘radical models’ 
which could then undergo 5-endo cyclisation. We looked at compounds with a 
tertiary halogen on the α-carbonyl carbon (204 X = CCl3, 205 X = C(Me)2Br) as 
these should undergo copper mediated cyclisations, and those with a primary halogen 
on the α-carbon (206 X = Cl, 207 X = Br) that could undergo tin mediated 
cyclisations (Figure 2.26).  
 
Figure 2.26. General structures of halogenated enamides. 
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2.2.4.1 α-Haloenamides 
A number of chlorinated analogues of the tetrasubstituted enamides 206-207 were 
prepared from the corresponding oximes 169 using chloroacetic anhydride (Scheme 
2.11). Upon carrying out the alkylation reaction with benzyl bromide some of the 
bromoenamide product 207 is obtained alongside the desired chlorinated product 206 
due to displacement of the chlorine with bromide.  
 
Scheme 2.11: Synthesis of tetrasubstituted chloroenamides. Reagents and conditions: a) 2 eq. 
Fe(0), 3 eq. chloroacetic anhydride, 3 eq. chloroacetic acid, toluene, 85 
o
C, b) 5 eq. NaH, 1.1 eq 
benzyl bromide, THF, 0 
o
C – reflux. 
 
Figure 2.27: Tetrasubstituted chloroenamides. 
Figure 2.27 shows the chloroenamides that were synthesised. When preparing 210, a 
side product 213 was formed in 12% yield by the sequential addition of  second 
benzyl group on the α-carbon to the carbonyl. As with the non-halogenated ‘radical 
analogues’ these enamides all had barriers of rotation that were too high to be 
calculated using 400 MHz 
1
H VT NMR with the benzyl protons appearing as two 
mutally coupled doublets that did not coalesce at 373K. Based upon the results from 
the chiral HPLC of the ‘radical analogues’ we did not expect separation of enamides 
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210 – 211 to be successful. We  sent enamides 209 and 210 to Curran and co-
workers for separation and analysis by chiral HPLC.  
      
Figure 2.28: HPLC chromatograms of enamides 209 and 210 on a Whelk-O column. 
Enamide 209 gave excellent separation (24.7 min and 31.7 min) and allowed 
isolation of a single atropisomer in >99:1 er which slowly underwent racemisation in 
iPrOH at 82 
o
C allowing the barrier to rotation to be calculated as 27.8 kcalmol
-1
 
giving a half life of 173 days at 298 K. This value is very similar to that for the 
‘radical analogue’ 164 (27.5 kcalmol-1) and is relatively high suggesting that 
chirality transfer may be possible in the tin mediated cyclisation of enamide 209. 
Enamide 210 gave an interesting result indicative of two atropisomers that were 
interconverting on the HPLC timescale. Based on a half life of mins at 298 K the 
barrier to rotation was estimated to be in the range 20 – 23 kcalmol-1. As the values 
for the barrier to rotation of enamides 164 and 209 are very similar it suggests that 
the addition of the chlorine atom on the α-carbon to the carbonyl has minimal effect 
on the barrier to rotation. Therefore, based upon the results of the ‘radical analogues’ 
enamides 211 is likely to be inseparable by chiral HPLC with a barrier similar to that 
of 210 in the range of 20 – 23 kcalmol-1. However enamide 212 should have a high 
barrier to rotation, similar to its radical analogue 197 (31.0 kcal mol-1) and is 
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therefore a good candidate for investigating chirality transfer in tin mediated 5-endo 
cyclisations. 
As 209 showed promise for the possibility of chirality transfer, this compound was 
chosen to make the brominated analogue 214. Although enamide 214 was also 
formed during the synthesis of 209, it was only a minor component. In order to 
obtain more of enamide 214, the Finklestein reaction was used to convert chloro-
enamide 209 into bromo-enamide 214. Hence, treatment of 209 with LiBr at room 
temperature for 60 hours yielded 214 in 84% yield. 
 
Scheme 2.12: Conversion of chloro-enamide 209 into bromo-enamide 214. Reagents and 
conditions: 10 eq. LiBr, acetone, r.t. 
As expected the 400 MHz 
1
H NMR of 214 showed two clearly resolved doublets for 
the benzyl protons at room temperature and coalescence was not observed at 373K. 
As with enamide 209, excellent separation was achieved on the Whelk-O column 
(28.6 min and 35.1 min) which allowed isolation of a single atropisomer in >98:2 er 
which slowly underwent racemisation in iPrOH at 82 
o
C allowing the barrier to 
rotation to be calculated as 29.3 kcalmol
-1
 giving a half life of 5.6 years at 298 K. 
This barrier is ~1.5 kcal mol
-1
 higher than that for the ‘radical analogue’ 164 and the 
chlorinated analogue 209, showing that the large size of the bromine atom increases 
tha barrier to rotation about the N-alkenyl bond. As with the chlorinated analogue, 
the high barrier to rotation and long half life suggest that chirality transfer may be 
possible upon cyclisation of enamide 214 even at elevated temperatures.  
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Figure 2.29: HPLC chromatogram of enamide 214. 
 
2.2.4.2 Enamides for copper mediated cyclisations. 
The α-haloenamides in section 2.2.4.1 can be subjected to tin cyclisation conditions, 
however we also wanted to investigate the possibility of chirality transfer in copper 
mediated ATRC reactions. For this we needed to synthesise enamides with tertiary 
halides e.g. 204  and 205, however preparing such substrates proved more 
challenging than with the ‘radical analogues’ and the α-haloenamides. 
 
Figure 2.30: Enamides that can undergo copper mediated ATRC reactions. 
We had prepared N-acetyl 195-200 and N-chloroacetyl 209-213 enamides by 
submitting them to the iron mediated acylation of oximes (method B, Scheme 2.2 ) 
with acetic anhydride and chloroacetic anhydride respectively. Trichloroacetyl 
anhydride can be used in this approach to prepare structures 204 but the yields were 
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low.  Previous work had shown that a bromine atom could not withstand these harsh 
conditions so it was not possible to prepare the tertiary bromide enamides 205 by this 
protocol. In addition the preparation of hindered enamides by the imine route 
(method A, Schmeme 2.2) is normally unsuccessful.
157
 Due to this, we investigated 
an alternative approach involving bromination of an isopropyl acetate group to 
introduce the halogen.  
 
2.2.4.2.1 Attempted Synthesis of 205 by Bromination 
In order to develop a protocol we initially investigated this approach for the synthesis 
of known enamide 96a.  This was for two reasons.  Firstly, cyclohexanone oxime 
was commercially available and secondly, we already had authentic samples of 96a 
which would help us identify any trace amounts produced during the investigation. 
 
Scheme 2.13: Retrosynthetic analysis of enamide 96a. 
Enamide 215 was synthesised by acylation of cyclohexanone oxime 216 with 
isobutyric anhydride, followed by benzylation of 217 using benzyl bromide and 
sodium hydride. 
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Scheme 2.14: Synthesis of N-benzyl-N-(cyclohexene-1-yl)isobutryamide. Reagents and conditions; 
a) Fe(0), isobutyric anhydride, isobutyric acid, toluene, reflux.; b) NaH, BnBr, THF, reflux. 
A range of literature conditions for bromination were then attempted with varying 
bromine sources and conditions, all of which were unsuccessful (Table 2.1). 
 
Scheme 2.15. The attempted bromination reactions. 
While two approaches (Table 2.2, entries 6 and 7) showed the correct mass for the 
product in the mass spectrum of the crude reaction mixtures, the 400 MHz 
1
H NMRs 
were very messy and there was no sign of the desired product following column 
chromatography. A peak at 256.1 suggestive of the eliminated product 218 was 
identified in both reaction mixtures. This peak was also seen in the crude mass 
spectra for entries 1, 2, 4, 6, 7, 8, 9, 10 and 11. A further peak at 274.2 (Table 2.2, 
entries 1, 2, 6, 7, 8, 9, and 10) which could correspond to the hydroxyl products 219 
or 220 was also observed. All the reactions gave very messy crude NMR spectra and 
none of these postulated products could be identified or isolated by column 
chromatography. 
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Entry Bromine Source  Conditions  
1
159
 Br2 s-BuLi, -78 
o
C, THF, forward addition  
2
159
 Br2 s-BuLi, -78 
o
C, THF, reverse addition 
3
160
 Br2 n-BuLi, -78 
o
C, THF, forward addition 
4
161
 Br2 AcOH, reflux  
5
162
 Br2 LDA, -78 
o
C, THF  
6
163
 Br2 DCM, r.t.  
7
164
 NBS  p-TsOH, MeCN, reflux  
8
165
 NBS  TMSOTf, MeCN, r.t.  
9
166
 NBS  NH4OAc, CCl4, reflux  
10
167
 NBS  1,1-Azobis(cyclohexylcarbonitrile), 
CCl4, reflux  
11
168
 Cu(II)Br2  EtOAc, CHCl3, reflux  
Table 2.2: Bromine sources and conditions used in the attempted bromination reactions.  
 
Figure 2.31: Possible products in the attempted bromination reactions. 
 
2.2.4.2.2 Attempted Modifications of Acylation Reaction. 
As we had no success with brominating enamide 215 we next tried modifying the 
conditions of the iron mediated acylation so that the bromine atom could be 
tolerated. Tang et. al. have shown that iron acetate can be used as a direct 
replacement to iron,
169
 however in our hands, heating cyclohexanone oxime 216 as a 
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model with iron acetate, acetic acid and acetic anhydride failed to produce the 
desired 222 instead the only product isolated was 221 which is thought to be an 
intermediate in the reaction to give the acylated product 222.
170
 
 
Scheme 2.16: Attempted acylation of cyclohexanone.  Reagents and conditions: 3 eq. Ac2O, 3 eq. 
AcOH, 2 eq. Fe(OAc)2, toluene. 
The reaction was attempted first at room temperature, then at 70 
o
C and then at 
reflux in order to try and push the reaction past this intermediate, however 221 was 
the only product obtained in all cases. We therefore concluded that iron acetate was 
not a strong enough mediator of the rearrangment reaction. 
Barton et. al. have reported that a similar transformation can be carried out using just 
the anhydride in pyridine.
171
 Hence we tried heating cyclohexanone oxime in 
pyridine with acetic acid, however, in our hands this again just gave us the 
intermediate 221. Barton also reported that metals such as chromium(II),  and 
titanium(II) acetate have been used to mediate this rearrangement.
171
  We chose not 
to test these metals as we felt that they too were unlikely to tolerate halogen 
substituents. 
Singh et. al. have reported a phosphine mediated reductive acylation of oximes 216 
to  222).
170
 They have shown that a range of phosphines can be used (Ph3P, DPPE, 
and Et3P) to mediate the reaction with numerous substrates.  In addition they have 
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shown that transformation of an oxime acetate 221 to the enamide 222 directly is 
possible by reacting with the Et3P in the absence of an anhydride.  
 
Scheme 2.17: Singh’s acylation of cyclohexanone: Reagents and conditions: R3P, Ac2O, toluene, 
reflux. 
These conditions were tried with both cyclohexanone 216 and tetralone oximes 
however only the intermediate oxime acetate 221 was evident. Heating 221 with 
Ph3P under the conditions of Singh et. al. for 90 hours did not facilitate the reaction 
to 222. 
 
Scheme 2.18: Attempted phosphine mediated acylation of cyclohexanone. Reagents and 
conditions; a) Ph3P, Ac2O, toluene, reflux.; b) Ph3P, toluene, reflux.  
In 2011 Guan and co-workers published a copper mediated acylation of oximes, 
primarily using acetic anhydride to give the acetate enamide (Scheme 2.19) but also 
using propionic anhydride to give the propionate derivative.
172
 Although they have 
reported the reaction was unsuccessful using the halogenated trifluoroacetic 
anhydride we attempted the reaction with 2-bromoisobutyric anhydride to see if we 
could obtain any of the desired bromoenamide 223 (Scheme 2.20). 
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Scheme 2.19. Guan’s copper mediated acylation of oximes.172 Reagents and conditions: 0.1 eq. 
CuI, 3 eq. NaHSO3, 2 eq. Ac2O. 
We initially tried the reaction on cyclohexanone oxime 216. Pleasingly a low yield of 
the desired bromide 223 was obtained (9%). Other compounds were produced from  
the reaction but were not identified at this point. We next focussed on whether we 
could carry out the N-benzylation step to give 96a (Scheme 2.21) on this material 
223, before any attempts at optimising the reaction. 
 
Scheme 2.20. Copper mediated acylation of oximes. Reagents and conditions: 0.1 eq. CuI, 3 eq. 
NaHSO3, 2 eq. 2-bromoisobutyryic anhydride. 
Unfortunately we were unsuccessful with alkylating enamide 223. Using the normal 
method of deprotonation with sodium hydride, followed by the addition of benzyl 
bromide there was no sign of the desired product 96a.  
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Scheme 2.21: Desired alkylation of enamide 223. 
 
2.2.4.2.3 Synthesis of Tetrasubstituted Enamides via the Imine Route 
As we were having no success trying to modify the conditions of the acylation 
reaction, we decided to further investigate the synthesis of these compounds via the 
imine route after coming across the preparation of one tetrasubstituted enamide this 
way by McDonagh.
173
 In this instance a mixture of the regioisomers 225 and 226 was 
obtained, which could not be separated.  
 
Scheme 2.22: Synthesis of tetrasubstituted enamides via an imine intermediate. Reagents and 
conditions: i) 1.0 eq. p-methoxybenzylamine, toluene, reflux, ii) 1.0 eq. 2-bromoisobutryl bromide, 
1.0 eq. N,N-diethylaniline, toluene, 0 
o
C – r.t.173 
Pleasingly, we found it was possible to synthesise enamides 229 and 231 by this 
route and have been able to go on to cyclise these (see chapter 3). As McDonagh 
found, we got a mixture of the two regioisomers which proved very difficult to 
separate, however after multiple attempts compounds 229 and 231 were obtained 
pure in yields of 21% and 13% respectively. 
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Scheme 2.23: Synthesis of tetrasubstituted enamides via an imine intermediate. Reagents and 
conditions: a) i) 1.0 eq. benzylamine, toluene, reflux, ii) 1.1 eq. trichloroacetyl chloride, 1.2 eq. Et3N, 
toluene, 0 
o
C – r.t. b) i) 1.0 eq. benzylamine, toluene, reflux, ii) 1.1 eq. 2-bromoisobutyryl bromide, 
1.2 eq. Et3N, toluene, 0 
o
C – r.t.  
Having had success with synthesising enamides 229 and 231 via the imine route, we 
applied the same conditions to the synthesis of enamides 232 – 236. The desired 
products were obtained in better yields (38-74%) as there was only one possible 
regioisomer, which also meant purification was easier.  
 
Figure 2.32: Tetrasubstituted enamides synthesised via the imine route showing yields and the 
ratio of amide rotamers.  
These compounds all provided unusual 400 MHz 
1
H NMR results; whereas all 
tetrasubstituted enamides synthesised previously showed one set of peaks consistent 
of largely a single E-amide rotamer in solution, the 
1
H NMR of enamides 232 – 236 
at 298 K showed two sets of peaks (Figure 2.33), however at 373 K there was just a 
single set of peaks (Figure 2.34). This is indicative of the presence of both E-235 and 
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Z-235 amide rotamers in solution. The population of the two rotamers seems to be 
independent of the alkene group, and dictacted by the acyl substitutent, with 233 and 
235 showing similar ratios of rotamers and 232, 234 and 236 showing similar ratios. 
Heating a sample of 232 to reflux in toluene for 24h followed by cooling did not 
change the ratio of rotamers showing that they are at equilibrium in solution. Thus as 
the enamides become more hindered at the acyl position the E-amide rotamer 
becomes less favourable. Unfortunately, as the Z rotamer is not predisposed for 
cyclisation this means heating may be required to cause an appropriate population of 
the reactive E-conformer.  This in turn will increase the rate of rotation around the N-
alkenyl bond and may reduce the chance of chirality transfer in these substrates.  
 
Figure 2.33: 400 MHz 
1
H NMR of enamide 235 at 298 K showing slow rotation around both the 
NC=O and NC=C bonds. 
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Figure 2.34: 400 MHz 
1
H NMR of enamide 235 at 373 K. 
Based upon the failure to separate the atropisomers of the related acetate analogues 
195 – 196, we did not expect separation of enamides 232 – 235 by chiral HPLC. 
However, increased substitution at the α-carbonyl has been shown to increase this 
barrier to rotation so we sent enamides 232 and 233 to Curran to attempt separation 
by chiral HPLC, although unfortunately no separation was achieved. 
      
Figure 2.35: HPLC chromatograms of enamides 232 and 233 
The barrier to rotation calculated for enamide 197 was calculated as 31.0 kcalmol
-1
, 
we therefore expect the trichloroacetate analogue 236 to also have a high barrier to 
rotation, as previous results have shown that increased substitution at the acetate 
Chapter 2: Investigations into the Barrier to Rotation in Enamides 
 
92 
 
increases the barrier to rotation.
111
 Enamide 236 is therefore a suitable compound to 
attempt chirality transfer in a copper mediated ATRC reaction.  
 
Figure 2.36: Enamide 236 and the acetate analogue 197. 
2.2.4.2.4 Synthesising the Methyltetralone Analogue 237 
As enamides 164, 209, and 214 all gave barriers to rotation high enough to make 
them suitable to be separated at room temperature, we were also particularly 
interested in synthesising enamide 237. 
 
Figure 2.36: Methyltetralone based enamides 
Attempts at preparing the imine derived from benzylamine and methyltetralone using 
TsOH catalysis failed. Instead we prepared the imine in situ by reaction with  
titanium isopropoxide at 80 
o
C.  After addition of triethylamine and bromoisobutyryl 
bromide it was possible to prepare the desired 237, albeit in a 9% yield. As before for 
232-236, the 600 MHz 
1
H NMR of 237 indicated that both the E- and Z- amide 
rotamers were present in solution in a 1:0.17 ratio. Based on the barriers to rotation 
of enamides 164, 209 and 214 and results showing increased substitution at the α-
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carbon increases the barrier to rotation we expect enamide 237 to have a high barrier 
to rotation and be separable by chiral HPLC, therefore a suitable compound to 
attempt chirality transfer in copper mediated ATRC reactions. 
 
Figure 2.37: 600 MHz 
1
H NMR of enamide 237. 
 
2.2.4 Structural Analysis by Crystallography 
Crystallography also provides some interesting insight into the conformation of the 
prepared enamides. Crystals structures of enamides 161, 164 and 238, made 
previously within the group, had been obtained and show that the N-alkenyl bond 
prefers to lie orthogonal to the plane of the N-CO bond with torsion angles ranging 
from 53
o
 to 85
o 
(Table 2.3, entries 1-3).
157
 We obtained crystal structures of the 
synthesised enamides 195, 229 and 235 and these also followed this trend with the 
torsion angles between the alkene bond and the N-CO bond between 65
o
 and 95
o 
(Table 2.3, entries 4-6). This indicates there is restricted rotation about the N-alkenyl 
bond as the two planes are not lying flat as expected if the bond was freely rotating. 
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Figure 2.38: Compounds with structures elucidated by crystallography. 
Entry Compound Torsion Angle
a Amide 
conformation 
1 238 53
o
 E 
2 161 85
 o
 E 
3 164 74
 o
 E 
4 195 65
 o
 E 
5 229 95
 o
 Z 
6 235 69 
o
 Z 
Table 2.3: Torsion angles and amide conformations deduced from crystal structures. 
a
Torsion 
angle between N-CO bond and alkene bond. 
    
Figure 2.39. X-ray crystal structure of enamide 195 occupying the E-amide rotamer. 
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It is also interesting to observe the conformation of the amide bond in the crystal 
structures obtained. Whereas enamides 161, 164, 238 and 195 showed a preference 
for the E-amide rotamer in the solid state, the more hindered tetrasubstituted 
enamides with the larger acyl groups, 229 and 235 show a preference for the less 
common Z-amide rotamer in the solid state. This is in agreement with the 
1
H NMR 
where both amides rotamers were observed. 
     
Figure 2.40: X-ray crystal structure of enamide 235. 
     
Figure 2.41: X-ray crystal structure of enamide 229. 
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In the crystal structure of 229 both atropisomers can be seen co-crystallising but 
interestingly, whereas one atropisomer shows only one conformation for the 
cyclohexenyl ring, the other has a degree of disorder here with two observed 
conformations in a 54:46 ratio. 
Based upon these results, an interesting question arises, as to whether it is possible 
that molecules with exceptionally high barriers to rotation, e.g. 209 and 237, will 
prove difficult to cyclise as significant steric crowding from the alkenyl substituents 
will occur on moving to planarity.   
 
2.2.5 Summary 
A range of different enamides (171 - 176, 195 - 201, 209 - 214, 229, 231 and  232 - 
237) have been synthesised of which the majority exhibited slow rotation about the 
N-alkenyl bond, with barriers to rotation varying between <9.4 and 31 kcal mol
-1
. 
The level of substitution at the alkene was found to be a key factor in controlling the 
rate of rotation about the N-alkenyl bond, with tetrasubstituted enamides e.g. 209, 
214 and 236, giving the highest barriers to rotation. However tetrasubstituted 
enamides with freely rotating -substituents, e.g. 195, appear to have a co-operative 
gearing leading to lower than expected barriers to rotation. Contrastingly 
tetrasubstituted enamides with rigid - and ’- substituents e.g. 239 and 240 have 
high enough barriers to rotation to allow separation at room temperature by chiral 
HPLC with half lives ranging from 5.5 days to 128 years at 298 K. This suggests that 
enamides of general structure 239 and 240 are suitable for further investigations into 
the possibility of chirality transfer in copper mediated ATRC reactions.    
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Figure 2.41: Tetrasubstituted enamides. 
However, for hindered tetrasubstituted enamides with large acyl groups (232 - 237) 
both E- and Z- amide rotamers were observed in solution at room temperature. This 
may affect the efficiency of any cyclisation reaction as in the Z-amide rotamer the 
halogen is not positioned in proximity of the alkene. Heating the enamides to 373 K 
was found to lead to fast interconversion of the E- and Z- amide rotamers on the 
NMR timescale so cyclisations at elevated temperatures may be more efficient, 
although at higher temperatures the half lives of the atropisomers will be 
significantly lower. 
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3.0: 5-Endo Cyclisations of Atropisomeric Enamides 
 
3.1 Introduction 
Having successfully synthesised a variety of tetrasubstituted enamides, including a 
number of which it was possible to separate their atropisomers at room temperature, 
we next investigated the radical cyclisation of these enamides, and the results are 
described in this chapter. 
 
Figure 3.1: Atropisomeric enamides with high barriers to rotation. 
We envisaged that cyclisation of enantiomerically pure samples of these enamides 
could lead to chirality transfer to the product if krot of the radical intermediate is 
slower than kc (Scheme 3.1). Radical 241 has been shown to undergo 5-endo trig 
radical cyclisation reactions at rates in the order of 10
4
 s
-1
.
153
 If we assume 164 is a 
model for radical 151 we can estimate that the krot for this radical is in the order of 
4.2 x 10
-8
 s
-1 
at room temperature,
157
 indicating that there is some merit in exploring 
this hypothesis. 
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Scheme 3.1: Possible chirality transfer in the cyclisation of enamides. 
 
3.1.1. Existing Conditions for Cyclisation 
Over the past couple of decades there have been many developments in conditions 
for the cyclisation of enamides (see Chapter 1, section 1.2 in particular section 1.2.4 
for 5-endo cyclisations) with ligand accelerated copper mediated conditions proving 
very popular. Common ligands are based upon polydentate nitrogen compounds such 
as bipy,
104
 TMEDA,
105
 hexamethyl triethylenediamine (Me6-tren),
71
 or tris(2-
pyridylmethyl)amine (TPA)
174
 with the latter being the ligand of choice for slow 
cyclisations. The vast majority of published cyclizations involve disubstituted 
structures such as 242
71
 or trisubstituted structures where the alkene is part of a ring 
(e.g 96a),
71
 with only limited examples of the cyclisation of tetrasubstituted 
enamides in the literature.
173
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Scheme 3.2: Copper mediated 5-endo cyclisations. Reagents and conditions: a) CuCl, ligand 42a, 
DCM, 40 
o
C. b) CuBr, ligand. 
These processes generally proceed to give an -amido radical 100a which is then 
oxidised to an acyl iminium ion 101a by the CuBr2 liberated in the first step.  This 
acyl iminium ion 101a can eliminate a proton to give alkene regioisomers 97a and 
98a, or it can be trapped by external nucleophiles (e.g. alcohols) to give 244 
depending upon the reaction conditions.
5
  Although lactam 98a is not chiral, lactams 
97a and 244 contain stereocentres produced during the cyclisation process and 
therefore provide opportunity for chirality transfer upon cyclisation. 
 
McDonagh has carried out the cyclisation of an inseparable mixture of 
tetrasubstituted enamide 245 and trisubstituted enamide 246 using both Me6-Tren 
and TPA as ligands.
173
 When treated with 30 mol% CuBr:TPA in toluene at reflux 
both enamides cyclised in a 5-endo fashion to yield lactams 247 and 248. However 
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when treated with 30 mol% CuBr:Me6-tren in DCM at room temperature lactam 249, 
formed from the 4-exo cyclisation of 245 followed by elimination, was observed 
alongside 248, and the 5-endo cyclisation product 247 was not observed (Scheme 
3.3).
173
 Both the 5-endo and the 4-exo products from the cyclisation of 245 contain 
stereocentres formed in the cyclisation process, therefore suggesting compounds of 
similar structure could be possible candidates for chirality transfer upon cyclisation. 
 
Scheme 3.3: Cyclisation of enamides 245 and 246. Reagents  and Conditions: a) 0.3 eq. CuBr, 0.3 
eq. TPA, toluene, reflux. b) 0.3 eq. CuBr, 0.3 eq. Me6-tren, DCM, r.t. 
The AGET ATRC conditions of Clark have also been shown to mediate the 
cyclisation of bromo enamides, giving a mixture of reduced (118 and 119) and 
oxidatively terminated products (120 and 121).
81
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Scheme 3.4: CuSO4/KBH4 mediated 5-endo cyclisation. Reagents and Condition: 1 mol% 
CuSO4.5H2O, 100 mol% KBH4, MeOH, r.t., 30 min. 
Successful copper mediated conditions have not been reported for the cyclisation of 
primary α-halo enamides such as 209 and 214, instead the more traditional tin 
mediated conditions must be used. Ishibashi has reported that 5-endo-trig cyclisation  
of α-chloroenamides can be mediated by Bu3SnH to give 5-membered lactams.
23
 
Treatment of enamide 8 with Bu3SnH in the presence of AIBN led to the 5-endo 
cyclisation product 10 in 63% yield along with the reduced non-cyclised compound 
11 as a minor product (Scheme 3.5). 
 
Scheme 3.5: Tin mediated cyclisation of N-vinylic α-chloroacetamides: Reagents and conditions: 
Bu3SnH (1.1 eq.), AIBN (cat.) toluene, reflux. 
1,1’-Azobis(cyclohexanecarbonitrile) (ACN) 255 has also been used as an initiator 
instead of AIBN and has been shown to lead to better conversions.
175
 Ishibashi used 
the ACN initiator in the sequential radical cyclisation of 250.
6
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Scheme 3.6: Sequential radical cyclisation of 250 initiated by ACN. Reagents and Conditions: 2.4 
eq. Bu3SnH, 5 eq. Bu3SnF, 0.1 eq. ACN, toluene, reflux. 
 
3.2 Results and Discussion 
Due to the lack of precedent for the cyclisation of tetrasubstituted enamides we 
decided to first investigate the cyclisation of racemic mixtures to determine how 
easily the tetrasubstituted enamides underwent cyclisation, allowing us to determine 
suitable conditions for the reactions and to identify the products of the cyclisations. 
 
3.2.1 Tin Mediated Cyclisations of α-Halo Enamides. 
We first turned our attention to the methyl-tetralone analogues 209 and 214. 
Calculations showed that enamide 209 had an estimated half life of 312 s at 110 ˚C, 
whereas bromide 214 had a significantly longer half life of 18.6 h at 80 ˚C or 39 
mins at 110 ˚C. As Bu3SnH mediated cyclisations of enamides are generally carried 
out at elevated temperatures for example in refluxing toluene, chirality transfer is 
much more likely in the cyclisation of 214 than 209. We therefore chose to 
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investigate the Bu3SnH mediated cyclisation of 214 first. A 0.12M solution of 
bromide 214 was treated with 1.5 eq. of Bu3SnH and 0.2 eq. of ACN at reflux. After 
22 hours there was still a large amount of starting material present so a further 1.5 
eq. of Bu3SnH and 0.2 eq. of ACN were added and the reaction refluxed for a further 
2 hours.   
 
Scheme 3.7: Predicted product from Bu3SnH mediated radical cyclisation of 214. Reagents and 
Conditions: 1.5 eq. Bu3SnH, 0.2 eq. ACN, toluene, reflux. 
It was apparent that the reaction was proceeding slowly under these conditions due 
to significant amounts of starting material remaining and that these conditions (>39 
mins at 110 ˚C) would NOT be suitable for efficient asymmetry transfer in the 
cyclisation of 214.  It appeared that any radical chain process was inefficient and 
significant amounts of initiator was required.  In fact a further 0.2 eq. of ACN was 
added, in two further portions after a further 4 and 6 hours before starting material 
was not detected by tlc. The reaction mixture was then concentrated in vacuo and 
partitioned between acetonitrile and hexane and the acetonitrile phase concentrated 
to give the crude product. 
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Scheme 3.8: Attempted cyclisation of tetrasubstituted enamide 214. Reagents and conditions: 
Bu3SnH, ACN, toluene, 110 
o
C, 18h, syringe pump. 
The 400 MHz 
1
H NMR of the crude reaction mixture was complicated indicating a 
number of products, but importantly no cyclised product 152 could be identified. 
Although no products could be isolated pure, the naphthalene 256 and oxidatively 
cleaved product 257 were identified in the reaction mixture based upon previous 
characterization of these compounds and comparison of their reported 
1
H spectra, 
Scheme 3.8.
157
 The naphthalene 256 was thought to be formed by initial radical 
formation 258 via homolysis of the C-Br bond and reduction by Bu3SnH without 
cyclisation, followed by ACN mediated oxidation / aromatisation of the tetralene 
ring to the naphthalene. This would explain why such a large amount of initiator was 
needed in the reaction.   
 
Scheme 3.9: Formation of naphthalene 256. Reagents and conditions: Bu3SnH, ACN, toluene, 110 
o
C, 18h. 
Mechanistically is postulated that 257 was formed via the mechanism shown in 
Scheme 3.10. 5-Endo cyclisation of radical 258 may be hindered due to the 
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significant steric crowding from the alkenyl substituents on moving to planarity, 
which could lead to alternative reaction manifolds for radical 258 in the reaction 
mixture. Reaction of 258 with advantageous O2 would likely furnish the peroxy 
radical 259 which after 6-exo cyclization to give 260 could be trapped by a second 
molecule of O2 to give 261. Cyclisation of 259 is likely to be more facile than 258. A 
model of the intermediate tertiary radical 260 indicates attack of the second molecule 
of oxygen is likely to take place at the least hindered face giving 261. 
Scheme 3.10: Speculated mechanism for the formation of 257. 
At this point we speculate that the oxygen radical in 261 is close enough to the 
second peroxide bond for an intramolecular homolytic substitution to occur which 
would lead to molozonide 262.  Collapse and reduction of the molozonide by 
Bu3SnH would initially lead to the keto-imide 263 which after acyl transfer would 
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furnish the observed ketone 257.  The same rearrangement was also observed for 
cyclisation of the iodo analogue 165.
157 
As the cyclisation of the both the bromo- and the iodo analogues 214 and 165 had 
been unsuccessful we chose not to attempt the cyclisation of the chloro- analogue 
209, presuming it would give similar results. Instead we turned our attention to the 
cyclisation of α-chloroenamides not based upon methyltetralone.  While structure 
210 was known to have too low a barrier to rotation around the N-C alkenyl bond for 
the separation of atropisomers at room temperature to be accomplished, we 
investigated its reaction with Bu3SnH in order to gain an understanding of the scope 
and limitation of cyclisations onto hindered enamides. 
A 0.02M solution of 210 in toluene was treated with 1.5 eq. of Bu3SnH and 0.2 eq. 
ACN and refluxed for 26 hours. The reaction mixture was then concentrated in 
vacuo, partitioned between acetonitrile and hexane and the acetonitrile phase 
concentrated to give the crude product.  
 
Scheme 3.11: Bu3SnH mediated cyclisation of 210. Reagents and Conditions: 1.5 eq. Bu3SnH, 0.2 
eq. ACN, toluene, reflux 26 h. 
The reaction did not go to completion, with some starting material still observed in 
the crude reaction mixture (21%). Three other products were also identified; the 
reduced pre-cyclised product 195, the reduced 5-endo cyclisation product 264 and 
the oxidatively terminated 5-endo cyclisation product 265. The ratio of the products 
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was determined from the 300 MHz 
1
H NMR as 1 : 1.44 : 1.28 : 0.79 (210 : 195 : 264 
: 265) with the non-cyclised reduced product 195 as the major product. The ratio of 
195/[264 + 265] indicates that the rate constant of cyclisation is in the order of 1 x 
10
6 
M
-1
s
-1
 (assuming the rate constant for reduction of an -amide radical with 
Bu3SnH at 383K is 9.3 x 10
6 
M
-1
s
-1
).
176,177
  Mechanistically, the cyclisation has been 
terminated both reductively 264 (presumably by conventional reduction of the 
radical by Bu3SnH) and oxidatively 265.  Oxidative termination of 5-endo 
cyclisation reactions mediated by Bu3SnH is well known and is thought to proceed 
via the acyl iminium ion,
153
 normally by loss of a proton to give an alkene.  In this 
case elimination is not possible and the reaction is terminated by trapping with water 
(either by advantageous moisture or upon work-up).  Unfortunately the cyclisation of 
210 does not result in a stereocentre formed in the cyclisation step and is therefore 
not a suitable candidate for chirality transfer. It does however show that Bu3SnH 
mediated cyclisation of tetrasubstituted α-halosubstrates is possible at synthetically 
useful rates. 
We next investigated the cyclisation of enamide 212, which, should it cyclise in the 
same manner as 210 to give 5-endo products 267 and 268 would form a chiral centre 
in the cyclisation step. Enamide 197, a model for the radical 266, was found to have 
a half-life of 128 years at room temperature or 10.6 days at 100 
o
C suggesting that 
even prolonged heating over 24 hours in toluene at reflux should not lead to 
significant racemisation. 
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Scheme 3.12: Possible outcome of Bu3SnH mediated cyclisation of 212. Reagents and Conditions: 
1.5 eq. Bu3SnH, 0.2 eq. ACN, toluene, reflux 22 h. 
Disappointingly the treatment of 212 with Bu3SnH and ACN resulted in 100% 
conversion to the reduced precyclised compound 197. Presumably the hindered 
nature of 212 and the corresponding radical 266 slows the rate of the cyclisation 
significantly so that reduction of radical 266 dominates.  
 
3.2.2 Copper mediated cyclisations of enamides with tertiary halides. 
Enamides of general structure 204 and 205 are known to undergo copper mediated 
cyclisations.
5
 These cyclisations can generally be achieved at room temperature and 
this would provide a significant advantage when attempting asymmetry transfer in 
reactions of atropisomers.  We initially chose to investigate the Cu(I)X mediated 
radical-polar crossover reactions of structures 229 and 231.   
 
Figure 3.2: Enamides for copper mediated cyclisation. 
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Based upon the conditions used by McDonagh for the cyclisation of 245 and 246 (30 
mol% Cu(TPA)Br or 100 mol% Cu(TPA)Cl in toluene at reflux, and 30 mol% 
Cu(Me6-Tren)Br or 100 mol% Cu(Me6-Tren)Cl in DCM at room temperature)
173
 we 
chose four sets of conditions (two temperatures and two solvents) for our initial 
investigations altering one variable at a time (Table 3.1) and applied these to the 
cyclisation of enamides 229 and 231.  
 
Scheme 3.13: Copper Mediated Cyclisation of enamides 229 and 231. Reagents and Conditions: 
a) 100 mol% CuCl, 100 mol% ligand, solvent, 24 h. b) 30 mol% CuBr, 30 mol% ligand, solvent, 24 h. 
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Entry Substrate 
Copper 
Ligand 
Solvent Temp Products Product ratio
a
 
1 229 Me6-tren DCM r.t. 269 + 229 1:2.9 
2 229 TPA DCM r.t. 269 + 229 1:3.4 
3 229 TPA Toluene r.t 269 + 229 1:2 
4 229 TPA Toluene 110 
o
C 269
b
 1:0 
5 231 Me6-tren DCM r.t. 
No 
reaction 
N/A 
6 231 TPA DCM r.t. 
No 
reaction 
N/A 
7 231 TPA Toluene r.t. 
No 
reaction 
N/A 
8 231 TPA Toluene 110 
o
C 270 + 231 2.6:1 
Table 3.1: Cyclisation conditions and products for compounds 229 and 231. 
a 
Taken from crude 
NMR. 
b
 100% conversion by crude NMR 
In contrast to the results of McDonagh, the 4-exo product was not observed in any of 
the cyclisations. Disappointingly low yields of 269 from 229 were obtained at room 
temperature and because copper mediated cyclisations of trichloroacetamides are 
generally faster than those of monobromoacetamides it came as no surprise to find 
that there was no reaction for derivative 231 under these conditions.  With the 
trichloro substrate 229 the 5-endo product 269 was observed under all conditions, 
although TPA in toluene at reflux (Table 3.1, entry 4) were the only conditions that 
gave full conversion to product. For compound 231 only TPA, in toluene at reflux 
yielded any of the 5-endo product 270 (Table 3.1, entry 8).  The X-ray structure of 
229 (Chapter 2, Figure 2.40) showed a (Z)-amide configuration in the solid state (as 
opposed to the normal (E)-configuration).  This may have a bearing on the need for 
high temperatures for successful reaction of these substrates, as the (E)-configuration 
is the only one that can lead to successful cyclisation. 
Chapter 3: 5-Endo Cyclisations of Atropisomeric Enamides 
 
112 
 
 
Figure 3.3. Chiral HPLC trace of compound 269. 
While the cyclisation of enamides 229 and 231 proceeded successfully, and the 
enantiomers of one product 269 could be separated by chiral HPLC on a Chiracel 
AD column (Figure 3.3), these substrates 229 and 231 were not suitable candidates 
for investigating chirality transfer during their cyclisations. As discussed in Chapter 
2 (section 2.2.4), it was not possible to separate the atropisomeric starting materials 
229 and 231 at room temperature by chiral HPLC due to relatively low barriers to 
rotation.  Cyclisation of these substrates did however identify suitable conditions for 
the further study on copper mediated cyclisations of tetrasubstituted enamides; CuX, 
TPA, toluene, at reflux. 
These conditions were subsequently applied to the cyclisation of enamides 232 – 
235. These substrates would not lead to any chirality transfer during cyclisation, as 
no chiral centre would be formed in the cyclisation step, however they would 
provide us further insight into the cyclisations of tetrasubstituted enamides.   All four 
of these substrates exhibited a doubling up of peaks in the 
1
H NMR, indicating the 
presence of both the E- and Z- amide rotamers in solution (see chapter 2, section 
2.2.4.2). As for 229 this could potentially hinder the cyclisation of these substrates as 
in the Z-rotamer the halogen is positioned to far away from the alkene to allow 
cyclisation. Pleasingly heating the samples to 100 
o
C led to coalescence of the two 
sets of signals to a single sharp set, indicating rapid interconversion of the rotamers 
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at high temperatures, suggesting that this should not be a problem when carrying out 
the cyclisation in refluxing toluene. 
 
Figure 3.4: Atropisomeric enamides. 
Trichloroenamides 232 and 234 were treated with 1 eq. CuCl and 1 eq. TPA in 
refluxing toluene for 2 hours followed by a simple work-up procedure of filtration 
through a silica plug. In both cases two hydroxyl terminated products were isolated 
(272, 273 and 275, 276 respectively, Scheme 3.14). Unlike the cyclisation of 
enamides 245 and 246 the intermediate acyl iminium ion cannot eliminate to give the 
unsaturated product, instead the products are derived from trapping of the 
intermediate acyl iminium ion with water (as observed for the Bu3SnH mediated 
cyclisation of 210, Scheme 3.11).  In addition to the expected products 273 and 276 
containing an -gem dichloro group two monochloro structures 272 and 275 were 
obtained. Stick models of 273 and 276 indicate that the gem-dichloro substituents at 
C-3 are eclipsed by the carbons attached at C-4.  It is postulated that facile reduction 
of one of the chlorine atoms occurs to relieve this steric strain between the gem-
dichloride and gem-dimethyl groups. This is likely to occur by a second atom 
transfer from Cu(TPA)Cl giving an -amide radical which is then reduced by the 
solvent. It was pleasing to see that no starting material was left in the reaction 
mixture, showing that the existence of the Z-amide rotamer in the starting material 
did not hinder the cyclisation at 110 ˚C. 
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Scheme 3.14: Copper mediated cyclisation of tetrasubstituted trichloroenamides. Reagents and 
Conditions: 100 mol% CuCl, 100 mol% TPA, toluene, reflux, 2 h 
Lactams 272 and 275 were obtained as single diastereomers and nOe experiments 
were carried out to determine the stereochemistry. 272 was tentatively assigned with 
the chloro- and hydroxyl- groups cis to one another (Figure 3.5), however the data 
for 275 proved inconclusive and it was not possible to assign the stereochemistry. 
 
Figure 3.5: nOe data and assigned stereochemistry of 273 
We next looked at the cyclisation of bromo analogues 233 and 235. Treatment of 
enamide 235 with 0.6 eq. CuBr and 0.6 eq. TPA in refluxing toluene yielded three 
products 278, 279 and 280 in 15%, 36% and 4% yields respectively. The major 
product 279 is thought to arise from trapping of the acyl iminium ion 282 with H2O 
as before, while the reduced product 278 may arise from abstraction of a hydrogen 
atom from the solvent.  
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Scheme 3.15: Copper mediated cyclisation of enamide 235. Reagents and Conditions: 0.6 eq. 
CuBr, 0.6 eq. TPA, toluene, reflux, 24 h. 
Cyclopropyl compound 280 was unexpected and was isolated in very low yield, 
however its formation deserves comment.  Trapping of an alkyl group to give a 
cyclopropane by loss of a proton during a 1,2-migration is rare.
178
 Nevertheless it is 
possible that within the acyl imimium ion intermediate 282 there is a significant 
steric clash between the two different gem-dimethyl groups (as in 273) and that in 
order to relieve these steric clashes a twisting of the ring occurs, placing the 
migrating carbon close in space to the carbon of the acyl iminium ion 283 initiating 
the process (Scheme 3.16). 
 
Scheme 3.16: Formation of cyclopropyl product 280. 
Cyclisation of enamide 233 under the same conditions yielded the same set of 
products, the hydroxyl product 285 (33%), the reduced product 286 (5%) and the 
cyclopropyl product 287 (21%). However in this case significantly more of the 
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cyclopropyl product 287 was isolated than in the analogous reaction of 235 (21% as 
opposed to 4%). Presumably, the more electron rich nature of methylene group 
compared to the methyl group is responsible for the greater yield of migration 
product 287. 
 
Scheme 3.17: Copper mediated cyclisation of enamide 233. Reagents and Conditions: 0.6 eq. 
CuBr, 0.6 eq. TPA, toluene, reflux, 24 h. 
It was also possible to mediate 5-endo cyclizations of 233 and 235 using the AGET 
ATRC protocol
81
 with CuSO4.5H2O and KBH4. In this instance the KBH4 acts in a 
dual role as catalyst generator and acyl iminium ion reducing agent.  It was hoped 
that inclusion of a reducing agent (KBH4) might suppress termination by oxidation 
and migration and increase the yield of 278 and 286. Hence, 235 was reacted with 
with 2.5 mol% Cu(TPA)SO4 and 1 equivalent of KBH4 in MeOH for 30 min at room 
temperature. The reductively terminated 278 was identified in the crude NMR in a 
1:2 ratio with another product tentatively assigned as the solvent trapped methoxy 
terminated 288 based upon mass spec and a characteristic methoxy peak at ~3.1 ppm 
in the 
1
H NMR. Unfortunately the crude reaction mixture proved more complex than 
the Cu(TPA)Br mediated cyclisation and it was not possible to isolate the products. 
The cyclisation of 233 under identical conditions gave similar results. Again the 
crude reaction mixture was complex, but the corresponding products 286 and 289 
were identified in a 1:0.7 ratio in the crude 
1
H NMR. As with 288, the methoxy 
terminated product 289 was assigned based upon mass spec and the characteristic 
Chapter 3: 5-Endo Cyclisations of Atropisomeric Enamides 
 
117 
 
methoxy peak at ~3.1 ppm in the 
1
H NMR. Despite the presence of a number of 
unidentified products, the cyclopropyl products 280 and 287 were not observed in 
either reaction. It is likely that in comparison to the standard Cu(TPA)Br process the 
nucleophilic solvent (MeOH) and stoichiometric reductant employed provide a rapid 
trap of the intermediate acyl iminium ion shutting down the methyl migration 
pathway. 
 
Scheme 3.18: Cyclisation of enamides 233 and 235 under AGET ATRC conditions. Reagents and 
Conditions: 2.5 mol% CuSO4.5H2O, 2.5 mol% TPA, 100 mol% KBH4, methanol, r.t. 
3.2.2.1 Copper Mediated Cyclisations of Enamides with High Barriers to 
Rotation. 
Both enamides 197 and 164 were separable by chiral HPLC and had high barriers to 
rotation of 31.0 kcal mol
-1
 and 27.5 kcal mol
-1 
respectively.   Based upon the barriers 
calculated for 197 and 164 we can assume that the halogenated analogues 236 and 
237 would also have high barriers to rotation. Cyclisation of both enamides 236 and 
237 would also lead to the generation of a chiral centre in the cyclisation step 
making them ideal candidates for investigating chirality transfer upon cyclisation.  
The tertiary nature of the halides would make them ideal substrates for Cu(TPA)X 
mediated cyclisations. 
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Figure 3.4: Tetrasubstituted enamides separable by chiral HPLC. 
Enamide 236 was treated with CuCl and TPA in reluxing toluene. Based upon the 
products obtained in the cyclisation of the related enamides 232 and 234 (Scheme 
3.14, page 114), the expected products were 290 and 291, however these were not 
observed. Instead the ring opened products 292 and 293 were isolated in 12% and 
38% respectively, along with 25% recovered starting material. The more hindered 
nature of the starting material 236 is likely to slow down the rate of cyclisation 
therefore it is not surprising that the reaction did not go to completion. Presumably 
the products 292 and 293 are formed by ring opening of the cyclised products 290 
and 291 to relieve strain caused by steric hinderance. The chiral centre formed in the 
cyclisation step is still present in the final products, so it is possible that chirality 
transfer could still occur, however at the time of writing we have not investigated 
this.  
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Scheme 3.19: Copper mediated cyclisation of enamide 236. Reagents and Conditions: 1 eq. CuCl, 
1 eq. TPA, toluene, reflux, 2  h. 
Enamide 237 was cyclised twice under slightly different conditions providing 
different results. Heating 237 with 60 mol% Cu(TPMA)Br in anhydrous degassed 
toluene (freeze/pump/thaw technique) at reflux for 15 hours hours led to three 
products 294-296 in 31%, 19%, and 7% yields respectively. These are the expected 
products based upon the results of the related cyclisations of 233 and 235, (Section 
3.2.2, page 109). Hence, cyclisation was terminated reductively 294, oxidatively by 
trapping with water 295 and by alkyl migration to give the cyclopropyl derivative 
296. In this case it is interesting to note that 1,2-migration of  the more electron rich 
methylene group is observed rather than the methyl group.  The significant amount 
of hydroxyl terminated product 295 observed (19%) and the fact that anhydrous 
toluene was used in the reaction suggests that the source of the hydroxyl group is 
likely to be from water provided upon work-up of the reaction. nOe experiments of 
294  and 295 allowed tentative assignment of cis stereochemistry at the ring junction 
in both compounds. 
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Scheme 3.20: Copper mediated cyclisation of 237. Reagents and Conditions: 0.6 eq. CuBr, 0.6 eq. 
TPA, toluene, reflux, 15 h. 
If the reaction was repeated without the solvent being thoroughly degassed then 
significant amounts of the ring-cleaved structure 297 were obtained alongside the 
hydroxyl terminated product 295. There was a significant amount of starting material 
left after 24 h, and therefore a further 0.6 eq. of CuBr and 0.6 eq. of TPA were added 
and the reaction refluxed for a further 20 h to try and push the reaction to 
completion. After 20 h there was no starting material left and the two products 295 
and 297 were still present in the same ratio as they were after 24 h. (295:297 = 
1:0.5). The by-product 297 is structurally similar to that observed 257 in the 
attempted cyclisation of 214 and we propose that it is formed via the same 
mechanism (see Scheme 3.8). 
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Scheme 3.21: Generation of by-products in cyclisations of methyltetralone based enamides. 
Reagents and Conditions: a) 1.2 eq. CuBr, 1.2 eq. TPA, toluene, reflux, 15 h. b) Bu3SnH, AIBN, 
toluene, 110 
o
C, 18h, syringe pump. 
We also attempted the cyclisation of 237 using the AGET ATRC conditions. As 
before we expected that the reactions would lead to a methoxy terminated 
heterocycle 298 and that the cyclopropyl terminated 296 would be absent (See 
Scheme 3.18).  Disappointingly upon treatment of 237 with 2.5 mol% 
Cu(TPA)SO4.5H2O and 100 mol% of  KBH4 in MeOH at room temperature for 8 
hours a complex mixture of products was obtained. Due to the complexity of the 
mixture it was not possible to isolate any of the products pure, however we  
tentatively assigned the presence of structures 295, 298-300 based on key peaks in 
the 
1
H NMR and mass spec data.  
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Scheme 3.22: Attempted cyclisation of enamide 237 under AGET ATRC conditions. Reagents 
and Conditions: 2.5 mol% Cu(TPA)SO4.5H2O, 100 mol% of  KBH4, MeOH, r.t., 8 h. 
 
3.2.3 Chirality Transfer in Radical Cyclisations 
The Cu(TPA)Br mediated cyclisation of 237 has the potential to proceed with 
chirality transfer; the two atropisomers can be partially resolved by chiral HPLC 
(although the barrier to rotation has not been calculated), and the three cyclisation 
products 294 – 296 have a chiral centre formed in the cyclisation step of the reaction. 
We therefore sent a sample of the enamide 237 to our collaborators in the Dennis 
Curran research group in Pittsburg in order to separate the atropisomers on a 
preparative scale by HPLC and use the enantiomerically enriched samples 237 in a 
cyclisation reaction to investigate the possibility of asymmetry transfer. In addition 
we sent authentic racemic samples of each of the cyclisation products 294 – 296 as 
well as the achiral ring-opened tricarbonyl derivative 297 so these could be resolved 
to facilitate enantiomeric excess determination after cyclisation. The three 
enantiomeric cyclisation products 294 – 296 could all be resolved on a Whelk-O 
chiral HPLC column. Pleasingly a co-injection of all three racemic cyclisation 
products along with structure 297 indicated that each component of the mixture 
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could be resolved (Figure 3.5), meaning that it should be a relatively simple task to 
assess any chirality transfer following cyclisation of an enatiomerically enriched 
sample of 237. 
 
Figure 3.6: Chiral HPLC trace of co-injection of the products from the cyclisation of 237. 
Unfortunately the cyclisation of the enantiomerically enriched enamide resulted in a 
racemic mixture of products, with no chirality transfer observed. The barrier to 
rotation of enamide 237 had not previously been measured, however based on 
previous results we predicted the barrier to be >29.3 kcalmol
-1
. Other methyl 
tetralone enamides with smaller acyl substituents gave high barriers to rotation >27.5 
kcalmol
-1
 (see compounds 164, 209 and 214 numbers, page 92), and increasing the 
size of the acyl group had been shown to result in an increase in the barrier to 
rotation (see section 2.1.1.1, page 58).  
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Figure 3.7: Previous calculated barriers to rotation. 
However, the barrier to rotation was subsequently measured to be significantly lower 
than expected at 25.6 kcalmol
-1
, giving a half life of only 0.1 hours at 80 
o
C, and 
therefore unlikely to result in any chirality transfer under our cyclisation conditions 
of 15 hours at 110 
o
C. It appears that the high level of steric hinderance about the N-
alkenyl bond resulting from the large acyl group and the highly substituted enamide 
causes the enamide to adopt predominantly the Z rotamer, moving the large 
bromoisobutyryl group away from the n-alkenyl bond, and hence reducing the steric 
clashing and lowering the barrier to rotation. Previous tetrasubstituted enamides with 
large acyl groups were shown to adopt both the E and Z rotamers rather than the 
expected E rotamer (see section 2.2.4.2.3, page 89-91). The methyl tetralone 
enamides have been shown to be more hindered so it is not surprising that in this 
case the enamide predominantly adopts the Z rotamer, resulting in the lower barrier 
to rotation. 
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Figure 3.8: Enamides occupying both E and Z rotamers. E and Z rotatmers not assigned. 
 
3.3 Conclusions 
A number of tetrasubstituted enamides have been subjected to both Bu3SnH and 
copper mediated cyclisation conditions with varying results. Primary α-halo 
enamides 210, 212 and 214, were treated with Bu3SnH and ACN, and unfortunately 
only 210 yielded any cyclised products. The major product was the precyclised 
reduced product 195, however the reductively terminated 264 and the oxidatively 
terminated 265 were also observed alongside recovered starting material. In the 
attempted cyclisations of the more hindered enamides 212 and 214 there was no 
evidence of any cyclised products, instead 212 yielded solely the reduced compound 
197 and 214 gave the reduced naphthalene 256 and oxidatively cleaved product 257. 
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Scheme 3.23: Bu3SnH mediated cyclisations of α-halo enamides. Reagents and conditions: 
Bu3SnH, ACN, toluene, 110 
o
C, 18h. 
The copper mediated cyclisations of tetrasubstituted enamides with tertiary halides 
(229 and 231 - 237) were then investigated. Cyclisations of 229 and 231 showed 
Cu(TPA)X in toluene at reflux to be the most effective conditions, yielding the 
unsaturated products 269  and 270. These conditions were used for the cyclisations 
of 232 – 235 yielding a range of both reductively and oxidatively terminated cyclised 
products (Scheme 3.14 - 3.16). When 236 was subjected to the same conditions the 
ring opened products 292 and 293 were obtained, presumably these were formed by 
ring opening of the cyclised products to release strain caused by steric hinderance. 
Cyclisation of 237 with Cu(TPA)Br  led to the three cyclised products 294 – 296, all 
of which have a chiral centre formed in the cyclisation step. The barrier to rotation of 
237 is high enough to allow reasonable separation of the two atropisomers by chiral 
HPLC at room temperature, and therefore this reaction is suitable for investigating 
chirality transfer upon cyclisation. We have shown that the products can all be 
resolved by chiral HPLC.  However although the barrier to rotation was high enough 
to allow reasonable separation of the atropisomers at room temperature, it was 
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significantly lower than expected, and not high enough to result in chirality transfer 
upon cyclisation. 
 
Scheme 3.24: Copper mediated cyclisation of 237. Reagents and Conditions: 0.6 eq. CuBr, 0.6 eq. 
TPA, toluene, reflux, 15 h. 
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4.0 Synthesis and Cyclisation of 2-Bromobenzyl Enamides 
 
4.1 Introduction 
In Chapter 3 we investigated the cyclisation of α-acyl radicals derived from 
enamides by copper and tin mediated methods to give a variety of lactam products. 
In theory, lactams can also be prepared by cyclisation of aryl radicals 302, generated 
from the corresponding aryl halide 301, onto enamide functionality.  In this chapter 
we investigate the tin mediated 5-exo and 6-endo cyclisations of 302 to give nitrogen 
heterocycles 303 and 304.  
 
Scheme 4.1: Tin mediated cyclisation of enamides with aryl radicals. 
 
4.1.1 Generation of Aryl Radicals 
There are a number of methods for the generation of aryl radicals from aryl halides, 
of which the most common by far is the use of Bu3SnH and AIBN.
179–181
 In 1991 
Curran reported the determination of rate constants for halide abstraction by a 
tributyltin radical from a series of aryl halides, comparing them to the more widely 
studied abstraction from sp
3
-hybridised carbon atoms.
179
 Relative reactivities were 
measured by competition reactions against a known standard of either 1-
bromooctane or benzyl chloroacetate (Scheme 4.2).  
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Scheme 4.2: Studies into halide abstraction from aryl halides by a tributyltin radical. R-Y = 1-
bromooctane or benzyl chloroacetate. 
The compounds were shown to have relatively high reactivity towards the tributyltin 
radical in view of the increased energies of sp
2
 C-X bonds compared to sp
3
 C-X 
bonds. Aryl iodides were shown to be as effective radical precursors as alkyl 
bromides, whilst aryl bromides were also shown to have a good level of activity 
towards the tributyltin radical and were shown to be more reactive than many classes 
of sp
3
 C-X chloride and phenyl selenide precursors (Table 4.1, entry 1).
179
 Within the 
series, differences in reactivity were small, with many of the trends consistent with a 
small polar effect on the halogen abstraction. This can be seen with the increasing 
reactivity from bromoanisole < bromoacetophenone < bromobenzonitrile (Table 4.1, 
entries 2/5/8, 3/6/9 and 4/7/10). The substituent position was also shown to have a 
small effect on the reactivity with increasing reactivity from para < meta < ortho 
substitution (Table 4.1, entries 2-4, 5-7, and 8-10). This trend was not thought to be 
steric in origin, but again reflecting the polar effect with bromine atoms closer to the 
inductive electron-withdrawing groups more reactive.
179
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Entry Precursor k (M
-1
 s
-1
) (80 
o
C) 
1 4-iodoanisole 8.8 x 10
8 
2 4-bromoanisole 2.4 x 10
6 
3 3-bromoanisole 4.0 x 10
6
 
4 2-bromoanisole 4.5 x 10
6
 
5 4-bromoacetophenone 3.9 x 10
6
 
6 2-bromoacetophenone 4.6 x 10
6
 
7 3-bromoacetophenone 1.6 x 10
7
 
8 4-bromobenzonitrile 6.8 x 10
6
 
9 3-bromobenzonitrile 9.0 x 10
6
 
10 2-bromobenzonitrile 1.6 x 10
7
 
Table 4.1: Studies into halide abstraction from aryl halides by a tributyltin radical. 
Effective replacements of tin hydrides for the generation of aryl radicals have 
included silanes such as tris(trimethylsilyl)silane
182,183
  and metals such as samarium 
diiodide
184,185
  as well as cathodic reduction
186
 and irradiation under reducing 
conditions.
187
  Potassium t-butoxide (KOtBu) has also been shown to be able to 
generate aryl radicals; Wang reported a KOtBu and bathophenanthroline (BPhen) 
305 mediated radical arylation of polysubstituted alkenes with aryl halides (Scheme 
4.3).
188
 Arenediazonium salts can also be dissociated to aryl radicals and nitrogen by 
the reductive formation of an aryl diazenyl radical.   Numerous methods have been 
used to generate such radicals and this area has been reviewed by Galli.
189
 
 
Scheme 4.3 KOtBu mediated radical arylation of poly substituted alkenes. Reagents and 
Conditions: KOtBu, BPhen, benzene, 110 
o
C. 
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4.1.2 Cyclisation of Aryl Radicals 
Cyclisations of aryl radicals are useful for formation of a range of different 
carbocyclic and heterocylic compounds.
148,181,190–193
  Radicals of type 309 can 
cyclise in either an exo or an endo fashion with different selectivities observed 
dependent upon the substrates.  In those systems with an alkene at the 5-position 
relative to the aryl radical centre, a 5-exo trig cyclisation is generally preferred over 
a 6-endo trig cyclisation. For example Bu3SnH mediated cyclisation of enamide 312 
and acryloylanilide 314 yielded only the five membered lactams 313
194
 and 315
190
 
respectively (Scheme 4.4). 
 
Scheme 4.4: 5-exo trig cyclisations of aryl radicals. Reagents and Conditions: a) Bu3SnH, ACN, 
toluene, b) Bu3SnH, AIBN, toluene. 
In contrast, when the carbonyl group is exocyclic to the forming ring, as in the 
cyclisation of 316, the reaction favours the 6-endo-trig pathway (Scheme 4.5).
181
 
This endo selectivity was postulated to occur due to the conformation of the 
precursor. Enamides of type 316 were shown to occupy the syn conformer in 
solution at room temperature irrespective of the nature of R
1
.
181
 In this conformer the 
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reacting radical is more proximate to the β-carbon leading to the observed endo 
selectivity.  
 
Scheme 4.5: Favoured 6-endo cyclisation of aryl radicals. Reagents and Conditions: Bu3SnH, 
ACN, toluene. 
 
4.1.1 Chirality Transfer in Cyclisation of Aryl Radicals 
Curran showed that the aryl radical derived from atropisomeric acrylanilide 145 
underwent 5-exo cyclisation with ~90% chirality transfer.
150
 
 
Scheme 4.6: Chirality transfer in the 5-exo cyclisation of acrylanilides.  Reagents and conditions: 
Bu3SnH, Et3B, O2, 20 
o
C, benzene. 
As shown in Chapter 2 enamides also exhibit atropisomerism and therefore also have 
the potential to result in chirality transfer upon cyclisation. The cyclisations of aryl 
radicals are normally relatively fast processes (~10
7
 – 108 s-1) in comparison to the 5-
endo cyclisations of acyl radicals (1 x 10
4
 s
-1
) and are more likely to be faster than 
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rotation about the N-alkenyl bond (krot), suggesting chirality transfer is possible in 
the cyclisations of enamides 320. 
 
Scheme 4.7: Chirality transfer in radical cyclisations. 
In Chapter 2 we showed that level of substitution at the alkene played a large role in 
influencing the barrier to rotation about the N-alkenyl bond with the more substituted 
enamides having significantly higher barriers to rotation (Scheme 4.1).  
 
Figure 4.1: Effect of alkene substitution on barrier to rotation. 
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There has been little information reported in the literature on the outcome of aryl 
radical cyclisations onto tri- and tetrasubstituted enamides and this chapter reports 
our results in this area. 
 
4.2 Results and Discussion 
We began our investigations with the trisubstituted cyclic enamide 320 which was 
synthesised via copper mediated acylation of cyclohexanone, followed by 
deprotonation and benzylation with 2-bromobenzyl bromide. 
 
Scheme 4.8: Synthesis of 2-bromobenzyl enamide 320. Reagents and Conditions:  a) Ac2O, 
NaHSO3,CuI, DCE, 120 
o
C, 16 h. b) NaH, 2-bromobenzyl bromide, THF, 0 
o
C 10 mins, reflux 16 h. 
Analysis of 320 by 400 MHz 
1
H NMR showed the benzyl protons to resonate as a 
broad singlet at room temperature, indicative of restricted rotation about the N-
alkenyl bond. The 500 MHz 
1
H VT NMR showed two mutually coupled doublets at 
low temperature (183 K) which coalesced at 268 K and appeared as a sharp singlet at 
high temperature (373 K). Line shape analysis using the WINDNMR
145
 software 
allowed ΔG‡298 to be calculated following the method described in chapter 2, section 
2.1.1.1 as 8.8 kcal mol
-1
. Interestingly, the addition of the relatively large bromine 
atom in the ortho position causes a lowering of the barrier to rotation compared to 
enamide 325 (ΔG‡298 = 10.1 kcal mol
-1
). Presumably this is due to the extra steric 
bulk of the ortho bromine twisting the sp
3
-sp
2
 C-C bond of the benzyl group so that 
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the aryl ring is located further away from the cyclohexene ring, hence having less 
influence on the barrier to rotation. 
 
Figure 4.2: Barriers to rotation of enamides 320 and 325. 
 
4.2.1 Cyclisation of bromobenzyl enamide 320. 
As we were uncertain as to the rate of cyclisation of the radical 318 derived from 320 
and in order to limit the amount of competitive reduction to give 325 prior to 
cyclisation we first carried out the reaction using a low concentration of  Bu3SnH.   
This was achieved via the gradual addition of Bu3SnH via a syringe pump.   Hence, 
1.5 eq. of Bu3SnH and 0.2 eq. of 1,1-azobis(cyclohexanecarbonitrile) (ACN) was 
added over 7 hours using a syringe pump to a refluxing solution of 320 in toluene, 
followed by a further 9 hours at reflux. After cooling the reaction mixture was 
concentrated in vacuo to give the crude product. Following the procedure of Berge 
and Roberts,
32
 the crude reaction mixture was then partitioned between acetonitrile 
and hexane to aid with the removal of the tin residue. 400 MHz 
1
H NMR of both 
extracts were compared to that of the crude reaction mixture showing a significant 
amount of the tin residue had been extracted into the hexane fraction with minimal 
amounts remaining in the acetonitrile fraction.  In addition it was possible to confirm 
that no cyclised materials were lost in the hexane layer.   This allowed crude ratios of 
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the cyclised products to be determined more easily by measurement from the 
acetonitrile fraction.  
 
Scheme 4.9: Cyclisation of Enamide 320 with a syringe pump. Reagents and Conditions: 1.5 eq. 
Bu3SnH, 0.2 eq. ACN, toluene, reflux, 16 h. 
The cyclisation was found to proceed in both a 5-exo and a 6-endo fashion to give a 
range of products; the 5-exo product 326 and both the cis 327a and trans 327b 
isomers of the 6-endo product were observed alongside the reduced pre-cyclised 
product 325 in a ratio of 0.56 : 1.82 : 1.20 : 0.17 (326 : 327a : 327b : 325). The 
relative stereochemistry of the 6-endo cis and trans isomers was assigned based upon 
previous reported results
195
 which were based upon nOe analysis and decoupling 
experiments.  Both isomers 327a and 327b were found to exist as two amide 
rotamers respectively in CDCl3 (cis isomer = 1 : 0.82 ratio, trans isomer = 1 : 0.62). 
Unfortunately the acetate peaks were too close in the 500 MHz 
1
H NMR to allow the 
E and Z rotamers to be assigned by nOe.  
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Scheme 4.10: Amide rotamers of 6-endo products. 
The 6-endo cyclisation pathway was found to predominate, as found by Ishibashi in 
the cyclisation of the related disubstituted enamide 316 (Scheme 4.5).
181
 This 
preference is thought to be partly due to the starting material 320 existing 
predominantly in the syn conformer where the radical is in closer proximity to the β-
carbon. Alternatively, the 6-endo product could arise via a neophyl rearrangement of 
the intermediate radical 328 arising from 5-exo cyclisation. This rearrangement was 
first observed in an aryl radical cyclisation by Parker
196
 and later observed by Jones 
in the synthesis of oxindoles 332 and 333,
197
 (Scheme 4.11). Formation of radical 
329 will be reversible but ring opening to give the more stable tertiary radical 330, 
followed by reduction would give the observed 6-endo products 327a and 327b  
(Scheme 4.11). Interestingly, the ratio of 5-exo to 6-endo products in the cyclisation 
of oxindoles is temperature and concentration dependent with more neophyl 
rearrangement taking place with lower concentrations of Bu3SnH.  This makes sense 
as lower concentrations would provide radical 328 with a longer lifetime giving it a 
chance to rearrange. 
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Scheme 4.11: Formation of the 6-endo product via a neophyl rearrangement. Reagents and 
Conditions: a) 1.5 eq. Bu3SnH, 0.2 eq. AIBN, t-butyl benzene, 169 ˚C. 
We next repeated the reaction without the use of the syringe pump adding all the 
Bu3SnH and ACN at the start of the reaction (0.02M). Pleasingly this did not 
significantly affect the ratio of the cyclised (326, 327a and 327b) to reduced pre-
cyclised material 325 (0.02 M Bu3SnH 326+327a+327b:325 = 1 : 0.062 compared to 
syringe pump addition of Bu3SnH 326+327a+327b:325 =  1 : 0.047). Consequently 
in future reactions a syringe pump was not used. 
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Scheme 4.12: Cyclisation of enmide 320 without a syringe pump. Reagents and Conditions: 1.5 
eq. Bu3SnH, 0.2 eq. ACN, toluene, reflux, 16 h. 
 
4.2.2 Rate Studies in Cyclisation of enamide 320. 
We next carried out studies in order to gain information on the approximate rate 
constants for the two modes of cyclisation. We reacted a 0.02M solution of 320 with 
different concentrations of Bu3SnH and determined the ratio of reduction product 
325, 5-exo cyclisation product 326 and 6-endo cyclisation products 327a and 327b 
by integration of representative protons in the 400 MHz 
1
H NMR of the crude 
mixture.   
Entry
a 
Bu3SnH 
(Equiv.) 
[Bu3SnH]c 
(M)
b 
Reduction : 
5-exo : 6-endo
c 
Red/5-exo Red/6-endo 
1 1.5 0.02 0.22 : 0.60 : 2.95 0.367 0.075 
2 3 0.05 0.23 : 0.60 : 2.87 0.383 0.080 
3 5 0.09 0.24 : 0.59 : 2.75 0.401 0.087 
4 12.5 0.24 0.44 : 0.63 : 2.74 0.698 0.161 
5 25 0.49 0.64 : 0.55 : 2.63 1.164 0.243 
6 37.5 0.74 0.79 : 0.52 : 2.64 1.519 0.299 
Table 4.2: Data for determination of 5-exo and 6-endo cyclisation rate constants. 
a
 0.649 mmol of 
substrate 320 in 32.5 mL of solvent was used in each run. 
b
 The average Bu3SnH concentration was 
used as recommended by Newcomb
198
 and was obtained from [Bu3SnH]c = {[Bu3SnH]initial
 
 + 
([Bu3SnH]initial
 
 + [Substrate]}/2. 
c
 Determined by integration from the crude 400MHz 
1
H NMR. 
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Whereas Jones found the ratio of 5-exo 322 and 6-endo 333 products to be dependent 
on the concentration of Bu3SnH
197
 (Scheme 4.11) we found the ratio of 5-exo and 6-
endo products to remain constant indicating that the 6-endo product is not arising 
from a neophyl rearrangement. 
We plotted the ratio of reduction 325 / cyclisation product against the mean 
[Bu3SnH]c  for each entry as recommend by Newcomb.
198
  Using Chatigilialoglu’s 
published ‘radical clock’ for reduction of an aryl radical by Bu3SnH (5.9 x 10
8
 M
-1
 s
-
1
)
176
 it was possible to determine approximate rate constants for the 5-exo cyclisation 
reaction pathway of 318 to be 3.5 x 10
8
 s
-1
 and the 6-endo cyclisation pathway to be 
1.8 x 10
9
 s
-1
 at 110˚ C.   
 
Scheme 4.13: 5-Exo vs 6-endo cyclisation of enamide radical 318. 
These are about 4 times and 2 times greater respectively than the reported 5-exo 
(1.5x 10
8
 s
-1
)
 
and 6-endo (4.6 x 10
8
 s
-1
)
 
aryl cyclisations onto the related enamine 334 
at the same temperature.
199
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Scheme 4.13: 5-Exo vs 6-endo cyclisation of enamide radical 334.  
It is notable that both plots do not pass through the origin and in fact at low Bu3SnH 
concentrations both show a trend away from the linear nature suggested by the 
trendlines, this is most notable for the 5-exo cyclisation data, Figure 4.4 (the points 
in question have been highlighted with a cross  × instead of a diamond ♦).   
  
Figure 4.3: Plots of reduced (325) / 6-endo cyclised products (327) against [Bu3SnH]c. 
 
y = 3.0043x - 0.2015 
0 
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Figure 4.4: Plots of reduced (325) / 5-exo cyclised products (326) against [Bu3SnH]c 
This is indicative of a background reduction mechanism of the aryl radical 
independent of Bu3SnH concentration.  Theoretically this background reduction 
could arise either from competitive reduction of the aryl radical 318 by toluene, the 
solvent, or by a competing 1,6-radical translocation pathway via intramolecular 
abstraction of either an allylic H-atom from the cyclohexenyl group or by a H-atom 
from the acetyl group.
200
  It should be possible to determine which mechanism is 
responsible for this ‘background’ reduction by either carrying out the reaction with 
d
8
-toluene or with Bu3SnD.  In any case, a very rough estimate of the rate of this 
process can be determined by extrapolating either the reduction / 5-exo ratio or the 
reduction / 6-endo ratio to zero Bu3SnH concentration. Both extrapolations should in 
theory give the same answer. This suggests that the rate of the background reduction 
for a 0.02M toluene solution of 320  is 14.95 times slower than kc 6-endo (estimate 
kbackground red at 0.02M = 1.2 x 10
8
 s
-1
)  or 3.37 times slower than kc 5-exo (estimate 
kbackground red at 0.02M = 1.0 x 10
8
 s
-1
).  Both extrapolations give similar magnitudes for 
kbackground red at 0.02M  ±20% with the errors largely due to uncertainty in the 
extrapolation as both plots move away from linearity at low Bu3SnH concentration.  
y = 0.5934x - 0.1765 
0 
0.2 
0.4 
0.6 
0.8 
0 0.5 1 1.5 2 
5-Exo cyclisation 
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The value is similar in magnitude, albeit slightly lower, than that reported for a 
related 1,5-hydrogen translocation from an aryl radical (5 x 10
8
 s
-1
).
201
  
 
4.2.3 Synthesis and Cyclisation of Dibromo Enamide 339 
We next synthesised the dibromo analogue 339. Enamide 324 was deprotonated with 
sodium hydride and then reacted with 338, formed from the bromination of 2,6-
dibromotoluene with N-bromosuccinimide in the presence of benzoyl peroxide.
202
  
 
Scheme 4.14: Synthesis of dibromo enamide 339. Reagents and Conditions: a) 1.1 eq. NBS, 0.05 
eq. benzoyl peroxide, CCl4, reflux. b) 5 eq. NaH, THF, reflux, 12 h. 
The barrier to rotation about the N-alkenyl bond was calculated by line shape 
analysis of the 500 MHz 
1
H VT NMR following the method described in chapter 2, 
section 2.1.1.1 and was found to be 12.6 kcal mol
-1
. Whereas the addition of one 
ortho bromo group was found to lower the barrier to rotation, thought to be due to 
aromatic ring twisting out of position, the addition of the second ortho bromo group 
increases the barrier to rotation, presumably due to the aromatic group twisting back 
to the original position along with increased steric bulk. These results indicate that 
gearing of the benzyl substituent during N-alkenyl bond rotation is likely.   
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Figure 4.5: The effect of ortho bromo groups on the barrier to rotation. 
Enamide 339 was then cyclised with 1.5 eq. Bu3SnH and 0.2 eq. ACN added to a 
solution of 339 in toluene and the resulting solution refluxed for 16 hours.  
 
Scheme 4.15: Cyclisation of enamide 339. Reagents and Conditions: 1.5 eq. Bu3SnH, 0.2 eq. ACN, 
toluene, reflux, 16 h. 
The same 5-exo 326 and 6-endo 327 products were obtained in low yield (17% and 
22% respectively) as in the cyclisation of the monobromo compound 320, however 
none of the reduced pre-cyclised product 325 was observed. This is to be expected as 
assuming the rate of cyclisation of dibromide 339 to give 340 and 341 is similar in 
magnitude to 320 giving 326 and 327, then at 0.02M concentration of Bu3SnH we 
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would expect to obtain about a 16:1 ratio of (340 + 341) : 320.  A second equivalent 
of Bu3SnH would then reduce the monobrominated cyclised products 340 and 341 to 
327 and 326 respectively as well as mediating the reaction of 320 to give cyclisation 
and reduction products (327 + 326) : 325 again in a 16:1 ratio.  Ultimately this 
should lead to a theoretical yield of 99.6% of cyclised products 327 and 326 and a 
0.3% yield of 325.  The crude mass spec also indicated the presence of a 
monobrominated compound such as 340 or 341 however neither product was 
isolated from the reaction mixture. 
4.2.4 Synthesis of Tetrasubstituted 2-Bromobenzyl Enamides 
In order to investigate the possibility of chirality transfer in the Bu3SnH mediated 
cyclisation of hindered 2-bromobenzyl enamides we next synthesised tetrasubstituted 
enamides 342 – 345. 
 
Figure 4.6:  Tetrasubstituted 2-bromobenzyl enamides. 
The enamides were synthesised via iron mediated acylation of the corresponding 
oxime followed by deprotonation with sodium hydride and benzylation with 2-
bromobenzyl bromide, Scheme 4.16. 
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Scheme 4.16: Synthesis of tetrasubstituted enamides with 2-bromobenzyl bromide. Reagents and 
conditions: a) 2eq. Fe(0), 3eq. AcOH, 3eq. Ac2O, toluene, 85 
o
C, b) 5eq. NaH, 1.1 eq 2-bromobenzyl 
bromide, THF, 0 
o
C – reflux. c Yield over two steps. 
 
4.2.5 Analysis of barriers to rotation in tetrasubstituted enamides 
As expected the tetrasubstituted 2-bromobenzyl enamides 342 – 345 all had high 
barriers to rotation with the benzyl protons appearing as two well resolved mutually 
coupled doublets in the 400 MHz 
1
H NMR at room temperature. Enamides 343 and 
345 were sent to our collaborators, Curran and co-workers, in Pittsburg, America for 
attempted separation on a Whelk-O column (Figure 4.7). 
       
Figure 4.7: Chiral HPLC traces of enamides 343 and 345. 
It was not possible to separate the atropisomers of enamide 343, however good 
separation was achieved with enamide 345 (20.0 min and 22.9 min). Isolation of a 
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single atropisomer was possible with >99:1 er.  This isomer then underwent slow 
racemisation in iPrOH at 82 
o
C allowing the barrier to rotation to be calculated as 
28.5 kcal mol
-1
. Whereas the addition of an ortho bromo substituent to trisubstituted 
enamide 325 caused the barrier to rotation to decrease by ~1.3 kcal mol
-1
, addition of 
an ortho bromo substituent to tetrasubstituted enamide 164 caused the barrier to 
rotation to increase by ~1.0 kcal mol
-1
. We had postulated that the decrease in barrier 
to rotation between 325 and 320 resulted from a gearing mechanism of the benzyl 
group during rotation about the N-alkenyl bond. In the case of enamides 345 and 164 
it is possible that due to the extra steric bulk of the bromine atom and that around the 
N-alkenyl bond the benzyl group is no longer able to rotate to a position that aids 
rotation.  
 
Figure 4.8: Barriers to rotation in 2-bromobenzyl enamides. 
A crystal structure of compound 345 (figure 4.9) showed a torsion angle between the 
N-alkenyl bond and the plane of the N-CO bond of 79
o
, showing that they prefer to 
lie in orthogonal planes, as observed with other tetrasubstituted enamides. It is also 
interesting to see from this crystal structure that the bromine is situated over the 
alkene making cyclisation possible, and that this is the only detected conformer. 
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Figure 4.9. Crystal Structure of enamide 345. 
 
4.2.6 Cyclisation of Tetrasubstituted 2-Bromobenzyl Enamides 
Cyclisation of the four tetrasubstituted enamides 342 – 345 was attempted by 
treatment with 1.5 eq. Bu3SnH and 0.2 eq. of ACN.  
 
Scheme 4.17: Attempted cyclisations of enamides 342 and 343. Reagents and Conditions: 1.5 eq. 
Bu3SnH, 0.2 eq. ACN, toluene, reflux, 16 h. 
Unfortunately the cyclisations of enamides 342 and 343 yielded a complicated 
mixture from which the major products identified were the reduced compounds 201 
and 195. It is not that surprising that the reduced product is formed as the major 
79
o
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product, comparing the rates calculated earlier (section 4.2.2) for the 5-exo (3.5 x 10
8
 
s
-1
) and 6-endo (1.8 x 10
9
 s
-1
) cyclisations of 320 to Chatgilialoglu’s published rate 
for reduction of an aryl radical (5.9 x 10
8
 M
-1
 s
-1
)
176
 the rate of cyclisation only needs 
to be slowed by one order of magnitude in order for reduction to dominate. The 
alkene bonds in 342 and 343 are significantly more hindered than that in the 
trisubstituted enamide 320 and therefore the rate of cyclisation may be significantly 
lowered leading to the reduced compounds 201 and 195 as the major products. 
 
Scheme 4.18: Attempted cyclisations of enamide 345. Reagents and Conditions: 1.5 eq. Bu3SnH, 
0.2 eq. ACN, toluene, reflux, 16 h. 
The attempted cyclisation of enamide 345 also proved unsuccessful. In this case the 
major product obtained was identified as the naphthalene compound 256 along with 
unreacted starting material 345 in a 0.85 : 1 ratio (256 : 345). The formation of the 
naphthalene product had been observed previously in the attempted Bu3SnH 
mediated cyclisation of related methyltetralene enamide 214 (see Chapter 3, Section 
3.2.1). It is thought to arise from initial formation of radical 346 via homolysis of the 
C-Br bond followed by reduction by Bu3SnH without cyclisation, and then ACN 
mediated oxidation / aromatisation of the tetralene ring to the naphthalene (Scheme 
4.19). 
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Scheme 4.19: Formation of naphthalenes 256. Reagents and conditions: Bu3SnH, ACN, toluene, 
110 
o
C, 18h. 
Pleasingly, the treatment of enamide 344 with Bu3SnH and ACN did yield some 
cyclised products. The similarity of the products meant separation proved difficult 
however the 5-exo compound 347 was identified as the major product and was 
isolated in a 21% yield. Interestingly, only one diastereomer was observed however 
at the time of writing it has not been possible to determine its stereochemistry. The 
6-endo product was also tentatively assigned, however it could not be obtained pure. 
 
Scheme 4.20: Cyclisation of enamide 344. Reagents and conditions: Bu3SnH, ACN, toluene, 110 
o
C, 18h. 
a
Isolated yield. 
The preference for the 5-exo cyclisation was not expected based upon the cyclisation 
of trisubstituted enamide 320 and the results of Ishibashi’s cyclisations of related 
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enamides.
181
 However, 5-exo cyclisation of enamide 344 gives rise to a resonance 
stabilised benzyl radical which is trapped by Bu3SnH.   
 
Scheme 4.21: Competitive 5-exo vs 6-endo cyclisation of enamide 344.  
Comparing enamide 344 to the other tetrasubstituted enamides 342, 343 and 345 
which did not undergo successful cyclisation, enamide 344 is less hindered with 
substitution at only the β-position, whereas enamides 342, 343 and 345 are 
substituted at both the β- and β’-positions, and this may explain why cyclisation 
occurred only in this instance. 
 
Figure 4.10: Tetrasubstituted 2-bromobenzyl enamides. 
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4.3 Conclusion 
A selection of 2-bromobenzyl enamides have been synthesised and their barriers to 
rotation about the N-alkenyl bond investigated. It was found that the addition of an 
ortho bromo group to the non halogenated enamide 325 resulted in a decrease in the 
barrier to rotation, however the addition of a second ortho bromo group increased the 
barrier again. This is indicative of gearing of the benzyl group taking place during 
rotation about the N-alkenyl bond. In contrast in the more hindered tetrasubstituted 
enamides the addition of an ortho bromo group was found to increase the barrier to 
rotation by ~1 kcal mol
-1
. 
 
Figure 4.11: Barriers to rotation in 2-bromobenzyl enamides. 
 The Bu3SnH mediated cyclisation of these enamides has also been investigated. 
Initial cyclisation of enamide 320 showed the 6-endo pathway to be favoured over 
the 5-exo pathway. Based upon the results of Ishibashi,
181
 this is postulated to be due 
to the starting material existing in the syn conformer where the radical is in closer 
proximity to the β-carbon. Carrying out cyclisations of 320 at varying concentrations 
of Bu3SnH allowed us to calculate the rates of 5-exo and 6-endo cyclisations as 3.5 x 
10
8
 s
-1
 and 1.8 x 10
9
 s
-1
 at 110 ˚C respectively. 
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Scheme 4.22: 5-Exo vs 6-endo cyclisation of enamide 320. 
The cyclisations of tetrasubstituted 2-bromobenzyl enamides 342 – 345 were less 
successful with only the cyclisation of 344 yielding cyclised product. In this case the 
5-exo cyclisation was the favoured route, most likely due to the formation of the 
stabilised intermediate benzyl radical 349. It appears that the extra steric bulk of the 
tetrasubstituted enamides significantly hinders the rate of cyclisation leading to the 
formation of other products such as the reduced compounds 195 and 201 and the 
naphthalene 256 instead. Further work would have to be carried out in this area to 
find more successful cyclisation conditions before investigating chirality transfer in 
the cyclisation of 2-bromobenzyl enamides.  
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5.0 Oxindole Synthesis by Copper-Mediated Cyclisation 
 
5.1 Introduction 
In previous chapters we have shown that we can produce a number of lactam 
products via cyclisation of an α-acyl radical onto an alkene, and nitrogen 
heterocycles via cyclisation of an aryl radical onto an alkene. In this chapter we 
investigate the use of copper mediated radical cyclisations as a route to oxindoles via 
cyclisation of an α-acyl radical onto an aromatic nucleus in an oxidative fashion.  
 
Scheme 5.1: Synthesis of oxindoles via copper mediated cyclisation. 
Oxindoles are a class of heterocycles present in a number of natural products, e.g. 
speciophylline 351
203
 and horsfiline 352,
204
 and are of great interest in medicinal 
chemistry due to their biological properties. They have proven activity as protein 
kinase inhibitors
205
 and  phosphodiesterase inhibitors
206
 as well as exhibiting anti-
rheumatic,
207
 anti-tumoral,
203
 and anti-viral
208
 properties. 
 
Figure 5.1:Oxindole containing natural products and pharmaceutical compounds. 
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5.1.1 Synthesis of Oxindoles 
There are many approaches in the literature for the synthesis of oxindoles. A 
classical approach is Friedel-Crafts cyclisation onto α-halo209 and α-hydroxy210 
acetanilides, however the strongly acidic conditions and high temperatures required 
limit the range of functional groups that can be tolerated. Palladium catalysed 
reactions have been particularly popular such as intramolecular Heck couplings
211–213
 
and Buchwald-Hartwig type reactions. Direct coupling between C-H and Ar-H 
bonds has also been successful, both with a palladium catalyst and without. A 
number of different radical approaches have also been employed. 
5.1.1.1 Palladium Catalysed Heck Reactions 
Zhu has reported a domino intramolecular Heck-cyanation sequence; when ortho-
iodoanilide 355 was dissolved in DMF and treated with potassium ferro(II)cyanide 
in the presence of palladium acetate and sodium carbonate the oxindole 356 was 
afforded in 83% yield.
211
 The conditions were successful with a wide range of 
substrates with varying electronic properties, and the use of (S)-
DIFLUOROPHOS
214
 allowed for the reaction to be carried out enantioselectively 
giving 79% ee.
211
  
 
Scheme 5.2: Palladium catalysed domino Heck-cyanation reaction. Reagents and Conditions:  1.5 
mol% Pd(OAc)2, 0.22 eq. K4[FeCN]6, 1.0 equiv. Na2CO3, DMF, Argon, 120 
o
C, 3h. 
Taylor has also used a intramolecular Heck reaction as part of a tandem sequence to 
give 3-alkenyloxindoles 360 from haloanilides 357.
212
 The one-pot, microwave 
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accelerated process involves a Horner-Wadsworth-Emmons olefination followed by 
a palladium catalysed Heck reaction. A range of aldehyde trapping reagents 358 can 
be employed to give a range of both N-alkylated and NH oxindole products (R
2
 = H) 
in 30 – 60 mins. 
 
Scheme 5.3: Tandem Horner-Wadsworth-Emmons/Heck reaction. Reagents and Conditions: 5 
eq. R
3
COH, 6 eq. Cs2CO3, 5 mol% Pd(OAc)2, 11 mol% PPh3, THF, 100 
o
C, MW, 30-60 mins.  
 
5.1.1.2 Buchwald and Hartwig Palladium Catalysed Oxindole Synthesis 
Buchwald has reported a development of the Friedel-Crafts procedure using 
palladium catalysed functionalisation, obviating the need for harsh reaction 
conditions. The combination of palladium acetate, 2-(di-tert-
butylphosphino)biphenyl 363 as a ligand and triethylamine as a base allowed smooth 
conversion of α-chloroacetanilides 361 into oxindoles 362 with high yields and high 
levels of regioselectivity.  
 
Scheme 5.4: Buchwald palladium catalysed synthesis of oxindoles. Reagents and Conditions: 1-3 
mol% Pd(OAc)2, 2-6 mol% 363, 1.5 eq. Et3N, toluene, 80 
o
C, 2.5-6 h. 
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Hartwig has applied similar conditions, with a palladium source, a phosphino ligand 
and a base, to the synthesis of oxindoles from ortho-haloanilides. Both bromo- and 
chloro-anilides were shown to react to give a range of substituted oxindoles with 
good yields.
215–217
 
 
Scheme 5.5: Hartwig palladium catalysed synthesis of oxindoles. Reagents and Conditions: 5 
mol% Pd(OAc)2, 5 mol% PCy3, 1.5 eq. NaOtBu, 1,4-dioxane. 
Although these palladium catalysed reactions give good yields with relatively low 
catalyst loadings, the palladium and ligands can prove expensive on an industrial 
scale. 
 
5.1.1.3 Direct Coupling of C-H and Ar-H 
The methods of Buchwald and Hartwig require a functionalised precursor with either 
an ortho halogen, an α-halogen or an α-hydroxy group. Kündig and co-workers 
reported the synthesis of oxindoles without this functionalisation via the direct 
coupling of two C-H centres.
218
 The proposed pathway for this reaction is an 
intramolecular oxidative coupling process. The initial radical 369 is formed via 
amide enolate oxidation and then cyclises onto the aromatic ring to give the 
cyclohexadienyl radical 370 which readily aromatises to the oxindole product 372. 
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Scheme 5.6: Kündig’s synthesis of oxindoles by direct coupling of two C-H centres. Reagents and 
Conditions: 2.2 eq. CuCl2, 5.0 eq. NaOtBu, DMF, 110 
o
C, 5 h. 
Taylor has also reported a C-H, Ar-H coupling method for the synthesis of oxindoles 
(Scheme 5.7).
219
 The reaction required significantly less metal than Kündig’s 
method, however stoichiometric amounts were still required along with DMF as the 
solvent and high reaction temperatures. 
 
 Scheme 5.7: Taylor’s synthesis of oxindoles by direct coupling of two C-H centres. Reagents and 
Conditions: 2.2 eq. CuCl2, 5.0 eq. NaOtBu, DMF, 110 
o
C, 5 h. 
 
5.1.1.4 Radical Cyclisations in Oxindole Synthesis 
Intramolecular aryl radical cyclisation reactions have also been widely used in the 
synthesis of oxindoles. Bowman showed that the radical derived from 375 can 
undergo intramolecular addition to the α-position of the α,β-unsaturated N-
alkylamide using Bu3SnH and AIBN to give exclusively the exo-cyclisation product 
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376.
20
 This approach was used by Ishibashi towards the synthesis of (±)-
Physostigmine 379, with the cyclisation of 377 giving the oxindole intermediate 378 
in 98% yield.
220
 
 
Scheme 5.7: Intramolecular aryl radical cyclisations to afford oxindoles. Reagents and 
Conditions: a) 1.1 equiv. Bu3SnH, 0.2 equiv. AIBN, toluene, 110 
o
C. b) 1.25 equiv. Bu3SnH, 0.12 
equiv. AIBN, benzene, reflux. 
The major disadvantage of these reactions is the use of stoichiometric amounts of the 
toxic tin hydride at high temperatures, therefore alternative redox conditions using 
transitions metals such as samarium
221
 and cobalt
222
 have been developed, however 
these reactions still require large amounts of metal and excess additives. 
 
5.1.1.5 Previous work in the Clark group on oxindole synthesis 
Previously the Clark group have investigated the cyclisation of anilides such as 380 
using copper mediated cyclisation conditions to give oxindoles.
223
 In particular the 
AGET-ATRC conditions using KBH4 were investigated, however the reactions were 
not that efficient with average to low yields (23-50%) and stoichiometric amounts of 
KBH4 required. In this chapter we investigate further the use of copper mediated 
cyclisations of anilides towards oxindoles to try and improve upon the poor 
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performance of the reductive CuBr / KBH4 procedure and to probe the mechanism of 
the process. 
 
Scheme 5.8: Copper mediated cyclisation to give oxindoles. Reagents and Conditions: 10 mol% 
CuBr/TPA, 100 mol% KBH4, 0.1M, 50 
o
C, 16 h. 
 
5.2 Results and Discussion 
We first decided to probe the mechanism of the copper mediated cyclisation process.  
Two mechanisms could be envisaged.  Firstly, a conventional oxidative radical 
cyclisation (via copper(I) mediated homolysis of the C-Br bond followed by a Cu(II) 
mediated oxidation aromatisation reaction, Scheme 5.9) or a conventional Friedel-
Crafts (non-radical) process with CuBr acting as the Lewis acid, Scheme 5.10.    
 
Scheme 5.9: Possible mechanism via conventional oxidative radical cyclisation. 
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Scheme 5.10: Possible mechanism via Friedel-Crafts type reaction. 
We synthesised the meta-substituted anilide 394 so that the regiochemistry of the 
cyclisation could be investigated. Aniline 390 was deprotonated with sodium hydride 
and subsequent addition of iodobutane yielded 392 in 26% yield after workup and 
purification by column chromatography. Treatment of 392 with 2-bromoisobutyryl 
bromide 393 in the presence of triethylamine yielded pure anilide 394 after a 
standard organic workup. 
 
Scheme 5.11: Synthesis of anilide 394.  Reagents and Conditions: a) 1 eq. NaH, 1 eq. BuI, DMF, b) 
1.2 eq. 393, 1.2 eq. Et3N, Et2O, r.t. 24 h.  
The two possible oxindole regioisomers 395 and 396 that could be formed from the 
cyclisation of 394 had been characterised previously
223
 allowing us to analyse the 
reactions and determine the ratio of the regioisomers from the crude 
1H NMR’s. We 
first carried out an intramolecular Friedel-Crafts acylation, treating 394 with 
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aluminium trichloride at elevated temperature under nitrogen. The reaction 
proceeded cleanly in 94% yield to give a 0.53:1.0 ratio (395:396) of the two 
regioisomers with the less hindered regioisomer 396 as the major product.  
 
Scheme 5.12: Friedel-Crafts cyclisation of anilide 394. Reagents and Conditions: 2.5 eq. AlCl3, 
50
o
C 10 min, 160
o
C 1 h. 
The aromatic region of the 300 MHz 
1
H NMR clearly showed the two regioisomers; 
the aromatic protons of 395 resonate as a triplet at 7.14 ppm, and two doublets at 
6.81 ppm and 6.71 ppm (highlighted in blue), whereas the aromatic protons in 396 
appear as two doublets at 7.08 ppm and 6.86 ppm and a singlet at 6.68 ppm 
(highlighted in red).    
 
Figure 5.2: Aromatic region of 300 MHz 
1
H NMR of the intramolecular Friedel-Crafts reaction 
of 394. 
Blue = 395 
Red = 396 
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We next carried out a conventional radical cyclisation using Bu3SnH and AIBN.  1.1 
eq. of Bu3SnH and 0.125 eq. of AIBN were added by syringe pump to a boiling 
solution of 394 in toluene over two hours and the reaction left to reflux for a further 
6 hours at this temperature. A further 1.1 eq. of Bu3SnH and 0.125 eq. of AIBN were 
then added over an hour and the reaction mixture refluxed for a further 8 hours. It is 
known that greater amounts of AIBN are necessary to accomplish radical 
cyclisations onto aromatic groups as the generated radicals are thought to initiate the 
oxidation of the intermediate radicals.
224
 
 
Scheme 5.13: Bu3SnH mediated cyclisation of anilide 394. Reagents and Conditions: 2.2 eq. 
Bu3SnH, 0.25 eq. AIBN, reflux, 16 h. 
The 300 MHz 
1
H NMR of the crude reaction mixture was significantly messier than 
the Friedel-Crafts method, with a number of other unidentified products present, 
although there was no starting material left in the crude reaction mixture. Both 
oxindole regioisomers were observed in a 1.00:0.72 ratio (395:396), however in 
contrast to the Friedel-Crafts method the more hindered regioisomer 395 was the 
major product. This suggested that the two approaches led to different 
regiochemistries. 
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Figure 5.3: Aromatic region of 300 MHz 
1
H NMR of the Bu3SnH mediated cyclisation of 394. 
We next carried out the cyclisation of 394 using the AGET ATRC conditions, hence 
30 mol% CuBr/TPA was added to a solution of 394 in methanol, followed by the 
portion-wise addition of 3 eq. KBH4. The reaction mixture was then refluxed for 24 
h before filtering through a silica plug and an aqueous workup to give the crude 
product with a 93% mass conversion.  
 
Scheme 5.14: Copper mediated cyclisation of anilide 394. Reagents and Conditions: 0.3 eq. CuBr, 
0.3 eq. TPA, 3 eq. KBH4, MeOH, 50
o
C. 
Disappointingly the crude 300 MHz 
1
H NMR was very complicated showing many 
products, with the desired compounds 395 and 396 present only as minor 
components. However the ratio of the two regioisomers could still be calculated and 
the more hindered 395 was found to be the favoured regioisomer (395:396 = 
1.00:0.45), the same favoured regioisomer as the Bu3SnH mediated radical 
Blue = 395 
Red = 396 
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cyclisation giving tentative evidence that the process was a radical reaction rather 
than a Friedel-Craft process.  However, the results need to be treated with caution as 
the products were only detected in minor amounts. 
 
Figure 5.4: Aromatic region of 300 MHz 
1
H NMR of the copper mediated cyclisation of 394. 
 
5.2.1 Development of Copper Mediated Cyclisation Conditions  
While the cyclisation of 394 with CuBr and KBH4 was disappointing due to its low 
yield and the many by-products produced we decided to initially explore the scope of 
the process further. It has been reported that the replacement of CuBr with CuSO4 in 
KBH4 mediated ATRC reactions can improve the yields and rates of the processes.
81
 
We chose a series of anilide precursors 397a-f for our investigations, varying the 
electronics of the aromatic group and the size of N-alkyl group.  
 
 
Blue = 395 
Red = 396 
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Figure 5.5: Anilides synthesised with varying aromatic subsituents and N-alkyl group. 
 
5.2.1.1 Synthesis of Substrates 397a-f  
The anilide precursors were synthesised by acylation of the appropriate N-alkylated 
aniline with 2-bromoisobutyryl bromide in the presence of Et3N. Standard organic 
work up after 24 h yielded the pure products in good yields. 
 
Scheme 5.15: Synthesis of oxindole precursors. Reagents and Conditions: 1.2 eq. Et3N, 1.1eq. 393, 
24 h., r.t. 
a
The compound used was synthesised previously by Hemal Parekh. 
 
5.2.2 Cyclisations of Anilides 397a-f  
We initially cyclised the compounds using AGET ATRC conditions, replacing CuBr 
with CuSO4.  Hence, reaction of 397 with 0.2 eq. CuSO4.5H2O, 0.2 eq. TPA and 2 
eq. KBH4 over 24 hours at 50 
o
C in MeOH led to a complex mixture of products. 
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Scheme 5.16: CuSO4.5H2O /TPA, KBH4 mediated cyclisation of anilides. Reagents and 
Conditions: 0.2 eq. CuSO4.5H2O, 0.2 eq. TPA, 2 eq. KBH4, MeOH, 50
o
C. 
While the reactions generally did yield the cyclised products 399a-f, yields were low 
and there were a number of other by-products. Due to difficulties with separation the 
by-products were not obtained pure however the main by-products were assigned as 
the  reduced products 400a-f and the methacrylates 401a-f based upon characteristic 
peaks in the 
1
H NMR along with mass spectrum. The methacrylates 401a-f, formed 
by the elimination of HBr from the starting materials 397a-f, showed two 
characteristic singlets ~5 ppm for the two alkene protons.  In the majority of cases 
(Table 5.1) the reduced products 400a-f were observed as the major compounds and 
were identified by a characteristic septet at ~2.5 ppm and a doublet ~1.1 ppm 
representing the iso-propyl group. The best yield and cleanest crude reaction mixture 
was obtained from the cyclisation of the chlorinated analogue 397d (Table 5.1, entry 
4).  
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Entry 
Starting 
Material 
R X 
Isolated Yield of 
Cyclised product 
Ratio 399:400:401 
1 397a Me H 10% 1 : 2.81 : 1.80  
2 397b iPr H 
a 
1 : 1.40 : 1.28 
3 397c Bn H 24%
b 
1 : 0.63 : 0.50 
4 397d Me Cl 33% 1 : 0.33 : 0.16 
5 397e Me OMe 20% 1 : 1.58 : 1.38 
6 397f Me NO2 22%
 b
 1 : 2.64 : 0.36 
Table 5.1: CuSO4.5H2O/TPA, KBH4 mediated cyclisation of anilides. 
a
Product was only isolated 
as a mixture with an unidentified product. 
b
Product only isolated as a mixture of two compounds, the 
yield is calculated based on the ratio of the compounds. 
The role of KBH4 in ‘normal’ ATRC is supposed to be as a reductant to reduce any 
‘deactive’ copper(II) species to active copper(I) species. However, in these reactions 
it is likely that we need the copper(II) species to oxidise any cyclised radicals to 
cations which can then undergo rearomatisation by loss of a proton. Reasoning that 
the poor yields could be due to the use of 2 eq of KBH4 within the reaction mixture 
causing a range of side-reactions we re-investigated the use of CuBr as the copper 
source, but instead of using a ‘catalytic’ amount (0.2 eq) we utilised 1 eq with 1 eq 
of TPA and no KBH4. 
 
Scheme 5.17: CuBr/TPA mediated cyclisation of anilides. Reagents and Conditions: 1eq. CuBr, 1 
eq. TPA, MeOH, 0.12M, 50 
o
C. 
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Again the reactions were messy with the three main products being the cyclised 
product 399, the reduced product 400, and the eliminated product 401 along with a 
number of other unidentified materials. In comparison with the borohydride 
cyclisations there was significantly less reduced products 400a-f in the reaction 
mixtures (presumably due to the absence of the reducing agent), and the cyclised 
products 399a-f were the major components in the majority of cases, (Table 5.2). 
The starting material was fully consumed in most reactions, however for the 
cyclisation of 397b and 397e, significant amounts remained (0.69:1 and 0.46:1 ratio 
of starting material:cyclised product respectively (Table 5.1, entry 2)). It was found 
that the smaller N-methyl group 397a led to a higher yield of cyclised product 399a 
compared to the bulkier iso-propyl 397b and benzyl groups 397c (Table 5.1, entries 
1-3). Cyclisation of the chlorinated analogue 397d again gave the best yield and 
cleanest crude reaction mixture (Table 5.1, entry 4).  
Entry 
Starting 
Material 
R X 
Isolated Yield of 
Cyclised product 
Ratio 399:400:401:397 
1 397a Me H 35% 1 : 0.22 : 0.48 : 0.00 
2 397b iPr H 8%
a 
1 : 0.59 : 0.78 : 0.69 
3 397c Bn H 13%
a 
1 : 0.87 : 0.56 : 0.00 
4 397d Me Cl 52% 1 : 0.27 : 0.11 : 0.00 
5 397e Me OMe 13% 1 : 0.50 : 0.35 : 0.46 
6 397f Me NO2 13% 1 : 0.45 : 0.25 : 0.00 
Table 5.2: CuBr/TPA mediated cyclisation of anilides. 
a
Product only isolated as a mixture of two 
compounds, the yield is calculated based on the ratio of the compounds. 
Conventional ATRC reactions use chlorinated or aromatic solvents rather than 
alcohols (the latter solvent is necessary for KBH4 mediated processes). Thus, the 
next attempt to optimise the process was changing the solvent.  We next decided to 
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try stoichiometric CuBr/TPA in refluxing toluene as opposed to methanol (this also 
increased the temperature of the reaction from 50 to 110 
o
C. Pleasingly this yielded 
much better results, with significantly cleaner reactions in the majority of cases to 
give the cyclised products 399, with mass conversions of 89-99%. The one exception 
was the cyclisation of 397b which yielded the cyclised product 399b as minor 
product.   
 
Scheme 5.18: CuBr/TPA mediated cyclisation of anilides. Reagents and Conditions: 1eq. CuBr, 1 
eq. TPA, Tol, 0.12M, 110 
o
C. 
Entry 
Starting 
Material 
R X Mass Conversion Ratio 399:400:401 
1 397a Me H 97% 1 : 0.07 : 0.00 
2 397b iPr H 89%
 a 
3 397c Bn H 98%
 
1 : 0.02 : 0.00 
4 397d Me Cl 95% 1 : 0.03 : 0.00 
5 397e Me OMe 99% 1 : 0.02 : 0.00 
6 397f Me NO2 95% 1 : 0.11 : 0.00 
Table 5.3: CuBr/TPA mediated cyclisation of anilides in toluene. 
a
Too many products in reaction 
mixture to allow calculation of ratios. 
Figures 5.6 and 5.7 compare the crude 400 MHz 
1
H NMRs for the CuBr/TPA 
mediated cyclisation of 397c and 397e in both methanol and toluene showing how 
much cleaner the reactions are in toluene. 
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Figure 5.6: Crude 400 MHz 
1
H NMR for cyclisation of 397c in toluene and methanol. 
 
Figure 5.7: Crude 400 MHz 
1
H NMR for cyclisation of 397e in toluene and methanol. 
5.3 Conclusion  
Anilides 397a-f have been shown to undergo copper mediated cyclisations to give 
oxindole products 399a-f. Attempts at cyclising the anilides using the AGET ATRC 
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conditions with catalytic CuSO4.5H2O and KBH4 did yield the cyclised oxindole 
product, however only in low yields (10-33%). The reactions were messy with 
several other products, in particular the reduced compounds 400a-f and the 
eliminated compounds 401a-f. Cyclisation mediated by CuBr and TPA in methanol 
again gave messy reaction mixtures yielding the same products, although with 
significantly lower amounts of the reduced compounds 400a-f. Pleasingly however, 
when the cyclisations were carried out in toluene, in most cases the reactions 
proceeded cleanly to give the desired oxindole products 399a-f in pleasing yields. 
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6.0 Experimental 
6.1 General Information and Procedures 
Unless stated, the chemicals and solvents, including anhydrous solvents, used in 
these syntheses were obtained from commercial suppliers and were used without 
further purification and without exhaustive deoxygenation of solvents. All reactions 
were performed using oven dried glassware and heat transfer was achieved using 
drysyn© apparatus. Sodium hydride dispersion in mineral oil (60% w/w) was 
washed three times with hexane under a constant flow of nitrogen to remove the oil 
prior to use. Where petroleum ether was used it was the 40-60 
o
C fraction and all 
water used was deionised.  
Reactions were followed by TLC, performed on Merck silica gel 60 F-254 TLC 
sheets; the TLC plate was then visualized with UV fluorescence (254 nm) and then 
stained with potassium permanganate or vanillin. Flash chromatography was carried 
out using Merck silica gel 60, 35-75μm as the stationary phase according to the 
procedure of Still et. al.
225
 
NMR spectra were obtained at 298 K unless otherwise stated. 
1
H and 
13
C NMR were 
recorded on Bruker DPX-300, DPX-400 and DRX-500 instruments and are 
referenced to tetramethylsilane (TMS) at 0.00 ppm. Chemical shifts (δH) are quoted 
in parts per million (ppm), coupling constants J are quoted in hertz (Hz), and data is 
quoted as (δH, integration, multiplicity). Proton and carbon NMR assignments were 
routinely confirmed by 
1
H-
1
H (COSY), 
1
H-
13
C (HMQC) and 
1
H-
13
C (HMBC) 
experiments. For variable temperature NMR samples were submitted to the NMR 
service and analysis on a Bruker DPX500 spectrometer. Spectra obtained were 
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analysed using Mestrec© and NUTS© software prior to lineshape analysis using 
WINDNMR.
145
 
Low resolution mass spectra were recorded on Bruker Esquire 2000 for electro spray 
conditions. Accurate mass spectroscopy was available through the in house mass 
spec service using either Bruker HCT or Bruker HCT Ultra machines to perform 
accurate mass ESI analysis. Only molecular ions fractions from molecular ions and 
other major peaks are reported as mass/charge (m/z) ratios.  
IR was achieved using a Perkin-Elmer Avatar 320 FTIR spectrometer. Solids were 
compressed into a thin tablet and oils/non-volatile liquids were analysed as films 
over a diamond sensor. Absorption maxima (υmax) are recorded in wavenumbers (cm
-
1
).  
Analytical chiral HPLC was performed by the Curran group in Pittsburgh and was 
conducted using either an (S,S)-Whelk-O 1 column (Pirkle, 250 mm x 4.6 mm ID) or 
a Chiralcel OD column (Daicel, 250 mm x 4.6 mm ID).  
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6.2 Compounds Synthesised in Chapter Two 
 
6.2.1 General Procedure for the Synthesis of Enamides via an Imine. 
Ketone (1 eq.) and benzylamine (1.0 eq.) were dissolved in dry toluene and heated to 
reflux under Dean-Stark conditions for 4-16 hours. The reaction mixture was then 
cooled and concentrated in vacuo and a crude NMR of the imine intermediate taken, 
before redisolving in toluene and cooling to 0 
o
C. Triethylamine (1.2 eq.) was then 
added slowly followed by the dropwise addition of the appropriate acid chloride (1.1 
eq.). The reaction mixture was then allowed to warm to room temperature and stirred 
for 12 hours. NaHCO3 (~50 mL) was then added and the layers separated. The 
aqueous phase was extracted with Et2O (3 x 50 mL) and the organic layers 
combined, dried over MgSO4, filtered and concentrated in vacuo to give the crude 
product. Products were purified by column chromatography. 
 
N -benzyl-N-vinylacetamide
226
 (171) 
 
The general procedure for the formation of enamides via imines (6.2.1) was applied 
using acetaldehyde (2 g, 45.4 mmol), benzylamine (4.96 mL, 45.4 mmol), toluene 
(45 mL, 90 mL), triethylamine (7.56 mL, 54.5 mmol) and acetyl chloride (3.55 mL, 
49.9 mmol). The crude product was purified by column chromatography (pet 
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ether/EtOAc, 4:1) to yield the pure product as an orange oil (1.3 g, 15%). The 
isolated product was a 1:2 mixture of amide rotamers. 
Discernable data for major rotamer: Rf 0.45 (pet ether/EtOAc, 4:1); υmax 2039 (CH), 
1670 (C=O), 1619 (C=O); δH (300MHz, CDCl3) 7.03 – 7.40 (5H, m, 5 x ArH), 6.84 
(1H, dd, J = 15.5, 9.0 Hz, NCH), 4.87 (2H, s, ArCH2), 4.42 (1H, d, J = 15.5 Hz, 
CHCHaHb), 4.30 (1H, dd, J = 9.0 Hz, CHCHaHb), 2.31 (3H, s, CH3); δC (151 MHz, 
CDCl3) 169.61 (C=O), 136.93 (ArC), 133.29 (NCH), 128.52 (ArCH), 126.99 
(ArCH), 126.79 (ArCH), 95.32 (CHCH2), 45.39 (NCH2), 22.11 (CH3); m/z (ES
+
) 
198.1 [M+Na]
+
. 
Discernable data for minor rotamer: Rf 0.45 (pet ether/EtOAc, 4:1); υmax 2039 (CH), 
1670 (C=O), 1619 (C=O); δH (300MHz, CDCl3) 7.60 (1H, dd, J = 16.0, 9.5 Hz, 
NCH), 7.03 – 7.40 (5H, m, 5 x ArH), 4.76 (2H, s, ArCH2), 4.36 – 4.39 (1H, br m, 
CHCHaHb), 4.32 (1H, br m, CHCHaHb), 2.15 (3H, s, CH3); δC (151 MHz, CDCl3) 
169.88 (C=O), 136.04 (ArC),  131.76 (NCH), 128.95 (ArCH), 127.42 (ArCH), 
125.58(ArCH), 94.67(CHCH2), 48.73(NCH2), 22.42(CH3); m/z (ES
+
) 198.1 
[M+Na]
+
. 
 
N -benzyl- N -(prop-1-en-2-yl)acetamide
227
 (172) 
 
The general procedure for the formation of enamides via imines (6.2.1) was applied 
using acetone (3 g, 51.7 mmol), benzylamine (5.64 mL, 51.7 mmol), toluene (50 mL, 
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100 mL), triethylamine (8.60 mL, 61.9 mmol) and acetyl chloride (4.04 mL, 56.8 
mmol). The crude product was purified by column chromatography (pet 
ether/EtOAc, 4:1) to yield the pure product as a brown oil (3.11 g, 29%). Rf 0.3 (pet 
ether/EtOAc, 4:1); υmax 2922 (CH), 1642 (C=O); δH (300MHz, CDCl3) 7.11 – 7.38 
(5H, m, 5 x ArH), 4.95 (1H, s, C=CHaHb), 4.64 (1H, s, C=CHaHb), 4.61 (2H, s, 
NCH2), 2.09 (3H, s, C=OCH3), 1.80 (3H, s, C=CCH3); δC (75MHz, CDCl3) 168.97 
(C=O), 143.81 (NC=C), 137.21 (ArC), 127.92 (ArCH), 127.72 (ArCH), 126.64 
(ArCH), 115.25 (NC=CH2), 48.33 (NCH2), 21.18 (C=CCH3), 20.36 (C=OCH3); m/z 
(ES
+
) 190.2 [M+H]
+
, 212.2 [M+Na]
+
. 
 
6.2.2 General procedure for formation of oximes  
Ketone (1 eq.), sodium acetate (1.2 eq.) and hydroxylamine hydrochloride (1.2 eq.) 
in methanol were heated to reflux under an inert atmosphere for 12-16 h. The 
mixture was then concentrated in vacuo and the residue taken up in ethyl acetate 
(~50 mL) and washed with water (3 × 50 mL). The organic phase was then dried 
over MgSO4, filtered and then concentrated in vacuo to give the product which was 
taken on without further purification.  
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Isobutyraldehyde oxime
228
 (173a) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 
isobutryaldehyde (3 g, 41.6 mmol), sodium acetate (4.10 g, 49.9 mmol), 
hydroxylamine hydrochloride (3.47 g, 49.9 mmol) and methanol (80 mL). The 
isolated product was a yellow oil (3.39 g, 94%) and a mixture of isomers in a 1:3.2 
ratio. 
Major isomer; 0.18 (pet ether/EtOAc, 8:1); υmax 3271 (OH), 2964 (CH);; δH (400 
MHz, CDCl3) 8.22 (1H, br s, OH), 7.39 (1H, d, J = 6.0 Hz, N=CH), 2.53 (1H, dhept, 
J = 7.0, 6.0 Hz, CH(CH3)2), 1.11 (6H, d, J = 7.0 Hz, CH(CH3)2); δC (100MHz, 
CDCl3) 156.78 (C=N), 29.37 (CH(CH3)2), 19.81 (CH(CH3)2); m/z (ES
+
) 110.1 
[M+Na]
+
. 
Minor isomer; Rf 0.18 (pet ether/EtOAc, 8:1); υmax 3271 (OH), 2964 (CH); δH (400 
MHz, CDCl3) 8.22 (1H, br s, OH), 6.66 (1H, br s, N=CH), 3.23 (1H, apparent octet, 
J = 7.0 Hz, CH(CH3)2), 1.09 (6H, d, J = 7.0 Hz, CH(CH3)2); δC (100MHz, CDCl3) 
157.82 (C=N), 24.66 (CH(CH3)2), 19.51 (CH(CH3)2); m/z (ES
+
) 110.1 [M+Na]
+
. 
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3-Methylbutan-2-one oxime
158
 (176a) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 3-
methyl-2-butanone (5 g, 58.1 mmol), sodium acetate (5.71 g, 69.7 mmol), 
hydroxylamine hydrochloride (4.84 g, 69.7 mmol) and methanol (100 mL). The 
product was isolated as a colourless liquid (3.59 g, 61%) and a mixture of isomers in 
a 1:7.9 ratio. 
Discernable data for major isomer: Rf 0.36 (pet ether/EtOAc, 6:1); υmax 3240 (OH), 
2965 (CH) ; δH (400MHz, CDCl3) 8.22 (1H, br s, OH), 2.50 (1H, hept, J = 7.0 Hz, 
CH), 1.86 (3H, s, N=CCH3), 1.10 (6H, d, J = 7.0 Hz, CH(CH3)2); δC (75 MHz, 
CDCl3) 161.89 (N=C), 33.86 (CH(CH3)2), 19.04 (CH(CH3)2), 10.55 (N=CCH3); m/z 
(ES
+
) 102.4 [M+H]
+
. 
Discernable data for minor isomer: Rf 0.36 (pet ether/EtOAc, 6:1); υmax 3240 (OH), 
2965 (CH); δH (400MHz, CDCl3) 8.22 (1H, br s, OH), 3.47 (1H, hept, J = 7.0 Hz, 
CH), 1.79 (3H, s, N=CCH3), 1.05 (6H, d, J = 7.0 Hz, CH(CH3)2); δC (75 MHz, 
CDCl3) 162.5 (N=C), 25.1 (CH(CH3)2), 18.2 (CH(CH3)2), 14,8 (N=CCH3); m/z (ES
+
) 
102.4 [M+H]
+
. 
 
6.2.3 General Procedure for Iron Mediated Synthesis of Enamides  
Oxime (1 eq.), acetic acid or chloroacetic acid (3 eq.), acetic anhydride or 
chloroacetic anhydride (3 eq.) and iron powder (2 eq.) in anhydrous toluene were 
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heated to reflux under an inert atmosphere for 6-16 hours. The mixture was then 
filtered through celite, diluted with DCM and washed with 2M NaOH and NaCl(aq). 
The organic phase was then dried over MgSO4, filtered and then concentrated in 
vacuo to give the crude product. Products were purified by column chromatography 
or recrystallisation as stated below. 
 
N-(2-Methylprop-1-enyl)acetamide
229
 (173b) 
 
The general procedure for the iron mediated synthesis of enamides (6.1.3) was 
applied using isobutryaldehyde oxime (2 g, 22.9 mmol), acetic acid (3.94 mL, 68.9 
mmol), acetic anhydride (6.50 mL, 68.9 mmol), iron powder (2.56 g, 45.3 mmol) 
and anhydrous toluene (30 mL). The crude product was purified by column 
chromatography (pet ether/EtOAc, 1:1) to give the product as a yellow oil (113 mg, 
4%). Rf  0.2 (pet ether/EtOAc, 1:1); δH (400MHz, CDCl3) 6.88 (1H, br s, NH), 6.51 
(1H, d, J = 10.5 Hz, NCH), 2.06 (3H, s, C=OCH3), 1.70 (3H, s, C=C(CH3)(CH3)), 
1.63 (3H, s, C=C(CH3)(CH3)); δC (100MHz, CDCl3) 167.1 (C=O), 117.0 (NCH), 
115.2(HC=C(CH3)2), 23.3 (C=OCH3), 22.4 (C=C(CH3)(CH3)), 16.5 
(C=C(CH3)(CH3)); m/z (ES
+
) 136.2 [M+Na]
+
. 
 
(Z)-N-(But-2-en-2-yl)acetamide
171
 (174a) and (E)-N-(But-2-en-2-yl)acetamide
171
 
(175a) 
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The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using butanone oxime (3 g, 34.4 mmol), acetic acid (5.91 mL, 103 mmol), 
acetic anhydride (9.74 mL, 103 mmol), iron powder (3.84 g, 68.9 mmol) and 
anhydrous toluene (60 mL). The product was taken on to the next step without 
further purification. δH (400MHz, CDCl3) 6.53 (1H, br s, NH), 5.72 (1H min, q, J = 
7.0 Hz, C=CH), 5.04 (1H maj, q, J = 6.5 Hz, C=CH), 2.06 (3H maj, s, C=OCH3), 
2.01 (3H min, s, C=COCH3), 1.98 (3H maj, s, NHCCH3), 1.86 (3H min, s, 
NHCCH3), 1.63 (3H min, d, J = 7.0 Hz, C=CHCH3), 1.54 (3H maj, d, J = 6.5 Hz, 
C=CHCH3); m/z (ES
+
) 136.2 [M+Na]
+
.  
 
N-(3-Methylbut-2-en-2-yl)acetamide
230
 (176b) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using 3-methylbutan-2-one oxime (3.2 g, 31.6 mmol), acetic acid (5.43 mL, 
94.9 mmol), acetic anhydride (8.95 mL, 94.9 mmol), iron powder (3.53 g, 63.3 
mmol) and anhydrous toluene (120 mL). The crude product was purified by column 
chromatography (pet ether/EtOAc, 1:1) followed by recrystallisation from 10:1 pet 
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ether/EtOAc to give the product as an orange solid (617 mg, 15%). The product was 
a 4:1 ratio of amide rotamers.  
Discernable data for major rotamer: Rf 0.12 (pet ether/EtOAc, 1:1); m.p. 70 - 72 
o
C; 
υmax 3240 (CH) 2912 (CH), 1643 (C=O); δH (400MHz, CDCl3) 6.37 (1H, s, NH), 
2.03 (3H, s, C=OCH3), 1.88 (3H, s, C=C(CH3)NH), 1.71 (3H, s, C=C(CH3)(CH3)), 
1.63 (3H,  s, C=C(CH3)(CH3)); δC (100MHz, CDCl3) δ 168.0 (C=O), 124.8 
(C=C(CH3)2), 123.5 (C=C(CH3)2), 22.7 (C=OCH3), 19.0 (CH3), 18.9 (CH3), 16.8 
(CH3); m/z (ES
+
) 128.2 [M+H]
+
, 150.1 [M+Na]
+
, 277.0 [2M+Na]
+
.  
Discernable data for major rotamer: Rf 0.12 (pet ether/EtOAc, 3:1); m.p. 70 - 72 
o
C; 
υmax 3240 (CH) 2912 (CH), 1643 (C=O); δH (400MHz, CDCl3) 6.21 (1H, s, NH), 
1.90 (3H, s, C=OCH3), 1.83 (3H, s, C=C(CH3)NH), 1.74 (3H, s, C=C(CH3)(CH3)), 
1.69 (3H,  s, C=C(CH3)(CH3)); δC (100MHz, CDCl3) 168.0 (C=O), 124.8 
(C=C(CH3)2), 123.5 (C=C(CH3)2), 19.2 (CH3),  19.1 (CH3),  19.0 (CH3),  18.6 (CH3); 
m/z (ES
+
) 128.2 [M+H]
+
, 150.1 [M+Na]
+
, 277.0 [2M+Na]
+
. 
 
6.2.4 General procedure for the alkylation of enamides 
Enamide (1 eq.) was added to sodium hydride (5 eq.) in anhydrous THF and cooled 
to 0 
o
C. Benzyl bromide (1.05 eq.) was then added and the reaction heated to reflux 
under an inert atmosphere for 10-16 hours. The reaction mixture was then added to 
water and extracted with ethyl acetate. The combined organic layers were then dried 
over MgSO4, filtered and then concentrated in vacuo to give the crude product. 
Products were purified by column chromatography or recrystallisation as stated 
below. 
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(Z)-N-Benzyl-N-(but-2-en-2-yl)acetamide (174) and (E)-N-Benzyl-N-(but-2-en-2-
yl)acetamide (175) 
 
The general procedure for the alkylation of enamides (6.2.4) was applied using N-
(But-2-en-2-yl)acetamide (200 mg, 1.77 mmol), sodium hydride (354 mg, 8.84 
mmol) and benzyl bromide (0.22 mL, 1.86 mmol) and anhydrous THF (25 mL). The 
crude product showed a 2:1 (Z:E) ratio of isomers. This was purified by column 
chromatography (pet ether/EtOAc, 6:1) to give (Z)-N-Benzyl-N-(but-2-en-2-
yl)acetamide as a yellow oil (57 mg, 16%), and a (E)-N-Benzyl-N-(but-2-en-2-
yl)acetamide as a 1:1.8 (Z:E) mixture with the Z isomer (153 mg). 
 
(Z)-N-Benzyl-N-(but-2-en-2-yl)acetamide: Rf 0.1 (pet ether/EtOAc, 6:1); υmax 2934 
(CH), 1655 (C=O); δH (400MHz, CDCl3) δ 7.08 – 7.34 (5H, m, 5 x ArH), 5.30 (1H, 
q, J = 7.0 Hz, C=CH), 4.73 (1H, d, J = 14.0 Hz, NCHaHb), 4.32 (1H, d, J = 14.0 Hz, 
NCHaHb), 1.93 (3H, s, C=OCH3), 1.67 (3H, s, C=C(N)CH3), 1.11 (3H, d, J = 7.0 Hz, 
C=CHCH3); δC (100MHz, CDCl3) δ 169.7 (C=O), 137.7 (ArC), 136.3 (NC=CH), 
129.3 (ArCH), 128.2 (ArCH), 127.4 (ArCH), 124.2 (NC=CH), 48.5 (NCH2Ar), 21.3 
(C=C(N)CH3), 21.1 (C=OCH3), 12.6 (NC=CHCH3); m/z (ES
+
) C13H18NO requires 
204.1383, found: 204.1383 [M+H]
+
. 
(E)-N-Benzyl-N-(but-2-en-2-yl)acetamide: Rf 0.075 (pet ether/EtOAc, 6:1); υmax 
2934 (CH), 1655 (C=O); δH (400MHz, CDCl3) δ 76.99 – 7.42 (5H, m, 5 x ArH), 
5.11 (1H, q, J = 7.0 Hz, C=CH), 4.53 (1H, s, NCHaHb), 1.97 (3H, s, C=OCH3), 1.64 
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(3H, s, C=C(N)CH3), 1.50 (3H, d, J = 7.0 Hz, C=CHCH3); δC (100MHz, CDCl3) δ 
170.0 (C=O), 138.1 (ArC), 137.3 (NC=CH), 128.7 (ArCH), 127.1 (ArCH), 126.4 
(ArCH), 125.9 (NC=CH), 49.4 (NCH2Ar), 21.7 (C=C(N)CH3), 15.7 (C=OCH3), 13.2 
(NC=CHCH3); m/z (ES
+
) C13H18NO requires 204.1383, found: 204.1383 [M+H]
+
. 
 
N-benzyl-N-(2-methylprop-1-enyl)acetamide
231
 (173) 
 
The general procedure for the alkylation of enamides (6.2.4) was applied using N-
(But-2-en-2-yl)acetamide (200 mg, 1.77 mmol), sodium hydride (354 mg, 8.84 
mmol) and benzyl bromide (0.22 mL, 1.86 mmol) and anhydrous THF (25 mL). The 
crude product showed a 2:1 (Z:E) ratio of isomers. This was purified by column 
chromatography (pet ether/EtOAc, 4:1) to give the product as a colourless oil (99 
mg, 28%). Rf 0.35 (pet ether/EtOAc, 4:1); υmax 2914 (CH), 1647 (C=O); δH 
(400MHz, CDCl3) 7.11 – 7.37 (5H, m, 5 x ArH), 5.75 (1H, apparent quintet, J = 1.0 
Hz, NC(H)=C), 4.56 (2H, s, NCH2Ar), 1.97 (3H, s, C=OCH3), 1.65 (3H, d, J = 1.0 
Hz, C=C(CH3)(CH3)), 1.39 (3H, d, J = 1.0 Hz, C=C(CH3)(CH3)); δC (100MHz, 
CDCl3) 170.2 (C=O), 136.8 (ArC), 135.7 (C(H)=C(CH3)2), 128.1 (ArCH), 127.7 
(ArCH), 126.6 (ArCH), 123.2 (NC(H)=C, 49.9 (NCH2Ar), 21.4 (C=OCH3), 21.2 
(C(H)=C(CH3)(CH3), 16.8 (C(H)=C(CH3)(CH3); m/z (ES
+
) 204.1 [M+H]
+
, 226.1 
[M+Na]
+
, 429.0 [2M+Na]
+
. 
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N-benzyl-N-(3-methylbut-2-en-2-yl)acetamide (176) 
 
The general procedure for the alkylation of enamides (6.2.4) was applied using N-(3-
methylbut-2-en-2-yl)acetamide (500 mg, 3.93 mmol), sodium hydride (786 mg, 
19.66 mmol) and benzyl bromide (0.49 mL, 4.13 mmol) and anhydrous THF (60 
mL). The crude product was purified by column chromatography (pet ether/EtOAc, 
4:1) to give the product as a yellow oil (680 mg, 80%). Rf 0.33 (pet ether/EtOAc, 
4:1); υmax 2920 (CH), 1644 (C=O); δH (400MHz, CDCl3) 7.18 – 7.44 (5H, m, 5 x 
ArH), 4.67 (1H, d, J = 14.0 Hz, NCHaHbAr), 4.53 (1H, d, J = 14.0 Hz, NCHaHb), 
1.98 (3H, s, C=OCH3), 1.71 (3H, s, NC(CH3)=C(CH3)(CH3)), 1.67 (3H, s, 
NC(CH3)=C(CH3)(CH3)), 1.30 (3H, s, NC(CH3)=C(CH3)(CH3)); δC (375 MHz, 
CDCl3) 170.2 (C=O), 137.8 (ArC), 131.1 (NC=C(CH3)2), 129.5 (ArCH), 129.4 
(NC=C), 128.2 (ArCH), 127.3 (ArCH), 49.1 (NCH2Ar), 21.3 (C=OCH3), 19.6 
(NC(CH3)=C(CH3)2), 19.4 (NC(CH3)=C(CH3)(CH3)), 17.5 (NC(CH3)= 
C(CH3)(CH3)); m/z (ES
+
) C14H20NO requires 218.1539, found: 218.1540 [M+H]
+
.  
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Cyclohexyl phenyl ketoxime
170 
(181) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 
cyclohexyl phenyl ketone (2 g, 10.6 mmol), sodium acetate (1.05 g, 12.7 mmol), 
hydroxylamine hydrochloride (0.886 mg, 12.7 mmol) and methanol (25 mL). The 
isolated product was an off white solid (2.00 g, 93%) and a mixture of isomers in a 
2:1 ratio. Rf 0.34 (pet ether/EtOAc, 6:1); m.p. 162-164 
o
C, lit
232
 158-158.5 
o
C; υmax 
3230 (OH), 2925 (CH); δH (400MHz, CDCl3) 9.33 (1H, s, OH), 7.23 – 7.56 (5H, m, 
5 × ArH), 3.25 – 3.49 (0.33H, m, N=CCH min), 2.42 – 2.60 (0.67H, m, N=CCH 
maj), 1.99 – 1.08 (10 H, m, cy); δC (100MHz, CDCl3) 162.8 (C=N), 136.1, 134.0 
(N=C), 128.4, 128.2, 128.1, 128.0, 127.5 (ArC), 44.3 (N=CCH), 38.2 (N-CCH), 30.5 
(cy) 29.3 (cy), 26.3 (cy), 26.2 (cy), 26.0 (cy); m/z (ES
+
) 204.2 [M+H]
+
, 226.2 
[M+Na]
+
. 
 
2,6-dimethylcyclohexanone oxime
233 
(182) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 2,6-
dimethylcyclohexanone (2 g, 15.8 mmol), sodium acetate (1.56 g, 19.0 mmol), 
hydroxylamine hydrochloride (1.32 g, 19.0 mmol) and methanol (30 mL). The 
isolated product was a pale yellow oil (2.18 g, 97%). Rf 0.55 (pet ether/EtOAc, 6:1); 
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υmax 3249 (OH), 2964 (C-H); The product was identified by GC-MS as the 
1
H-NMR 
spectrum was inconclusive, showing a complex mixture of isomers. 
 
2,2,6-trimethylcyclohexanone oxime
234
 183 
 
The general procedure for the formation of oximes (6.2.2) was applied using 2,2,6-
trimethylcyclohexanone (3 g, 21.4 mmol), sodium acetate (2.11 g, 25.7 mmol), 
hydroxylamine hydrochloride (1.78 g, 25.7 mmol) and methanol (40 mL). The 
isolated product was a white solid (2.74 g, 82%) and a single isomer. Rf 0.24 (pet 
ether/EtOAc, 6:1); m.p. 102-103 
o
C, lit
235
 103 
o
C; υmax 3244 (OH), 2936 (CH); δH 
(400MHz, CDCl3) 3.50 – 3.6 (1H, m, CH), 1.73 – 1.88 (1H, m, cy), 1.55 – 1.66 (3H, 
m, cy), 1.43 – 1.55 (2H, m, cy), 1.24 (6H, s, C(CH3)2), 1.21 (3H, d, J = 10.0, 
CHCH3); δC (100MHz, CDCl3) 168.6 (C=N), 40.5 (CH2), 37.0 (C(CH3)2), 
31.3(CH2), 29.1, 28.7 (C(CH3)2), 26.5 (CHCH3), 18.5 (CHCH3), 17.3 (CH2);  m/z 
(ES
+
) 156.1 [M+H]
+
, 178.1 [M+Na]
+
.  
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Isobutyrophenoxime
154
 (184) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 
isobutyrophenone (5 g, 33.7 mmol), sodium acetate (3.32 g, 40.5 mmol), 
hydroxylamine hydrochloride (2.81 g, 40.5 mmol) and methanol (60 mL). The 
isolated product was a colourless crystalline solid (4.93 g, 89%) and a mixture of 
isomers in a 2:1 ratio. Rf  0.28 (pet ether/EtOAc, 6:1); m.p. 65-67 
o
C, lit
236
 58-60 
o
C; 
υmax 3134 (OH), 2959 (CH); δH (300MHz, CDCl3) 8.95 (1H, s, OH), 7.23 – 7.46 
(5H, m, 5 × ArH), 3.60 (0.33H, hept, J = 7.0, N=CCH min), 2.83 (0.65H, hept, J = 
7.0, N=CCH maj), 1.22 (2H, d, J = 7.0, 2 × CH3 min), 1.12 (4H, d, J = 7.0, 2 × CH3 
maj); δC (100MHz, CDCl3) 165.0 (C=N), 163.4 (C=N), 135.8, 13.7 (quarternary), 
128.5, 128.5, 128.2, 128.1, 127.8, 127.6 (ArC), 34.6 (CH maj), 27.7 (CH min), 20.1 
(CH3 maj), 19.4 (CH3 min); m/z (ES
+
) 164.2 [M+H]
+
, 186.2 [M+Na]
+
. 
 
2-Phenylcyclohexanone oxime
237
 (185) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 2-
phenylcyclohexanone (3 g, 17.2 mmol), sodium acetate (1.69 g, 20.7 mmol), 
hydroxylamine hydrochloride (1.44 g, 20.7 mmol) and methanol (35 mL). The 
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isolated product was an off white solid (3.19 g, 98%) and was a mixture of isomers 
in a 3:1 ratio. Rf 0.64 (pet ether/EtOAc, 6:1); m.p. 169-172 
o
C, lit
238
 174-175 
o
C; υmax 
3213 (OH), 2935 (CH); δH (400MHz, CDCl3) 7.19 – 7.44 (5H, m, 5 × ArH), 4.73 – 
4.98 (0.25H, m, N=CCH min), 3.45 – 3.61 (0.75H, m, N=CCH maj), 2.88 – 3.04 
(0.75H, m, N=CCHH maj), 2.34 – 2.52 (0.50H, m, N=CCH2 min), 2.22 – 2.32 
(0.75H, m, N=CCHH maj), 2.01 – 2.18 (2H, m, cy), 1.77 – 1.96 (2H, m, cy), 1.52 – 
1.74 (2H, m, cy); δC (100MHz, CDCl3) 161.3 (C=N), 139.9 (quarternary), 127.7, 
127.6, 125.9 (ArC), 47.4 (CH), 32.4, 25.1, 24.0, 23.3 (CH2); m/z (ES
+
) 190.1 
[M+H]
+
. 
 
2-Methyl-1-indanone oxime
239
 (186) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 2-
methylindanone (3 g, 20.5 mmol), sodium acetate (2.02 g, 24.6 mmol), 
hydroxylamine hydrochloride (1.71 g, 24.6 mmol) and methanol (40 mL). The 
isolated product was an orange crystalline solid (3.21 g, 97%) and was a mixture of 
isomers in an 11:6 ratio. Rf 0.29 (pet ether/EtOAc, 6:1); m.p. 94-96 
o
C, lit
240
 104 
o
C; 
υmax 3056 (OH), 2866 (CH), 1655 (C=N); δH (400MHz, CDCl3) 8.59 – 8.34 (0.35H, 
m, J = 7.5, ArH min), 7.67 (0.65H, d, J = 7.5, ArH maj), 7.19 – 7.49 (3H, m, 3 × 
ArH), 3.54 – 3.65 (0.65H, m, N=CCH maj), 3.34 (1H, dd, J = 16.5, 8.0, ArCHH maj 
+ min), 3.12 – 3.23  (0.35H, m, N=CCH min), 2.72 (0.35H, dd, J = 16.5, 4.5, 
ArCHH min), 2.65 (0.65H, d, J = 16.5, ArCHH maj), 1.38 (1.95H, d, J = 7.0, CH3 
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maj), 1.37 (1.05H, d, J = 7.0, CH3 min); δC (100MHz, CDCl3) 167.0, 163.7 (C=N), 
147.6, 147.0, 135.2, 133.22 (quarternary), 131.1, 130.5, 129.8, 127.1, 126.9, 125.8, 
125.5, 122.0 (ArC), 38.21, 38.1 (CH2), 36.3, 34.2 (CH), 20.0, 18.2 (CH3); m/z (ES
+
) 
162.0 [M+H]
+
, 184.0 [M+Na]
+
.  
 
2,4-Dimethyl-3-pentanone oxime
241
 (187) 
 
The general procedure for the formation of oximes (6.2.2) was applied using 2,4-
dimethyl-3-pentanone (5 g, 43.8 mmol), sodium acetate (4.31 g, 52.5 mmol), 
hydroxylamine hydrochloride (3.65 g, 52.5 mmol) and methanol (80 mL). The 
isolated product was a colourless crystalline solid (4.72g, 83%). Rf  0.46 (pet 
ether/EtOAc, 6:1); m.p. 34-36 
o
C, lit
242
 33-34 
o
C; υmax 3264 (OH), 2964 (CH); δH 
(400MHz, CDCl3) 9.35 (1H, s, OH), 3.21 (1H, hept, J = 7.0, CH), 2.56 (1H, hept, J = 
7.0, CH), 1.16 (6H, d, J = 7.0, 1CH3), 1.12 (6H, d, J = 7.0, CH3); δC (100MHz, 
CDCl3) 168.6 (C=N), 30.6, 27.5 (CH), 21.2, 18.8 (CH3); m/z (ES
+
) 103.3 [M+H]
+
, 
152.2 [M+Na]
+
. 
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N-(cyclohexylidene(phenyl)methyl)-acetamide
169
 (188) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using cyclohexylphenylketoxime (1.60 g, 7.87 mmol), acetic acid (1.35 mL, 
23.6 mmol), acetic anhydride (2.23 mL, 23.6 mmol), iron powder (879 mg, 15.7 
mmol) and anhydrous toluene (12 mL).  The crude product was purified by 
recrystallisation from petroleum ether /ethyl acetate 10:1 to give N-
(cyclohexylidene(phenyl)methyl)-acetamide as a yellow crystalline solid (877 mg, 
49%) and a mixture of rotamers in a 7:3 ratio. Rf 0.55 (pet ether/EtOAc, 1:1); m.p. 
124-127 
o
C, lit
169
 130-131 
o
C; υmax 3235 (NH), 2914 (CH), 1655 (C=O); δH 
(400MHz, CDCl3) 7.17 – 7.49 (5H, m, 5 × ArH), 6.68 (0.3H, br s, NH min), 6.47 
(0.7H, br s, NH maj), 2.21 – 2.48 (4H, m, C=C(CH2)2), 2.08 (2.1H, s, CH3 maj), 1.84 
(0.9H, s, CH3 min), 1.55 – 1.74 (6H, m, cy); δC (75MHz, CDCl3) 173.4 (C=O), 168.3 
(C=0), 138.8, 138.6, 138.1, 137.6 (Ar/NC=C quarternary), 129.1, 128.3, 128.1, 
127.6, 127.2 (ArC), 127.0, 124.9 (NC=C), 31.1, 31.0, 30.9, 30.6, 28.1, 27.6, 27.4, 
26.5, 26.4 (cy), 23.5 (CH3 maj), 20.7 (CH3 min); m/z (ES
+
) 252.1 [M+Na]
+
. 
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N-(2,6- dimethylcyclohexen-1-yl)-acetamide (189) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using 2,6-dimethycyclohexanone oxime (1.8 g, 12.6 mmol), acetic acid (2.19 
mL, 38.3 mmol), acetic anhydride (3.61 mL, 38.3 mmol), iron powder (1.42 g, 25.5 
mmol) and anhydrous toluene (18 mL). The crude product was purified by column 
chromatography (pet ether/EtOAc, 6:1 to 1:1) to yield the pure product as an off 
white solid (490 mg, 23%). The isolated product was a mixture of isomers in a 2:1 
ratio. Rf 0.36 (pet ether/EtOAc, 1:1); m.p. 125-127 
o
C; υmax 3251 (NH), 2925 (CH), 
1638 (C=O); δH (400MHz, CDCl3) 6.25 (1H, s, NH), 2.36 – 2.50 (0.67H, m, CH 
maj), 2.15 (0.33H, m, CH min), 2.05 (2H, s, C(O)CH3 maj), 2.00 – 2.07 (2H, m, 
CCH2), 1.89 (1H, s, C(O)CH3 min), 1.71 – 1.83 (2H, m, CH2CH2CH2), 1.64 (1H, s, 
CCH3 min), 1.52 – 1.68 (1H, m, CHCHH), 1.58 (2H, s, CCH3 maj), 1.36 – 1.50 (1H, 
m, CHCHH), 1.03 (1H, d, J = 7.0, CHCH3 min), 0.99 (2H, d, J = 7.0, CHCH3 maj); 
δC (75MHz, CDCl3) 168.3 (C=O), 130.5, 128.8 (C=C), 34.23 (CH), 32.14 (CH3), 
31.40, 31.28, 31.21, 31.01 (CH2), 23.42, 19.73 (CH3), 19.48 (CH2), 18.97, 18.76, 
18.57 (CH3); m/z (ES
+
) C10H17NNaO
+
 requires 190.1202, found 190.1207 [M+Na]
+
. 
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N-(2,2,6- trimethylcyclohexen-1-yl)-acetamide
 
(190) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using 2,2,6-trimethylcyclohexanone oxime (2.40 g, 15.5 mmol), acetic acid 
(2.65 mL, 46.4 mmol), acetic anhydride (4.38 mL, 46.4 mmol), iron powder (1.73 g, 
30.9 mmol) and anhydrous toluene (25 mL). The crude product was purified by 
column chromatography (pet ether/EtOAc, 9:1 to 1:1) to give N-(2,2,6- 
trimethylcyclohexen-1-yl)-acetamide as a yellow solid (403 mg, 14%). The product 
was a mixture isomers in a 2:1 ratio. Rf 0.50 (pet ether/EtOAc, 1:1); m.p. 122-124 
o
C; υmax 3271 (NH), 2926 (CH), 1649 (C=O); δH (400MHz, CDCl3) 6.41 (0.33H, s, 
NH min), 6.32 (0.67H, s, NH maj), 2.07 (2H, s, C(O)CH3 maj), 2.03 – 2.09 (2H, m, 
C=CCH2), 1.89 (1H, s, C(O)CH3 min), 1.62 (1H, s, C=CCH3 min), 1.48 – 1.68 (4H, 
m, C(CH3)2CH2CH2), 1.54 (2H, s, C=CCH3 maj), 1.01 (2H, s, C(CH3)2 min), 1.00 
(4H, s, C(CH3)2 maj); δC (100MHz, CDCl3) 173.6, 168.3 (C=0), 134.4, 131.8, 131.5, 
130.3 (C=C), 38.83, 38.72, 35.61, 35.06 (CH2), 31.90, 31.69 (C=CCH2), 27.27, 
27.11, 27.0, 26.42 (C(CH3)2), 23.32, 19.45 (COCH3), 19.28, 19.19 (C=CCH3), 18.98, 
18.88 (C(CH3)2); m/z (ES
+
) C11H19NNaO
+
 requires 204.1364, found 204.1366 
[M+Na]
+
. 
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N-(1-phenyl-2-methylprop-1-en-1-yl)-acetamide
169
 (191) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using isobutyrophenoxime (4.93 g, 30.2 mmol), acetic acid (5.19 mL, 90.6 
mmol), acetic anhydride (8.55 mL, 90.6 mmol), iron powder (3.37 g, 60.4 mmol) 
and anhydrous toluene (120 mL). The crude product was purified by recrystallisation 
from hexane /ethyl acetate 10:1 to give N-(1-phenyl-2-methylprop-1-en-1-yl)-
acetamide as a white solid (3.92 g, 69%) and as a mixture of isomers in a 7:3 ratio. 
Rf 0.43 (pet ether/EtOAc, 1:1); m.p. 84-86 
o
C, lit
31
 82-82 
o
C; υmax 3271 (NH), 2907 
(CH), 1648 (C=O); δH (300MHz, CDCl3) 7.14 – 7.44 (5H, m, 5 × ArH), 6.75 (0.3H, 
s, NH min), 6.63 (0.7H, s, NH maj), 2.04 (2.1H, s, C(O)CH3 majo), 1.89 (0.9H, s, 
C(O)CH3 min), 1.85 (0.9H, s, C=CCH3 min), 1.80 (2.1H, s, C=CCH3 maj), 1.79 
(2.1H, s, C=CCH3 maj), 1.76 (0.9H, s, C=CCH3 min); δC (75MHz, CDCl3) 173.5, 
168.2 (C=O), 138.8, 138.2, 130.8, 130.2, 129.7 (quarternary), 129.1, 128.2, 128.0 
(ArC), 127.8 (quarternary), 127.6, 127.2 (ArC), 23.3, 21.3, 21.1, 20.8, 20.7 (CH3); 
m/z (ES
+
) 212.2 [M+H]
+
. 
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N-(2-phenylcyclohexene-1-yl)-acetamide
243
 (192) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using 2-phenylcyclohexanone oxime (3.00 g, 15.8 mmol), acetic acid (2.72 
mL, 47.6 mmol), acetic anhydride (4.49 mL, 47.6 mmol), iron powder (1.77 g, 31.7 
mmol) and anhydrous toluene (25 mL). The crude product was purified by column 
chromatography (pet ether/EtOAc, 6:1) to yield the pure product as an orange solid 
(640 mg, 19%). Rf 0.55 (pet ether/EtOAc, 1:1); m.p. 94-97 
o
C; υmax 3259 (NH), 2922 
(CH), 1636 (C=O); δH (300MHz, CDCl3) 7.35 (2H, t, J = 7.5, ArH), 7.26 (1H, t, J = 
7.5, ArH), 7.20 (2H, d, J = 7.5, ArH), 6.43 (1H, s, NH), 2.9 – 2.69 (2H, m, CCH2), 
2.28 – 2.38 (2H, m, CCH2), 1.83 (3H, s, C(O)CH3), 1.69 – 1.81 (4H, m, CH2); δC 
(75MHz, CDCl3) 168.6 (C=O), 140.8, 130.7 (quarternary), 128.7, 128.1, 127.0 
(ArC), 126.2 (quarternary), 30.8, 27.7 (C=CCH2), 23.9 (CH3), 22.8, 22.7 (CH2); m/z 
(ES
+
) 238.0 [M+Na]
+
. 
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N-(2-methylindene-1-yl)-acetamide
239 
(193) and N-Acetyl-N-(2-methylindene-1-
yl)-acetamide (193a) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using 2-methylindanone oxime (3.00 g, 18.6 mmol), acetic acid (3.20 mL, 
55.8 mmol), acetic anhydride (5.27 mL, 55.8 mmol), iron powder (2.08 g, 37.2 
mmol) and anhydrous toluene (30 mL). The crude product was purified by column 
chromatography (pet ether/EtOAc, 9:1 to 1:1) to give N-(2-methylindene-1-yl)-
acetamide (1.72 g, 49%) as a brown solid and a mixture of isomers in a 2:1 ratio and 
by-product N-Acetyl-N-(2-methylindene-1-yl)-acetamide (412 mg, 10%) as an 
orange solid. 
N-(2-methylindene-1-yl)-acetamide
239
 (193) 
Rf  0.50 (pet ether/EtOAc, 1:1); m.p. 126-128 
o
C; υmax 3236 (NH), 2972 (CH), 1654 
(C=O); δH (400MHz, CDCl3) 7.06 – 7.49 (4H, m, ArH), 6.69 (0.67H, s, NH maj), 
6.52 (0.33H, s, NH min), 3.39 (0.67H, s, CH2 min), 3.35 (1.33H, s, CH2 maj), 2.24 
(2H, s, C(O)CH3 maj), 2.10 (1H, s, C(O)CH3 min), 2.06 (2H, s, C=CCH3 maj), 1.92 
(1H, s, C=CCH3 maj); δC (100MHz, CDCl3) 168.9 (C=O), 142.8, 142.5, 141.0, 
140.7, 139.7, 136.4, 131.6 (quarternary), 126.7, 126.1, 125.1, 124.5, 123.8, 123.4, 
117.9, 117.6 (ArC), 40.7, 40.6 (CH2), 23.3, 20.2 (C(O)CH3), 14.0, 13.5 (C=CCH3); 
m/z (ES
+
) 210.0 [M+Na]
+
. 
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N-Acetyl-N-(2-methylindene-1-yl)-acetamide (193a) 
Rf 0.41 (pet ether/EtOAc, 3:1); m.p. 77-79 
o
C; υmax 2973 (CH), 1715, 1700 (C=O); 
δH (400MHz, CDCl3) 7.41 (1H, d, J = 7.5, ArH), 7.27 (1H, t, J = 7.5, ArH), 7.19 
(1H, t, J = 7.5, ArH), 7.01 (1H, d, J = 7.5, ArH), 3.47 (2H, s, CH2), 2.36 (6H, s, 
C(O)CH3), 2.01 (3H, s, C=CCH3); δC (100MHz, CDCl3) 172.36 (C=O), 141.70, 
141.68, 140.75, 135.24 (quaternary), 126.75, 125.15, 124.04, 117.17 (ArC), 40.79 
(CH2), 25.91 (C(O)CH3), 13.23 (C=CCH3); m/z (ES
+
) C13H15NNaO2
+
 requires 
252.0995, found: 252.0994 [M+Na]
+
. 
 
N-(2,4-dimethylpent-2-en-3-yl)-acetamide (194) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using 2,4-dimethyl-3-pentanone oxime (4.72 g, 36.3 mmol), acetic acid (6.23 
mL, 109 mmol), acetic anhydride (10.3 mL, 109 mmol), iron powder (4.06 g, 72.6 
mmol) and anhydrous toluene (120 mL). The crude product was purified by 
recrystallisation from hexane to give N-(2,4-dimethylpent-2-en-3-yl)-acetamide as an 
pale yellow crystalline solid (3.17 g, 56%) and a mixture of isomers in a 5:3 ratio. Rf 
0.60 (pet ether/EtOAc, 1:1); m.p. 64-66 
o
C; υmax 3242 (NH), 2972 (CH), 1641 
(C=O); δH (400MHz, CDCl3); δC (100MHz, CDCl3) 6.15 (0.37H, s, NH min), 6.07 
(0.63H, s, NH maj), 2.87 – 3.01 (1H, m, CH), 2.07 (1.89H, s, C(O)CH3 maj), 1.88 
(1.11H, s, C(O)CH3 min), 1.77 (3H, s, CCH3), 1.67 (1.11H, s, CCH3), 1.60 (1.89H, s, 
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CCH3), 0.96 (2.22H, d, J = 7.0, CHC(CH3)2 min), 0.95 (3.78H, d, J = 7.0, 
CHC(CH3)2 maj); δC (75MHz, CDCl3) 168.6 (C=O), 131.2, 127.6 (quarternary), 
29.6, 29.2 (CH), 23.3 (C(O)CH3 maj), 20.5, 20.5, 20.0, 19.7, 19.5, 19.2, 19.2 (CH3); 
m/z (ES
+
) C9H17NNaO
+
 requires 178.1202, found 178.1202 [M+Na]
+
. 
 
N-Benzyl-N-(cyclohexylidene(phenyl)methyl)-acetamide (195) 
 
The general procedure for enamide alkylation (6.2.4) was applied using N-
(cyclohexylidene(phenyl)methyl)-acetamide (600 mg, 2.62 mmol), sodium hydride 
(520 mg, 13.1 mmol) and benzyl bromide (0.33 mL, 2.75 mmol) and anhydrous THF 
(50 mL). The crude product was recrystallised from hexane to give N-Benzyl-N-
(cyclohexylidene(phenyl)methyl)-acetamide as a pale orange crystalline solid (0.721 
g, 86%). Rf 0.45 (pet ether/EtOAc, 4:1); m.p. 89-92 
o
C; υmax 2925 (CH), 1646 
(C=O); δH (400MHz, CDCl3) 7.15 – 7.46 (10H, m, ArH), 5.37 (1H, d, J = 14.0, 
ArCHH), 3.37 (1H, d, J = 14.0, ArCHH), 2.38 – 2.54 (1H, m, cy), 2.18 (3H, s, 
C(O)CH3), 1.77 – 1.94 (2H, m, cy), 1.60 – 1.74 (2H, m, cy), 1.43 – 1.54 (1H, m, cy), 
1.22 – 1.42 (3H, m, cy), 0.42 – 0.56 (1H, m, cy); δC (100MHz, CDCl3) 170.68 
(C=O), 140.69, 137.33, 136.42, 130.68 (quarternary), 129.96, 129.25, 128.41, 
128.18, 127.91, 127.36 (ArC), 47.94 (ArCH2), 31.32, 31.24, 27.94, 26.59, 26.30 (cy 
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CH2), 21.39 (C(O)CH3); m/z (ES
+
) C22H26NO
+
 requires 320.2009, found 320.2005 
[M+H]
+
. 
 
N-Benzyl-N-(2-phenylcyclohexene-1-yl)-acetamide
244 
(196) 
 
The general procedure for enamide alkylation (6.2.4) was applied using N-Benzyl-N-
(2-phenylcyclohexene-1-yl)-acetamide (300 mg, 1.39 mmol), sodium hydride (279 
mg, 6.97 mmol) and benzyl bromide (0.17 mL, 1.46 mmol) and anhydrous THF (30 
mL). Crude product was purified by column chromatography (pet ether/EtOAc 2:1) 
to give the product as a pale yellow oil (293 mg, 69%). Rf  0.48 (pet ether/EtOAc, 
2:1); υmax 2928 (CH), 1638  (C=O); δH (400MHz, CDCl3) 7.01 – 7.42 (10H, m, 
ArH), 5.11 (1H, d, J = 14.5, ArCHH), 3.52 (1H, d, J = 14.5, ArCHH), 2.33 – 2.61 
(2H, m, C=CCH2), 2.11 (3H, s, C(O)CH3), 1.94 – 2.07 (2H, m, C=CCH2), 1.55 – 
1.79 (4H, m, CH2CH2CH2CH2); δC (75MHz, CDCl3) 169.5 (C=O), 140.0, 137.5, 
135.6, 134.8 (quarternary), 128.1, 127.9, 127.6, 126.6, 126.5, 126.3 (ArC), 49.9 
(ArCH2), 31.0, 30.6, 22.3, 21.9 (CH2), 21.4 (CH3); m/z (ES
+
) 306.1 [M+H]
+
, 
328.1[M+Na]
+
. 
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N-Benzyl-N-(2,2,6- trimethylcyclohexen-1-yl)-acetamide (197) 
 
The general procedure for enamide alkylation (6.2.4) was applied using N-(2,2,6- 
trimethylcyclohexen-1-yl)-acetamide (300 mg, 1.65 mmol), sodium hydride (331 
mg, 8.27 mmol) and benzyl bromide (0.21 mL, 1.73 mmol) and anhydrous THF (30 
mL). The crude product was purified by column chromatography (pet ether/EtOAc 
3:1) to give N-Benzyl-N-(2,2,6- trimethylcyclohexen-1-yl)-acetamide as a pale 
yellow oil (0.331 g, 74%). Rf  0.52 (pet ether/EtOAc, 3:1 ); υmax 2931 (CH), 1641 
(C=O); δH (400MHz, CDCl3) 7.11 – 7.49 (5H, m, ArH), 5.00 (1H, d, J = 14.5, 
ArCHH), 4.35 (1H, d, J = 14.5, ArCHH), 1.99 – 2.07 (2H, m, C=CCH2), 1.97 (3H, s,  
C(O)CH3), 1.50 – 1.83 (4H, m, C=CCH2CH2CH2), 1.17 (3H, s, C=CCH3), 1.07 (3H, 
s, C(CH3)(CH3)), 1.06 (3H, s, C(CH3)(CH3)); δC (100MHz, CDCl3) 172.1 (C=O), 
139.4, 137.8, 133.8 (quarternary), 129.4, 128.1, 127.0 (ArC), 51.6 (ArCH2), 41.1 
(CH2), 35.9 (CH), 31.7 (C=CCH2), 30.4 (C=CCH3), 27.6 (C(CH3)(CH3)), 21.8 
(C(O)CH3), 19.3 (C(CH3)(CH3), 18.5 (CH2); m/z (ES
+
) C18H25NNaO
+
 requires 
294.1828, found 294.1829 [M+Na]
+
. 
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N-Benzyl-N-(2-methyl-3,3-dibenzylindene-1-yl)-acetamide (198) 
 
The general procedure for enamide alkylation (6.2.4) was applied using N-(2-
methylindene-1-yl)-acetamide (1.00 g, 5.34 mmol), sodium hydride (1.07 g, 26.7 
mmol) and benzyl bromide (0.67 mL, 5.61 mmol) and anhydrous THF (100 mL). 
The crude product was purified by column chromatography (pet ether/EtOAc 4:1) to 
give N-Benzyl-N-(2-methyl-3,3-dibenzylindene-1-yl)-acetamide as an orange solid 
(376 mg, 44%). Rf  0.43 (pet ether/EtOAc, 4:1); m.p. 151-153 
o
C; υmax 2921 (CH), 
1645 (C=O); δH (400MHz, CDCl3) 7.50 (1H, d, J = 7.5, ArH), 7.25 (1H, t, J = 7.5, 
ArH), 7.01 – 7.16 (7H, m, ArH), 6.86 – 6.99 (3H, m, ArH), 6.76 (2H, d, J = 6.5, 
ArH), 6.66 (2H, d, J = 7.5, ArH), 6.60 (2Hm d, J = 7.0, ArH), 6.37 (1H, d, J = 7.5, 
ArH), 4.37 (1H, d, J = 13.5, ArCHHN), 4.16 (1H, d, J = 13.5, ArCHHN), 3.48 (1H, 
d, J = 13.5, ArCHHC), 3.41 (1H, d, J = 13.5, ArCHHC), 3.07 (1H, d, J = 13.5, 
ArCHHC), 2.99 (1H, d, J = 13.5, ArCHHC), 1.75 (3H, s, C(O)CH3), 0.87 (C=CCH3, 
s, 3H); δC (75MHz, CDCl3) 170.98 (C=O), 146.49, 144.18, 142.01, 140.32, 137.89, 
136.78, 136.60 (quarternary), 129.75, 129.59, 129.24, 127.92, 127.78, 127.75, 
127.14, 127.11, 126.64, 126.58, 124.75, 123.53, 118.17 (ArC), 58.40 (C(Bn)2), 50.87 
(ArCH2N), 43.54, 43.16 (ArCH2C), 20.26 (C=CCH3), 11.04 (C(O)CH3); m/z (ES
+
) 
C33H32NO
+
 requires 458.2478, found 458.2480 [M+H]
+
. 
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N-Benzyl-N-(2,6- dimethylcyclohexen-1-yl)-acetamide
157
 (199) 
 
The general procedure for enamide alkylation (6.2.4) was applied using N-(2,6- 
dimethylcyclohexen-1-yl)-acetamide (250 mg, 1.49 mmol), sodium hydride (299 
mg, 7.47 mmol) and benzyl bromide (0.19 mL, 1.57 mmol) and anhydrous THF (30 
mL). The crude product was purified by column chromatography (pet ether/EtOAc 
9:1) to give N-Benzyl-N-(2,6- dimethylcyclohexen-1-yl)-acetamide as a yellow oil 
(313 mg, 81%). 
Discernible data for the major diastereomer; Rf 0.25 (3:1 pet ether/EtOAc); υmax 2930 
(CH), 1641 (C=O); δH (300 MHz, CDCl3) 7.22 - 7.33 (5H, m Ar), 5.13 (1H, d, J = 
14.0 Hz, Ar-CHaHb), 4.05 (1H, d, J = 14.0 Hz, Ar-CHaHb), 2.43 (1H, m, CH(CH3)), 
1.41 - 2.02 (6H, m, 3 x CH2), 1.97 (3H, s, CO(CH3)), 1.08 (3H, br s, C=C(CH3)), 
0.95 (3H, d, J = 7.0 Hz, CH(CH3)); δC (75 MHz, CDCl3) 170.9 (C=O), 138.0 (N-C), 
135.1 (Ar, quaternary), 133.3 (C=CCH3), 128.9, 128.1, 127.3 (Ar), 48.1 (Ar-CH2), 
31.6, 31.4, 25.6 (CH2), 29.9 (CO(CH3)), 27.6 (CHCH3), 18.8 (C=CCH3), 18.4 
(CHCH3); m/z (ESI) 280.2 [M+Na]
+
. 
Discernible data for the minor diastereomer: Rf 0.25 (3:1 pet ether/EtOAc) 0.25; υmax 
2930 (CH), 1641 (C=O); δH (300 MHz, CDCl3) 7.22 - 7.33 (5H, m Ar), 5.40 (1H, d, 
J = 14.5 Hz, Ar-CHaHb), 3.96 (1H, d, J = 14.5 Hz, Ar-CHaHb), 2.41 (1H, m, 
CH(CH3)), 1.41 - 2.02 (6H, m, CH2), 2.04 (3H, s, CH3), 1.19 (3H, br s, C=C(CH3)), 
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1.03 (3H, br d, CH(CH3)); δC (75 MHz CDCl3) 171.6 (C=O), 137.9 (N-C), 135.0 
(Ar, quaternary), 133.3 (C=CCH3), 130.1, 128.9, 127.0 (Ar), 50.8 (Ar-CH2), 31.6, 
31.4, 25.6 (CH2), 29.9 (CO(CH3)), 27.6 (CHCH3), 18.8 (C=CCH3), 18.4 (CHCH3); 
m/z (ESI) 280.2 [M+Na]
+
. 
 
N-Benzyl-N-(2,4-dimethylpent-2-en-3-yl)-acetamide
157
 (200) 
 
The general procedure for enamide alkylation (6.2.4) was applied using N-(2,4-
dimethylpent-2-en-3-yl)-acetamide (2.73 g, 17.6 mmol), sodium hydride (3.52 mg, 
87.9 mmol) and benzyl bromide (2.19 mL, 18.5 mmol) and anhydrous THF (300 
mL). The crude product was purified by column chromatography (pet ether/EtOAc 
4:1) to give N-Benzyl-N-(2,6- dimethylcyclohexen-1-yl)-acetamide as a yellow oil 
(2.63 g mg, 61%). Rf 0.36 (pet ether/EtOAc, 3:1); υmax 2965 (CH), 1642 (C=O); δH 
(400MHz, CDCl3) 7.38 (2H, dd, J = 7.5, 2.0 Hz, 2 x ArH), 7.18 – 7.34 (3H, m, 3 x 
ArH), 5.27 (1H, d, J = 14.0 Hz, ArCHaHbN), 3.99 (1H, d, J = 14.0 Hz, ArCHaHbN), 
2.98 (1H, hept, J = 7.0 Hz, CH(CH3)2), 1.96 (3H, s, COCH3), 1.72 (3H, s, C=CCH3), 
1.27 (3H, d, J = 7.0 Hz, CH(CH3)(CH3)), 1.05 (3H, d, J = 7.0 Hz, CH(CH3)(CH3)), 
1.04 (3H, s, C=CCH3); δC (100MHz, CDCl3) 171.2 (C=O), 137.6 (Ar quarternary), 
137.6 (NC=C), 131.7 (NC=C), 130.0, 128.2, 127.4 (ArCH), 50.7 (ArCH2N), 30.2 
(CH(CH3)2), 23.9 (CH(CH3)(CH3)), 21.7 (COCH3), 20.5 (C=CCH3), 19.5 
(C=CCH3), 19.4 ((CH(CH3)(CH3)); m/z (ES
+
) 268.2 [M+Na]
+
. 
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N-Benzyl-N-(1-phenyl-2-methylprop-1-en-1-yl)-acetamide
154
 (201) 
 
The general procedure for enamide alkylation was applied using N-(1-phenyl-2-
methylprop-1-en-1-yl)-acetamide (3.50 g, 18.5 mmol), sodium hydride (3.70 mg, 
92.5 mmol) and benzyl bromide (2.30 mL, 19.4 mmol) and anhydrous THF (300 
mL). The crude product was purified by column chromatography (pet ether/EtOAc 
9:1) to give N-Benzyl-N-(1-phenyl-2-methylprop-1-en-1-yl)-acetamide as a yellow 
oil (3.67 g, 71%). Rf  0.18 (pet ether/EtOAc, 6:1); υmax 2991, 2929 (CH), 1642 
(C=O);  δH (400MHz, CDCl3)  7.28 – 7.42 (3H, m, 3 x ArH), 7.19 – 7.28 (7H, m, 7 x 
ArH), 5.27 (1H, d, J = 14.0 Hz, ArCHaHbN), 3.48 (1H, d, J = 14.0 Hz, ArCHaHbN), 
2.16 (3H, s, COCH3), 1.76 (3H, s, C=CCH3), 1.28 (3H, s, C=CCH3); δC (100MHz, 
CDCl3) 170.7 (C=O), 137.18, 136.51 (Ar quarternary), 133.70, 133.46 (C=C), 
129.82, 129.33, 128.36, 128.11, 127.87, 127.31 (ArC), 48.46 (ArCH2N), 21.38 
(COCH3), 21.30 (C=CCH3), 20.81 (C=CCH3); m/z (ES
+
) 280.2 [M+H]
+
. 
 
2-Methyl-1-tetralone oxime
170 
(209a) 
 
The genereal procedure for the synthesis of oximes was applied using 2-methyl-1-
tetralone (3.17 g, 19.7 mmol, 1 eq.), hydroxylamine hydrochloride (1.65 g, 23.7 
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mmol, 1.2 eq.), sodium acetate (1.95 g, 23.7 mmol, 1.2 eq.) and methanol (32 mL). 
The product was isolated as a pale brown crystalline solid (3.38 g, 97%) which was 
taken on without further purification. Rf  0.30 (pet/EtOAc, 9:1 ); m.p. 97-99
 o
C, lit
245
 
95-96 
o
C; υmax 3187 (O-H), 2933 (C-H); δH (300MHz, CDCl3) 8.89 (1H, br s, OH), 
7.88 (1H, d, J = 9.0, ArH), 7.11 - 7.31 (3H, m, ArH), 3.61 - 3.73 (1H, m, C(O)CH), 
2.97 (1H, ddd, J = 16.5, 12.5, 4.5, ArCHH), 2.67 (1H, ddd, J = 16.5, 4.5, 4.0, 
ArCHH), 1.92 - 2.05 (1H, m, C(O)CHCHH), 1.75 (1H, ddd, J = 12.5, 4.5, 4.0, 
C(O)CHCHH), 1.23 (3H, d, J = 7.0, CH3); δC (75MHz, CDCl3) 159.0 (C=N), 138.9 
(quarternary), 129.8 (quarternary), 129.2 (ArC), 128.8 (ArC), 126.4 (ArC), 124.5 
(ArC), 28.4 (C(O)CHCH2), 26.8 (C(O)CH), 25.2 (ArCH2), 15.3 (CH3); m/z (ES
+
)  
C11H14NO
+
 requires 176.1070, found: [M+H]
+ 
176.1065. 
 
N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-chloroacetamide
157 
(209b) 
 
2-Methyl-1-tetralone oxime (2.94 g, 16.8 mmol, 1 eq.) as a mixture with 2,2-
dimethy-1-tetralone oxime (74% 2-methyl-1-tetralone) was dissolved in toluene (100 
mL). 2-Chloroacetic acid (4.76 g, 50.4 mmol, 3 eq.), 2-chloroacetic anhydride (8.61 
g, 50.4 mmol, 3 eq.) and iron powder (1.88 g, 33.6 mmol, 2 eq.) were then added and 
the reaction mixture heated to 70 
o
C for 36 h. The reaction mixture was then cooled 
and filtered through celite and washed with 2M NaOH (2 × 80 mL) and NaCl(aq) (80 
mL). The organic layer was then dried over MgSO4, filtered and concentrated in 
vacuo to give the crude product as a pale yellow solid (5.05 g). The crude product 
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was then purified by recrystallisation from hexane/EtOAc 10:1 to give the product as 
pale brown needles (2.09 g, 53%). Rf  0.23 (pet ether/EtOAc, 3:1); m.p. 139-141 
o
C; 
υmax 3229 (NH), 2933(CH), 1650 (C=O); δH (400MHz, CDCl3) 7.59 (1H, s, NH), 
7.22 – 7.09 (3H, m, 3 × ArH), 7.06 (1H, d, J = 7.5, ArH), 4.25 (2H, s, C(O)CH2), 
2.84 (2H, t, J = 8.0, ArCH2), 2.42 (2H, t, J = 8.0, NC=CCH2), 1.88 (3H, s, CH3); δC 
(100MHz, CDCl3) 164.6 (C=O), 135.2, 134.9, 132.4 (quarternary), 127.5, 126.9, 
126.5 (ArC), 125.1 (quarternary), 121.2 (ArC), 42.8 (C(O)CH2), 29.7 (NC=CCH2), 
27.4 (ArCH2), 19.5 (CH3); m/z (ES
+
) C13H14ClNNaO
+
 requires 258.0656, found: 
258.0656 [M+Na]
+
. 
 
N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-chloroacetamide
157 
(209) 
 
The general procedure for enamide alkylation (6.2.4) was applied using N-(2-methyl-
3,4-dihydronaphthalen-1-yl)-2-chloroacetamide (1.9 g, 8.06 mmol, 1 eq.), sodium 
hydride (520 mg, 13.1 mmol) sodium hydride (1.61 g, 40.3 mmol, 5 eq.) and benzyl 
bromide (1.01 mL, 8.46 mmol, 1.05 eq.)  and anhydrous THF (150 mL). The crude 
product was purified by column chromatography (petroleum ether/ethyl acetate, 9:1) 
yielded the product as a white solid (960 mg, 37%). Rf 0.18 (pet ether/EtOAc, 9:1); 
m.p. 99-101 
o
C; υmax 2925 (CH), 1666(C=O); δH (400MHz, CDCl3) 7.09 – 7.42 (8H, 
m, 8 × ArH), 6.95 (1H, d, J = 4.0, ArH), 5.45 (1H, d, J = 13.5, ArCHHN), 3.94 (2H, 
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s, C(O)CH2), 3.90 (1H, d, J = 13.5, ArCHHN), 2.70 – 2.89 (2H, m, ArCH2C), 2.32 – 
2.47 (1H, m, C=CCHH), 2.24 – 2.14 (1H, m, C=CCHH), 1.28 (3H, s, CH3); δC 
(75MHz, CDCl3) 166.2 (C=O), 137.6, 137.5, 135.7, 135.5, 130.6 (quarternary), 
129.7, 127.7, 127.3, 127.2, 127.1, 126.5, 121.1 (ArC), 50.1 (ArCH2N), 41.6 
(C(O)CH2), 28.9 (C=CCH2), 26.7 (ArCH2CH2), 18.6 (CH3); m/z (ES
+
) 326.2 
[M+H]
+
, 348.1 [M+Na]
+
. 
 
2-Chloro-N-(cyclohexylidene(phenyl)methyl)acetamide (210a) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using cyclohexyl(phenyl)methanone oxime (4 g, 19.7 mmol), chloroacetic 
acid (5.58 g, 59.1 mmol), chloroacetic anhydride (10.1 g, 59.1 mmol), iron powder 
(2.20 g, 39.4 mmol) and anhydrous toluene (80 mL). The crude product was purified 
by column chromatography (pet ether/EtOAc, 4:1) to give the product as a yellow 
crystalline solid (2.26 g, 48%). Rf 0.64 (pet ether/EtOAc, 1:1); m.p. 128-130 
o
C; υmax 
3232 (NH), 2917 (CH), 1654 (C=O); δH (400MHz, CDCl3) δ 7.56 (1H, s, NH), 7.12 
– 7.39 (5H, m, 5 x ArH), 4.09 (2H, s, C=OCH3), 2.17 – 2.26 (4H, m, C=C(CH2)2), 
1.51 – 1.69 (6H, m, 3 x  CH2CH2CH2); δC (100MHz, CDCl3) δ 164.2 (C=O), 138.4 
(C=C(N)Ar), 137.8 (ArC), 129.1 (ArCH), 128.2 (ArCH), 127.5 (ArCH), 124.0 
(ArC=C(CH2)2), 42.8 (C=OCH2), 31.0 (C=C(CH2)(CH2)), 30.7 (C=C(CH2)(CH2)), 
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28.0 (CH2CH2CH2), 27.4 (CH2CH2CH2), 26.4 (CH2CH2CH2); m/z (ES
+
) 
C15H18ClNNaO requires 286.0969, found: 286.0977 [M+Na]
+
. 
 
N-Benzyl-2-chloro-N-(cyclohexylidene(phenyl)methyl)acetamide (210) and N-
Benzyl-2-chloro-N-(cyclohexylidene(phenyl)methyl)-3-phenylpropanamide 
(213a)  
 
The general procedure for the alkylation of enamides (6.2.4) was applied using N-(2-
methyl-3,4-dihydronaphthalen-1-yl)-2-chloroacetamide (1.9 g, 8.06 mmol), sodium 
hydride (1.61 g, 40.3 mmol) and benzyl bromide (1.01 mL, 8.46 mmol) and 
anhydrous THF (150 mL). The crude product was purified by column 
chromatography (pet ether/EtOAc, 9:1) to give the product as an off white solid (1.1 
g, 46%), and the side product N-benzyl-2-chloro-N-
(cyclohexylidene(phenyl)methyl)-3-phenylpropanamide as a yellow oil (370 mg, 
12%) as a 1:0.85 mixture of diastereomers. 
N-Benzyl-2-chloro-N-(cyclohexylidene(phenyl)methyl)acetamide (210) 
Rf  0.4 (pet ether/EtOAc, 9:1); m.p. 111-113 
oC; υmax 2928 (CH), 1663 (C=O); δH 
(400MHz, CDCl3) δ 7.28 (4H, m, 4 x ArH), 5.25 (1H, d, J = 14.0 Hz, ArCHaHbN), 
4.28 (1H, d, J = 13.5 Hz, C=OCHaHbCl), 4.03 (1H, d, J = 13.5 Hz, C=OCHaHbCl), 
3.38 (1H, d, J = 14.0 Hz, ArCHaHbN), 2.39 (1H, d, J = 13.4 Hz, cyH), 1.75 – 1.87 
(1H, m, cyH), 1.64 – 1.74 (1H, m, cyH), 1.49 – 1.62 (2H, m, cyH), 1.35 – 1.44 (1H, 
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m, cyH), 1.09 – 1.36 (3H, m, cyH), 0.28 – 0.48 (1H, m, cyH); δC (100MHz, CDCl3) 
δ 166.5 (C=O), 142.0 (NC=C(CH2)2), 136.4 (ArCC=C), 135.5 (ArCCH2N), 130.1 
(ArCH), 129.8 (NC=C(CH2)2), 129.5 (ArCH), 129.3 (ArCH), 128.6 (ArCH), 128.3 
(ArCH), 127.7 (ArCH), 49.0 (ArCH2N), 41.8 (C=OCH2Cl), 31.4 (C=CCH2), 31.3 
(C=CCH2), 27.9 (CH2CH2CH2), 26.7 (CH2CH2CH2), 26.2 (CH2CH2CH2); m/z (ES
+
) 
C22H24ClNaO requires 376.1439, found: 376.1435 [M+Na]
+
. 
N-Benzyl-2-chloro-N-(cyclohexylidene(phenyl)methyl)-3-phenylpropanamide 
(213) 
 Rf 0.6 (pet ether/EtOAc, 9:1); υmax 2927 (CH), 1660 (C=O); δH (400MHz, CDCl3) δ 
7.18 – 7.46 (14H maj and 14 min, m, ArH maj and min), 6.72 (1H maj and 1H min, 
d, J = 7.5 Hz, ArH), 5.42 (1H maj, d, J = 14.0 Hz, ArCHaHbN maj), 5.12 (1H min, d, 
J = 14.0 Hz, ArCHaHbN min), 4.94 (1H maj, dd, J = 8.5, 5.5 Hz, C=OCHCl maj), 
4.83 (1H min, t, J = 7.0 Hz, C=OCHCl min), 3.82 (1H min, d, J = 14.0 Hz, 
ArCHaHbN min), 3.52 – 3.61 (1H maj and 1H min, m, ArCHaHbN maj and 
ClCHCHaHbPh min), 3.33 – 3.47 (2H maj, m, ClCHCH2Ph maj), 3.25 (1H min, dd, J 
= 13.5, 7.0 Hz, ClCHCHaHbPh min), 2.61 (1H maj, d, J = 14.0 Hz, C=CCHaHb maj), 
2.50 (1H min, d, J = 13.5 Hz, C=CCHaHb min), 1.18 – 2.18 (8H maj and 8H min, m, 
cyH maj and min), 0.48 – 0.64 (1H min, m, C=CCH2CHaHb min), 0.27 (q, J = 12.0 
Hz, C=CCH2CHaHb maj); δC (100MHz, CDCl3) δ (ppm) 169.4, 169.3 (2 x C=O maj 
and min), 143.1, 141.2, 136.9, 136.7, 136.1, 135.8, 130.6 (7 x quaternary C), 130.1, 
130.0, 130.0, 129.7 (4 x ArCH), 129.6 (quaternary C), 129.2, 128.7, 128.5, 128.5, 
128.3, 128.3, 127.9, 127.7, 127.6, 127.3, 127.1 (11 x ArCH), 55.6 (C=OCHCl min) , 
55.0 (C=OCHCl maj), 50.3 (ArCH2N min), 49.1 (ArCH2N maj), 42.6 (ArCH2CHCl 
min), 40.9 (ArCH2CHCl maj), 32.8, 31.9, 31.8, 31.7, 28.3, 28.1, 27.3, 27.1, 26.2, 
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26.2 (10 x cyC) (2 quaternary carbons missing); m/z (ES
+
) C29H30ClNNaO requires 
466.1908, found: 466.1915 [M+Na]
+
. 
 
2-Chloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide
246
 (211a) 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using 2-methyl-1-phenylpropan-1-one oxime (2 g, 12.2 mmol), chloroacetic 
acid (3.47 g, 36.8 mmol), chloroacetic anhydride (6.28 g, 36.8 mmol), iron powder 
(1.37 g, 24.5 mmol) and anhydrous toluene (20 mL). The crude product (1.58 g) was 
purified by recrystallisation (pet ether/EtOAc, 6:1) to give the product as an off 
white solid (676 mg, 25%). Rf 0.48 (pet ether/EtOAc, 4:1); m.p. 104-107 
o
C; υmax 
3138 (NH), 2988 (CH), 1648 (C=O); δH (400MHz, CDCl3) δ 7.63 (1H, s, NH), 7.24 
– 7.36 (5H, m, 5 x ArH), 4.10 (2H, s, C=OCH2Cl), 1.82 (6H, s, 2 x CH3); δC 
(100MHz, CDCl3) δ 163.9 (C=O), 137.8 (ArC), 131.0 (NC=C(CH3)2), 129.1 
(ArCH), 128.1 (ArCH), 127.5 (ArCH), 126.8 (NC=C(CH3)2), 42.7 (C=OCH2Cl), 
21.2 (CH3), 20.6 (CH3); m/z (ES
+
) 246.1 [M+Na]
+
. 
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N-Benzyl-2-chloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide (211) 
 
The general procedure for the alkylation of enamides (6.2.4) was applied using 2-
chloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide (500 mg, 2.24 mmol), sodium 
hydride (447 mg, 11.2 mmol) and benzyl bromide (278 μL, 2.35 mmol) and 
anhydrous THF (40 mL). The crude product was purified by column 
chromatography (pet ether/EtOAc, 9:1) to give the product as a yellow oil (x g, 
42%). Rf 0.28 (pet ether/EtOAc, 6:1); υmax 3028, 2933 (CH), 1659 (C=O) ; δH (400 
MHz, CDCl3) 7.30 – 7.43 (3H, m, ArH), 7.22 – 7.30 (7H, m, ArH), 5.24 (1H, d, J = 
14.0 Hz, ArCHaHb), 4.34 (1H, d, J = 13.5 Hz, COCHaHbCl), 4.10 (1H, d, J = 13.5 
Hz, COCHaHbCl), 3.60 (1H, d, J = 14.0 Hz, ArCHaHb), 1.80 (3H, s, CH3), 1.29 (3H, 
s, CH3); δC (100 MHz, CDCl3) 166.5 (C=O), 136.3 (Ar-CH2 quarternary), 135.6 
(Ar-C=C quarternary), 135.1 (NC=C), 132.5 (NC=C), 129.9, 129.5, 128.6, 128.3, 
127.7 (Ar), 49.6 (NCH2), 41.8 (COCH2Cl), 21.5 (CH3), 20.9 (CH3); m/z (ES
+
)  
C19H20ClNNaO requires 336.1131, found: 336.1126 [M+Na]
+
. 
 
 
 
 
 
Chapter 6: Experimental 
 
212 
 
N-Benzyl-2-chloro-N-(2,2,6- trimethylcyclohexen-1-yl)-acetamide (212) 
 
2,2,6-Trimethylcyclohexanone oxime (750 mg, 4.83 mmol), chloroacetic acid (1.37 
g, 14.5 mmol), chloroacetic anhydride (2.48 g, 14.5 mmol) and iron powder (0.54 g, 
9.65 mmol) in anhydrous toluene (25 mL) were heated to reflux under an inert 
atmosphere for 14 hours. The mixture was then filtered through celite, diluted with 
DCM (25 mL) and washed with 2M NaOH (2 x 50 mL) and brine (50 mL). The 
organic phase was then dried over MgSO4, filtered and then concentrated in vacuo to 
give a brown solid (390 mg). This solid was then added to sodium hydride (145 mg, 
1.81 mmol) in anhydrous THF (18 mL) and cooled to 0 
o
C. Benzyl bromide (0.226 
mL, 1.90 mmol) was then added and the reaction heated to reflux under an inert 
atmosphere for 16 hours. The reaction mixture was then added to water (50 mL) and 
extracted with ethyl acetate (3 x 60 mL). The combined organic layers were then 
dried over MgSO4, filtered and then concentrated in vacuo to give the crude product 
as a brown oil (515 mg). The crude product was purified by column chromatography 
(pet ether/EtOAc, 9:1) to give the product as a yellow oil (250 mg, 17%). Rf 0.26 
(pet ether/EtOAc, 6:1); υmax 2932 (CH), 1658 (C=O); δH (300 MHz, CDCl3) 7.30 – 
7.39 (2H, m, ArH), 7.18 – 7.30 (3H, m, ArH), 5.09 (1H, d, J = 14.0 Hz, ArCHaHb), 
4.31 (1H, d, J = 14.0 Hz, ArCHaHb), 4.10 (1H, d, J = 13.5 Hz, COHaHbCl), 3.92 (1H, 
d, J = 13.5 Hz, COHaHbCl), 2.02 (2H, t, J = 6.0 Hz, C=CCH2), 1.47 – 1.82 (4H, m, 2 
x CH2), 1.20 (3H, s, C=CCH3), 1.04 (3H, s, C(CH3)(CH3)), 1.02 (3H, s, 
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C(CH3)(CH3)); δC (75 MHz, CDCl3) 167.0 (C=O), 137.3 (NC=C), 136.2 (Ar 
quarternary), 135.1 (NC=C), 129.0, 127.7, 126.9 (Ar), 51.7 (NCH2), 41.3 
(COCH2Cl), 40.3 (CH2), 35.2 (C(CH3)2), 31.1 (C=CCH2), 29.8 (C=CCH3), 27.1 
(CH3), 18.8 (CH3), 17.7 (CH2); m/z (ES
+
)  [M+Na]
+
 C18H25ClNO requires 306.1625, 
found: 306.1622 [M+H]
+
. 
 
N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-bromoacetamide (214) 
 
N-benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-chloroacetamide (540 mg, 
1.66 mmol, 1 eq.) in acetone (35 mL) was cooled to 0 
o
C and lithium bromide (1.43 
g, 16.6 mmol, 10 eq.). The resulting mixture was then stirred at room temperature for 
60 h. The raction mixture was then concentrated in vacuo to give a white solid which 
was taken up in water (30ml) and extracted with DCM (3 × 20 mL). The combined 
organic extracts were then washed with cold water (30 mL), dried over MgSO4, 
filtered and concentrated in vacuo to give a white solid. The crude product was then 
purified by recyrstallisation from hexane to give N-benzyl-N-(2-methyl-3,4-
dihydronaphthalen-1-yl)-2-bromoacetamide as a orange crystalline solid (519 mg, 
84%).  Rf 0.19 (pet ether/EtOAc, 9:1); m.p. 94-96 
o
C; υmax 2926 (CH), 1660 (C=O); 
δH (300MHz, CDCl3) 7.09 – 7.85 (8H, m, ArH), 6.94 (1H, dt, J = 7.5, 2.0, ArH), 
5.40 (1H, d, J = 13.5, ArCHHN), 3.92 (1H, d, J = 13.5, ArCHHN), 3.77 (2H, s, 
C(O)CH2), 2.72 – 2.84 (2H, m, ArCH2CH2), 2.47 – 2.28 (1H, m, ArCH2CHH), 2.26 
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– 2.11 (1H, m, ArCH2CHH), 1.28 (3H, s, CH3); δC (75MHz, CDCl3) 166.3 (C=O), 
137.4, 135.7, 135.5, 130.7, 130.3 (quarternary), 129.7, 127.6, 127.2, 127.0, 126.4, 
121.3 (ArC), 50.2 (ArCH2N), 29.0 (CH2), 27.4 (C(O)CH2), 26.7 (CH2), 18.8 (CH3); 
m/z (ES
+
) C20H20BrNNaO
+
 requires 392.0620, found 392.0626 [M+Na]
+
. 
 
N-(cyclohexene-1-yl)isobutryamide (217)
 
 
The general procedure for the iron mediated synthesis of enamides (6.2.3) was 
applied using cyclohexanone oxime (5 g, 44 mmol, 1 eq.), isobutyric acid (12.3 mL, 
133 mmol, 3 eq.), isobutyric anhydride (22.0 mL, 133 mmol, 3 eq.), iron powder 
(4.94 g, 88 mmol, 2 eq.) and anhydrous toluene (200 mL). The crude product was 
purified by column chromatography (pet ether/EtOAc 9:1 to 3:1) to give the product 
as an orange solid (2.13 g, 29%). Rf 0.23 (pet ether/EtOAc, 9:1); m.p. 59-61 
o
C; υmax 
3291 (N-H), 2928 (C-H), 1658 (C=O); δH (300MHz, CDCl3) 6.28 (1H, br s, NH), 
6.05 - 6.11 (1H, m, C=CH), 2.22 - 2.37 (1H, m, C(O)CH), 2.02 - 2.14 (4H, m, 
C=CCH2), 1.61 - 1.71 (2H, m, NCCH2CH2), 1.49 - 1.59 (2H, m, NCCH2CH2CH2), 
1.14 (6H, d, J = 7.0, 2 × CH3); δC (75MHz, CDCl3) 175.3 (C=O), 132.5 (NC=C), 
112.8 (NC=CH), 36.6 (C(O)CH), 28.2 (NCCH2), 24.0 (NC=CCH2), 22.6 
(NCCH2CH2), 22.0 (NCCH2CH2CH2), 19.7 (CH3); m/z (ES
+
)  C10H17NNaO
+ 
 
requires 190.1202, found: 190.1210 [M+Na]
+
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N-benzyl-N-(cyclohexene-1-yl)isobutryamide (215) 
 
The general procedure for enamide alkylation (6.2.4) was applied using 1-
isobutyramido-1-cyclohexene (1.6 g, 9.6 mmol, 1 eq.), sodium hydride (1.91 g, 47.9 
mmol, 5 eq.)  benzyl bromide (1.19 mL, 10.0 mmol, 1.05 eq.) and anhydrous THF 
(200 mL). The crude product was purified by column chromatography (pet 
ether/EtOAc, 6:1) to give the product as a yellow crystalline solid (2.21 g, 89%). Rf 
0.6 (pet ether/EtOAc, 6:1 ); υmax 2926 (C-H), 1636 (C=O); δH (400MHz, CDCl3) 
7.23 - 7.34 (5H, m, 5 × ArH), 5.42 (1H, m, NC=CH), 4.63 (2H, br s, ArCH2), 2.84 
(1H, hept, J = 6.5, C(O)CH), 2.02 - 2.07 (2H, m, NC=CHCH2), 1.94 - 2.02 (2H, m, 
NCCH2), 1.65 - 1.73 (2H, m, NCCH2CH2), 1.52 - 1.60 (2H, m, NCCH2CH2CH2), 
1.16 (6H, d, J = 6.5, 2 × C(O)CHCH3); δC (100MHz, CDCl3) 177.0 (C=O), 138.6 
(ArC), 128.7, 128.2, (ArCH), 127.5 (NC=CH), 127.0 (ArCH), 60.4 (NC=C), 49.7 
(ArCH2), 31.4 (C(O)CH), 28.8 (NC=CCH2), 24.8 (NCCH2), 22.87 (NCCH2CH2), 
21.51 (NCCH2CH2CH2), 20.27 (C(O)CHCH3); m/z (ES
+
) C17H24NO
+
 requires 
258.1852, found: 258.1846 [M+H]
+
. 
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Cyclohexanone oxime acetate
247
 (221) 
 
Cyclohexanone oxime (300 mg, 2.65 mmol, 1 eq.), acetic anhydride (0.75 ml, 7.95 
mmol, 3 eq.), acetic acid (0.46 ml, 7.95 mmol, 3 eq.) and iron acetate (922 mg, 5.30 
mmol, 2 eq.) in toluene (4 mL) were heated to reflux under and inert atmosphere for 
3 h. The reaction mixture was then cooled, filtered through celite, diluted with DCM 
(10 mL) and washed with 2M NaOH (3 × 15 mL). The organic phase was then dried 
over MgSO4, filtered and then concentrated in vacuo to give the product as a brown 
oil (307 mg, 70%). Rf  0.39 (pet ether/EtOAc, 1:1); υmax 2927 (C-H), 1763 (C=N), 
1623 (C=O) 1560 (N-O); δH (300MHz, CDCl3) 2.46 – 2.53 (2H, m, C=NCH2), 2.27 
– 2.36 (2H, m, C=NCH2), 2.11 (3H, s, CH3), 1.53 – 1.76 (6H, m, CH2CH2CH2); δC 
(75MHz, CDCl3) 175.1 (C=O), 168.0 (C=N), 31.5, 26.2, 26.2, 25.2, 24.8 (CH2), 19.0 
(CH3); m/z (ES
+
) 178.1 [M+H]
+
. 
 
2-Bromo-N-cyclohexenyl-2-methylpropanamide (223) 
 
Cyclohexanone oxime (5 g, 44.2 mmol), copper iodide (842 mg, 4.42 mmol), 
sodium bisulphite (13.9 g, 133 mmol) and 2-bromoisobutyric anhydride (27.9 g, 88.4 
mmol) in DCE (200 mL) were heated to reflux for 4 hours. The reaction mixture was 
Chapter 6: Experimental 
 
217 
 
then cooled, diluted with EtOAc (100 mL) and washed with 2M NaOH (2 x 100 mL) 
and brine (100 mL). The organice layer was then dried over anhydrous MgSO4, 
filtered and concentrated in vacuo to give the crude product as a dark brown solid. 
This was then purified by column chromatography (pet ether/EtOAc 14:1) to give 
the desired product as a light brown solid (970 mg, 9%). Rf 0.37 (pet ether/EtOAc, 
14:1); m.p. 84-86 
o
C; υmax 3384, 3187 (NH), 2925 (CH), 1654 (C=O); δH (400MHz, 
CDCl3) 7.59 (1H, br s, NH), 6.15 (1H, t, J = 4.0 Hz, C=CH), 2.17 – 2.25 (2H, m, 
CH2C(N)=C), 2.12 – 2.17 (2H, m, NC=CCH2), 2.00 (6H, s, 2 x CH3), 1.69 – 1.79 
(2H, m, NC=CCH2CH2), 1.57 – 1.67 (2H, m, CH2CH2C(N)=C); δC (100MHz, 
CDCl3) 169.9 (C=O), 132.3 (NC=C), 114.1 (NC=C), 63.5 (C=OC(CH3)2Br, 32.6 
(CH3), 27.8 (CH2C(N)=C), 24.0 (NC=CCH2), 22.5 (CH2CH2C(N)=C),  21.9 
(NC=CCH2CH2); m/z (ES
+
) C10H16BrNNaO requires 268.0307, found: 268.0305 
[M+Na]
+
. 
 
N-Benzyl-2,2,2-trichloro-N-(2-phenylcyclohex-1-enyl)acetamide
248
 (229)  
 
The general procedure for the formation of enamides via imines (6.2.1) was applied 
using 2-phenylcyclohexanone (2.43 g, 13.9 mmol), benzylamine (1.52 mL, 13.9 
mmol), toluene (15 mL, 25 mL), triethylamine (2.32 mL, 16.7 mmol) and 
trichloroacetyl chloride (1.71 mL, 15.3 mmol). The crude product was purified by 
column chromatography (pet ether/EtOAc, 14:1) to yield N-benzyl-2,2,2-trichloro-
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N-(2-phenylcyclohex-1-enyl)acetamide as a colourless crystalline solid (1.18 g, 
21%). Rf 0.52 (pet ether/EtOAc, 14:1); m.p. 116-118 
o
C; υmax 2924 (CH), 1671 
(C=O); δH (700MHz, CDCl3) 7.37 (2H, t, J = 7.5 Hz, ArH), 7.34 – 7.33 (6H, m, 
ArH), 7.22 (2H, d, J = 7.5 Hz, ArH), 5.17 (1H, d, J = 14.0 Hz, ArCHaHbN), 3.55 
(1H, d, J = 14.0 Hz, ArCHaHbN), 2.44 (1H, apparent d, J = 18.0 Hz, 
NC=C(Ph)CHaHb), 2.34 (1H, apparent d, J = 17.0 Hz, PhC=C(N)CHaHb), 2.17 – 
2.26 (1H, m, NC=C(Ph)CHaHb), 1.64 – 1.73 (1H, m, NC=C(Ph)CH2CHaHb), 1.49 – 
1.59 (m, PhC=C(N)CH2CHaHb), 1.31 – 1.41 (1H, m, PhC=C(N)CH2CHaHb), 1.20 – 
1.30 (1H, m, NC=C(Ph)CH2CHaHb), 1.06 – 1.16 (1H, m, PhC=C(N)CHaHb); δC 
(176MHz, CDCl3) 159.3 (C=O), 140.2 (ArCC=C), 135.2 (C=C), 135.1 (C=C), 134.7 
(ArCCH2N), 129.4 (ArCH), 128.6 (ArCH), 128.2 (ArCH), 128.2 (ArCH), 127.5 
(ArCH), 127.3 (ArCH), 93.5 (C=OCCl3), 53.3 (ArCH2N), 31.2 (NC=C(Ph)CH2), 
28.9 (PhC=C(N)CH2), 22.5 (CH2CH2CH2), 22.4 (CH2CH2CH2); m/z (ES
+
) 408.0 
[M+H]
+
, 430.0 [M+Na]
+
. 
 
N-benzyl-2-bromo-2-methyl-N-(2-phenylcyclohex-1-enyl)propanamide (231) 
 
The general procedure for the formation of enamides via imines (6.2.1) was applied 
using 2-phenylcyclohexanone (2.43 g, 13.9 mmol), benzylamine (1.52 mL, 13.9 
mmol), toluene (15 mL, 25 mL), triethylamine (2.32 mL, 16.7 mmol) and 2-
bromoisobutyryl bromide (1.89 mL, 15.3 mmol). The crude product was purified by 
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column chromatography (pet ether/EtOAc, 14:1) to yield the product as a colourless 
solid (716 mg, 13%). Rf 0.33 (pet ether/EtOAc, 14:1); m.p. 83-86 
o
C; υmax 2940 
(CH), 1626 (C=O); δH (700MHz, CDCl3) 7.10 – 7.51 (10H, m, ArH), 5.33 (1H, d, J 
= 14.0 Hz, ArCHaHbN), 3.47 (1H, d, J = 14.0 Hz, ArCHaHbN), 2.39 (1H, apparent d, 
J = 17.5 Hz, NC=C(Ph)CHaHb), 2.32 (1H, apparent d, J = 17.0 Hz, 
PhC=C(N)CHaHb), 2.12 – 2.23 (1H, m, NC=C(Ph)CHaHb), 2.07 (3H, s, 
C=OC(CH3)(CH3)Br), 1.82 (3H, s, C=OC(CH3)(CH3)Br), 1.62 – 1.71 (1H, m, 
PhC=C(N)CH2CHaHb), 1.48 – 1.60 (1H, m, NC=C(Ph)CH2CHaHb), 1.28 – 1.39 (1H, 
m, NC=C(Ph)CH2CHaHb), 1.17 – 1.27 (m, PhC=C(N)CH2CHaHb), 1.05 – 1.16 (1H, 
m, PhC=C(N)CHaHb); δC (100MHz, CDCl3) 169.6 (C=O), 141.1, 136.2, 135.9, 
133.9, 129.4 (ArCH), 129.1 (ArCH), 128.5 (ArCH), 128.1 (ArCH), 127.5 (ArCH), 
127.3 (ArCH), 52.7 (ArCH2N), 33.8 (CH3), 31.5 (CH3), 31.2 (NC=C(Ph)CH2), 29.5 
(PhC=C(N)CH2), 22.7 (PhC=C(N)CH2CH2), 22.5 (NC=C(Ph)CH2CH2); m/z (ES
+
) 
C23H26BrNNaO requires 434.1090, found: 434.1087 [M+Na]
+
. 
 
6.2.5 General Procedure for the Synthesis of Enamides 232-236. 
Ketone (1 eq.), benzylamine (1.0 eq.) and TsOH, were dissolved in dry toluene and 
heated to reflux under Dean-Stark conditions for 4-16 hours. The reaction mixture 
was then cooled and concentrated in vacuo and a crude NMR of the imine 
intermediate taken, before redisolving in toluene and cooling to 0 
o
C. Triethylamine 
(1.2 eq.) was then added slowly followed by the dropwise addition of the appropriate 
acid halide (1.1 eq.). The reaction mixture was then allowed to warm to room 
temperature and stirred for 12 hours. NaHCO3 (~50 mL) was then added and the 
layers separated. The aqueous phase was extracted with Et2O (3 x 50 mL) and the 
organic layers combined, dried over MgSO4, filtered and concentrated in vacuo to 
Chapter 6: Experimental 
 
220 
 
give the crude product. Products were purified by column chromatography or 
recrystallisation. 
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N-Benzyl-2,2,2-trichloro-N-(cyclohexylidene(phenyl)methyl)acetamide (232) 
 
The general procedure for the formation of enamides (6.2.5) was applied using 
cyclohexylphenylketone (1.5 g, 7.97 mmol), benzylamine (0.87 mL, 7.97 mmol), 
TsOH (3.03 g, 1.60 mmol), toluene (9 mL, 15 mL), triethylamine (1.33 mL, 9.56 
mmol) and trichloroacetyl chloride (0.978 mL, 8.76 mmol). The crude product was 
recrystallised from 14:1 pet ether/EtOAc to yield the product as a cream solid in a 
4:1 ratio of amide rotamers (1.46 g, 43%). Rf 0.54 (pet ether/EtOAc, 6:1); m.p. 128-
129 
o
C; υmax 2972, 2932 (CH), 1671 (C=O); δH (400 MHz, CDCl3) 7.24 – 7.46 (2H, 
m, ArH), 7.20 (2H, d, J = 4.0 Hz, ArH), 7.06 (2H, d, J = 7.0 Hz, ArH), 5.45 (1H maj, 
d, J = 14.5 Hz, ArCHaHb maj), 5.14 (1H min, d, J = 14.5 Hz, ArCHaHb min), 4.06 
(1H maj, d, J = 14.5 Hz, ArCHaHb maj), 3.77 (1H, d, J = 13.5 Hz, ArCHaHb min), 
2.52 – 2.65 (1H min, m, cy CHaHb min), 2.12 – 2.24 (1H, m, cy CHaHb maj), 1.11 – 
2.07 (7H maj + 8H min, m, cy), 0.81 – 0.98 (2H maj, m, cy CH2 maj), 0.37 – 0.52 
(1H min, m, cy CHaHb min); δC (100 MHz, CDCl3) 167.6 (C=O min), 159.6 (C=O 
maj), 152.3, 141.0, 136.2, 135.5, 135.4, 134.9, 130.5, 130.3 (quarternary), 129.7, 
129.3, 128.4, 128.2, 128.2, 128.1, 127.6, 127.0 (ArCH), 94.4, 94.1 (CCl3), 54.1, 53.2 
(NCH2), 32.2, 31.8, 30.9, 27.6, 27.3, 26.5, 26.3, 26.2 (cy); m/z (ES
+
)
 
C22H22Cl3NNaO 
requires 444.0665, found: 444.0659 [M+Na]
+
. 
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N-Benzyl-2-bromo-N-(cyclohexylidene(phenyl)methyl)-2-methylpropanamide 
(233) 
 
The general procedure for the formation of enamides (6.2.5) was applied using 
cyclohexylphenylketone (1.5 g, 7.97 mmol), benzylamine (0.87 mL, 7.97 mmol), 
TsOH (3.03 g, 1.60 mmol), toluene (9 mL, 15 mL), triethylamine (1.33 mL, 9.56 
mmol) and 2-bromoisobutyryl bromide (1.08 mL, 8.76 mmol). The crude product 
was recrystallised from 14:1 pet ether/EtOAc to yield the product as a brown solid in 
a 1:0.62 ratio of amide rotamers (2.02 g, 59%). Rf 0.43 (pet ether/EtOAc, 6:1); m.p. 
102-104 
o
C; υmax 2973, 2929, 2852 (CH), 1656 (C=O); δH (400 MHz, CDCl3) 7.14 – 
7.58 (8H maj + 10H min, m, ArH), 7.01 (2H maj, d, J = 7.0 Hz, ArH), 5.52 (1H maj, 
d, J = 14.5 Hz, NCHaHb), 5.16 (1H min, d, J = 13.5 Hz, NCHaHb), 4.02 (1H maj, d, J 
= 14.5 Hz, NCHaHb), 3.63 (1H min, d, J = 13.5 Hz, NCHaHb), 2.69 (1H min, d, J = 
12.5 Hz, cy), 2.19 (3H maj, s, CH3), 2.10 (3H maj, s, CH3), 2.06 (6H min, s, CH3), 
1.08 – 2.12 (9H maj + 8H min, m, cy), 0.80 – 1.03 (1H maj, m, cy), 0.30 (1H min, d, 
J = 12.5 Hz, cy); δC (75 MHz, CDCl3) 172.2, 169.3 (C=O), 141.2, 140.4, 137.2, 
136.6, 136.3, 136.0, 131.3, 131.3 (quarternary), 130.4, 130.0, 129.7, 129.0, 128.5, 
128.2, 128.1, 128.0, 127.6, 127.1 (Ar), 62.8, 57.8 (C(CH3)2Br), 52.7, 52.7 (NCH2), 
33.6, 33.5, 32.7 (CH3), 32.2, 31.6, 30.9, 27.7, 27.5, 26.6, 26.4, 26.3 (cy); m/z (ES
+
)  
C22H22Cl3NNaO requires 448.1252, found: 448.1246 [M+Na]
+
. 
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N-Benzyl-2,2,2-trichloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide (234) 
 
The general procedure for the formation of enamides (6.2.5) was applied using  
isobutyrophenone (5.06 mL, 33.8 mmol), benzylamine (3.69 mL, 33.8 mmol), TsOH 
(1.92 g, 10.12 mmol), toluene (35 mL, 15 mL), triethylamine (1.40 mL, 10.1 mmol) 
and trichloroacetyl chloride (1.03 mL, 9.27 mmol). The crude product was purified 
by column chromatography (pet ether/EtOAc, 19:1) to yield the product as a mixture 
with isobutyrophenone. Pet ether (5 mL) was added to the solid and the mixture 
filtered to give the product as a colourless solid in a 1:0.26 ratio of amide rotamers 
(1.21 g, 38%). Rf 0.51 (pet ether/EtOAc, 6:1); m.p. 68-69 
o
C; υmax 3003, 2913 (CH), 
1680 (C=O); δH (300 MHz, CDCl3)  7.08 – 7.51 (10H min + 8H min, m, ArH), 7.02 
(2H maj, dd, J = 8.0, 1.5 Hz, ArH), 5.41 (1H maj, d, J = 14.5 Hz, ArCHaHb), 5.05 
(1H min, d, J = 13.5 Hz, ArCHaHb), 4.13 (1H maj, d, J = 14.5 Hz, ArCHaHb), 3.85 
(1H min, d, J = 13.5 Hz, ArCHaHb), 1.80 (3H min, s, CH3), 1.60 (3H maj, s, CH3), 
1.55 (3H maj, s, CH3), 1.29 (3H min, s, CH3); δC (75 MHz, CDCl3) 158.7 (C=O 
maj), 135.7, 134.0, 134.0, 130.2 (C - quarternary), 129.8, 129.7, 129.0, 128.5, 127.7, 
127.5, 127.5, 127.4, 126.9 (ArC), 93.4 (CCl3 maj), 53.9 (ArCH2 min), 52.8 (ArCH2 
maj), 21.4 (CH3 min), 20.3(CH3 maj); m/z (ES
+
)  C19H18Cl3NNaO requires 404.0352, 
found: 404.0346 [M+Na]
+
. 
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N-Benzyl-2-bromo-2-methyl-N-(2-methyl-1-phenylprop-1-enyl)propanamide 
(235) 
 
The general procedure for the formation of enamides (6.2.5) was applied using 
isobutyrophenone (5.06 mL, 33.8 mmol), benzylamine (3.69 mL, 33.8 mmol), TsOH 
(1.92 g, 10.12 mmol), toluene (35 mL, 15 mL), triethylamine (1.40 mL, 10.1 mmol) 
and 2-bromoisobutyryl bromide (1.15 mL, 9.27 mmol). The crude product was 
purified by column chromatography (pet ether/EtOAc, 9:1) to yield the product as a 
pale yellow solid in a 1:0.65 ratio of amide rotamers (2.39 g, 74%). Rf 0.37 (pet 
ether/EtOAc, 6:1); m.p. 74-76 
oC; υmax 2989, 2910 (CH), 1639 (C=O); δH (400 MHz, 
CDCl3) 7.10 – 7.56 (10H min + 8H maj, m, ArH), 7.00 (2H maj, d, J = 7.0 Hz, 
ArH), 5.49 (1H maj, d, J = 15.0 Hz, ArCHaHb), 5.07 (1H min, d, J = 13.5 Hz, 
ArCHaHb), 4.14 (1H maj, d, J = 15.0 Hz, ArCHaHb), 3.76 (1H min, d, J = 13.5 Hz, 
ArCHaHb), 2.18 (s, J = 4.5 Hz, 1H), 2.10 (s, 1H), 2.04 (s, 1H), 2.02 (s, 1H), 1.83 (s, 
1H), 1.60 (s, J = 6.2 Hz, 1H), 1.58 (s, J = 2.9 Hz, 1H), 1.25 (s, J = 12.8 Hz, 1H); δC 
(75 MHz, CDCl3) 171.3 (C=O min), 168.6 (C=O maj), 136.8, 135.8, 135.2, 133.8, 
133.4, 132.7, 130.9 (C-quarternary), 129.6, 129.5, 129.1, 128.3, 127.8, 127.5, 127.3, 
127.0, 126.9, 126.5 (ArC), 61.8 (C(CH3)2Br min), 57.2 (C(CH3)2Br maj), 52.5, 52.5 
(ArCH2), 33.3, 32.9, 32.7, 32.1 (C(CH3)2Br), 21.2, 21.2, 20.4, 20.2 (C=C(CH3)2); 
m/z (ES
+
)  C21H24BrNNaO requires 408.0939, found: 408.0933 [M+Na]
+
. 
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N-Benzyl-2,2,2-trichloro-N-(2,6,6-trimethylcyclohex-1-enyl)acetamide (236) 
 
The general procedure for the formation of enamides (6.2.5) was applied using 2,2,6-
trimethylcyclohexanone (1.00 g, 7.13 mmol), benzylamine (0.779 mL, 7.13 mmol), 
TsOH (271 mg, 1.45 mmol), toluene (15 mL, 15 mL), triethylamine (1.19 mL, 8.58 
mmol) and trichloroacetyl chloride (0.876 mL, 7.8 mmol). The crude product was 
purified by column chromatography (pet ether/EtOAc, 9:1) to yield the product as a 
colourless oil (1.18 g, 44%). Rf  0.54 (pet ether/EtOAc, 6:1); υmax 2934 (CH), 1678 
(C=O); δH (400 MHz, CDCl3) 7.36 – 7.50 (2H, m, ArH), 7.21 – 7.36 (3H, m, ArH), 
5.60 (1H maj, d, J = 15.0 Hz, NCHaHb), 5.09 (1H min, d, J = 14.0 Hz, NCHaHb), 
4.59 (1H maj, d, J = 15.0 Hz, NCHaHb), 4.45 (1H min, d, J = 14.0 Hz, NCHaHb), 
1.44 – 2.12 (6H, m, cy), 1.33 (3H min, s, C=CCH3), 1.24 (3H maj, s, C=CCH3), 1.20 
(3H min, s, C(CH3)(CH3)), 1.18 (3H min, s, C(CH3)(CH3)), 1.11 (3H maj, s, 
C(CH3)(CH3)), 0.97 (3H maj, s, C(CH3)(CH3)); δC (100 MHz, CDCl3) 159.6, 158.5 
(C=O), 135.8, 135.2, 135.1, 134.6, 134.0, 133.5 (ArC), 130.7, 130.1, 129.5, 128.5, 
128.1, 127.9 (ArCH), 94.5, 92.2 (COCCl3), 56.8, 54.21 (NCH2), 41.1, 40.0, 38.7, 
37.6, 36.7 (cy), 34.1 (CH3), 32.1, 31.7 (cy), 31.4, 30.0, 27.7, 26.8, 19.7 (CH3), 18.5 
(cy), 12.6 (CH3); m/z (ES
+
)  C18H22Cl3NNaO requires 396.0665, found: 396.0659 
[M+Na]
+
. 
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N-Benzyl-2-bromo-2-methyl-N-(2-methyl-3,4-dihydronaphthalen-1-
yl)propanamide (237) 
 
2-Methyl-1-tetralone (1.00 g, 6.24 mmol), benzylamine (0.818 mL, 7.49 mmol) and 
titanium isopropoxide (2.77 mL, 9.36 mmol) were heated to 80 
o
C for 48 hours. The 
reaction mixture was then cooled to room temperature and tolune (12 mL) was 
added. The resulting solution was then cooled further to 0 
o
C added triethylamine 
(1.30 mL, 9.36 mmol) was added followed by the dropwise addition of 2-
bromoisobutyryl bromide (0.93 mL, 7.49 mmol), and the reaction mixture stirred at 
room temperature for 14 hours. Saturated ammonium chloride (15 mL) was then 
added and the phases separated. The organic phase was diluted with toluene (20 mL) 
and washed with 2M HCl (3 x 30 mL), then dried over MgSO4, filtered and 
concentrated in vacuo to give the crude product as a brown oil (1.26 g). The crude 
product was purified by column chromatography (14:1, pet ether/EtOAc) to give the 
product as a light brown oil (144 mg, 6%). Rf 0.17 (pet ether/EtOAc, 14:1); δH (600 
MHz, CDCl3) 7.33 – 7.40 (2H maj, m, ArH), 7.25 – 7.29 (3H maj, m, ArH), 7.16 – 
7.25 (3H maj + 6H min, m, ArH), 7.07 – 7.14 (1H maj + 2H min, m, ArH), 6.98 (1H 
min, d, J = 7.5 Hz, ArH), 5.65 (1H min, d, J = 13.5 Hz, NCHaHb), 5.50 (1H maj, d, J 
= 13.5 Hz, NCHaHb), 4.56 (1H min, d, J = 13.5 Hz, NCHaHb), 3.90 (1H maj, d, J = 
13.5 Hz, NCHaHb), 2.75 – 2.89 (2H maj, m, ArCH2CH2), 2.52 – 2.59 (1H min, m, 
ArCHaHbCHaHb), 2.35 – 2.45 (2H min, m, ArCHaHbCHaHb), 2.20 – 2.33 (2H maj + 
6H min, m, ArCH2CH2 maj + C(CH3)2 min), 1.97 (3H, s, C(CH3)(CH3)), 1.89 (1H 
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min, dd, J = 10.0, 2.5 Hz, ArCH2CHaHb), 1.86 (3H, s, C(CH3)(CH3)), 1.45 (3H min, 
s, C=CCH3), 1.29 (3H maj, s, C=CCH3); δC (150 MHz, CDCl3) 171.9 (C=O maj), 
169.2 (C=O min), 137.4 (C=CCH3 maj), 136.8 (NCH2C(Ar) maj), 136.3 (C=CCH3 
min), 136.1 (NCC(Ar) min), 135.9 (NCC(Ar) maj), 135.2 (NCH2C(Ar) min), 132.9 
(CH2CH2C(Ar) maj), 132.1 (NC=C maj), 131.7 (CH2CH2C(Ar) min), 130.7 (ArH), 
130.2 ((NC=C min), 129.9, 128.1, 127.9, 127.8, 127.7, 127.7, 127.4, 127.2, 126.8, 
126.5, 126.3, 122.9, 121.5 (ArH), 60.2 (C(CH3)2Br maj), 57.7 (C(CH3)2Br min), 53.9 
(NCH2 maj), 53.2 (NCH2 min), 34.2 (C(CH3)(CH3)Br maj), 33.3 (C(CH3)(CH3)Br 
min), 32.8  (C(CH3)(CH3)Br maj + min), 29.7 (C=CCH2 maj), 29.4 (C=CCH2 min), 
27.5 (C=CCH2CH2 min), 27.2 (C=CCH2CH2 maj), 20.8 (C=CCH3 maj), 19.3 
(C=CCH3 maj); m/z (ES
+
)  C22H24BrNNaO requires 420.0933, found: 408.0930 
[M+Na]
+
. 
 
6.3 Compounds Synthesised in Chapter Three 
2-Benzyl-1-phenyl-2-azaspiro[4.5]decan-3-one (264) and 2-benzyl-1-hydroxy-1-
phenyl-2-azaspiro[4.5]decan-3-one (265) 
       
N-Benzyl-2-chloro-N-(cyclohexylidene(phenyl)methyl)acetamide (210) (500 mg, 
1.49 mmol), Bu3SnH (0.600 mL, 2.23 mmol) and ACN (72.7 mg, 0.298 mmol) in 
toluene (75 mL) were heated to reflux for 26 hours. The reaction mixture was then 
cooled and concentrated in vacuo. The residue was then partitioned between 
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acetonitrile (50 mL) and hexane (50 mL), and the acetonitrile phase concentrated in 
vacuo to give the crude product as a brown oil (434 mg). Purification of the crude 
mixture (14:1 to 9:1, pet ether/EtOAC) led to the identification of two products, 2-
benzyl-1-phenyl-2-azaspiro[4.5]decan-3-one and 2-benzyl-1-hydroxy-1-phenyl-2-
azaspiro[4.5]decan-3-one. 
Dicernable data for 2-benzyl-1-phenyl-2-azaspiro[4.5]decan-3-one (264): Rf  0.17 
(pet ether/EtOAc, 6:1); δH (400 MHz, CDCl3) 6.93 – 7.45 (10H, m, ArH), 5.15 (1H, 
d, J = 14.5 Hz, NCHaHb), 3.92 (1H, s, NCH), 3.41 (1H, d, J = 14.5 Hz, NCHaHb), 
2.43 (2H, q, J = 17.0 Hz, COCH2), 0.73 – 1.79 (10H, m, cy); δC (100 MHz, CDCl3) 
174.3 (C=O), 137.1, 136.4 (quarternary), 130.0, 129.6, 129.3, 128.6, 128.5, 128.4, 
128.2, 128.0, 127.9, 127.5, 127.4 (ArCH), 72.1 (NCH), 44.6 (NCH2), 37.8, 34.5, 
25.7, 23.0, 22.5 (cy); m/z (ES
+
)  C22H25NNaO requires 342.1834, found: 342.1825 
[M+Na]
+
. 
Discernable data for 2-Benzyl-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one 
(265): Rf  0.15 (pet ether/EtOAc, 6:1); δH (400 MHz, CDCl3) 6.93 – 7.45 (10H, m, 
ArH), 4.86 (1H, d, J = 15.0 Hz, NCHaHb), 3.90 (1H, d, J = 15.0 Hz, NCHaHb), 2.95 
(1H, br s, OH), 2.61 (1H, d, J = 17.0 Hz, COCHaHb), 2.35 (1H, d, J = 17.0 Hz, 
COCHaHb), 0.73 – 1.79 (10H, m, cy); δC (100 MHz, CDCl3) 175.0 (C=O), 138.9, 
138.7 (quarternary), 128.6, 128.5, 128.1, 128.1, 127.5, 127.2 (ArCH), 98.2 
(NC(OH)) 45.7 (NCH2), 39.5, 33.7, 25.5, 23.1, 22.8 (cy);  m/z (ES
+
)  C22H25NNaO2 
requires 358.1783, found: 358.1778 [M+Na]
+
. 
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6.3.1 General Procedure for Cyclisation of Trichloroenamides 
Enamide (1 eq.), CuCl (1 eq.) and TPA (1 eq.) were heated to reflux in toluene (0.12 
M) for 2-16 hours. The reaction mixture was then cooled to room temperature and 
filtered through a silica plug with EtOAc (15 mL). The filtrate was then concentrated 
in vacuo to give the crude product. The products were purified by column 
chromatography. 
6.3.2 General Procedure for Cyclisation of Bromoenamides. 
Enamide (1 eq.), CuBr (0.6 eq.) and TPA (0.6 eq.) were heated to reflux in toluene 
(0.12 M) for 2-15 hours. The reaction mixture was then cooled to room temperature 
and filtered through a silica plug with EtOAc. The filtrate was then concentrated in 
vacuo to give the crude product. The products were purified by column 
chromatography. 
 
1-Benzyl-3,3-dichloro-3a-phenyl-3a,4,5,6-tetrahydro-1H-indol-2(3H)-one (269) 
 
The general procedure for the cyclisation of trichloroenamides (6.3.1) was applied 
using N-benzyl-2,2,2-trichloro-N-(2-phenylcyclohex-1-enyl)acetamide (200 mg, 0.49 
mmol), CuCl (48.5 mg, 0.49 mmol), TPA (142 mg, 0.49 mmol) and toluene (4.2 
mL). The crude product was purified by column chromatography (pet ether/EtOAc, 
9:1) to give the product as a colourless oil (123 mg, 70%). Rf 0.37 (pet ether/EtOAc, 
9:1); δH (400MHz, CDCl3) δ 7.24 – 7.33 (5H, m, ArH), 7.07 – 7.15 (3H, m, ArH), 
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6.99 – 7.03 (2H, m, ArH), 5.25 (1H, t, J = 3.5 Hz, C=CH), 4.86 (1H, d, J = 15.0 Hz, 
ArCHaHbN), 4.69 (1H, d, J = 15.0 Hz, ArCHaHbN), 2.40 – 2.49 (2H, m, C=CHCH2), 
1.93 – 2.13 (3H, m, C(Ph)CH2), 1.59 – 1.68 (1H, m, CH2CHaHbCH2), 0.97 – 1.11 
(1H, m, CH2CHaHbCH2); δC (100MHz, CDCl3) δ 166.3 (C=O), 139.1 , 138.2, 135.1 
(quarternary) 129.0, 128.8, 128.1, 128.1, 128.1, 127.8 (ArCH), 105.4 (C=CH), 89.1 
(C=OCCl2), 56.8 (CCl2C(Ph)CH2), 45.2 (ArCH2N), 29.3 (C=CCH2), 23.1 
(C(Ph)CH2), 18.1 (CH2CH2CH2); m/z (ES
+
) C21H19Cl2NNaO requires 394.0736, 
found: 394.0732 [M+Na]
+
. 
 
1-Benzyl-3,3,3a-trimethyl-3a,4,5,6-tetrahydro-1H-indol-2(3H)-one (270) 
 
The general procedure for the cyclisation of bromoenamides (6.3.2) was apllied 
using N-benzyl-2-bromo-2-methyl-N-(2-phenylcyclohex-1-enyl)propanamide (150 
mg, 0.36 mmol), CuBr (15.6 mg, 0.11 mmol), TPA (31.9 mg, 0.11 mmol) and 
toluene (3 mL). The crude product was purified by column chromatography (8:1, pet 
ether/EtOAc) to give the product as a yellow oil (49 mg, 41%). Rf 0.37 (pet 
ether/EtOAc, 6:1); δH (400MHz, CDCl3) 6.98 – 7.39 (8H, m, ArH), 6.8 – 6.88 (2H, 
m, ArH), 5.01 (1H, t, J = 3.5 Hz, C=CH), 4.74 (1H, d, J = 15.0 Hz, ArCHaHbN), 
4.56 (1H, d, J = 15.0 Hz, ArCHaHbN), 2.14 (1H,  dt, J = 12.5, 3.5 Hz, C(Ph)CHaHb), 
2.06 – 1.81 (2H, m, C=CHCH2), 1.81 – 1.66 (1H, m, C(Ph)CHaHb), 1.40 – 1.56 (2H, 
m, CH2CH2CH2), 1.15 (3H, s, CH3), 0.75 (3H, s, CH3); δC (75 MHz, CDCl3) 178.8 
(C=O), 142.7 (ArC-CC=C), 142.1 (C=CH), 136.1 (ArC-CH2N), 128.0, 127.5, 127.3, 
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127.2, 126.9, 125.7 (ArCH), 100.9 (C=CH), 51.2 (CH=CCPh), 47.9 (C(CH3)2), 43.4 
(NCH2), 26.8 (CH2), 23.8 (CH3), 22.6 (C=CHCH2), 20.1 (CH2), 17.9 (CH3); m/z 
(ES
+
) C23H25NNaO requires 354.1834, found: 354.1828 [M+Na]
+
. 
 
2-Benzyl-4-chloro-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one (272) and 2-
Benzyl-4,4-dichloro-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one (273) 
     
The general procedure for the cyclisation of trichloroenamides (6.3.1) was applied 
using N-Benzyl-2,2,2-trichloro-N-(cyclohexylidene(phenyl)methyl)acetamide (232) 
(150 mg, 0.355 mmol), CuCl (35.1 mg, 0.355 mmol), TPA (103 mg, 0.355 mmol) 
and toluene (3.3 mL). The crude product was purified by column chromatography 
(pet ether/EtOAc, 10:1) to give 2-benzyl-4-chloro-1-hydroxy-1-phenyl-2-
azaspiro[4.5]decan-3-one as a colourless solid (21 mg, 16%) and 2-benzyl-4,4-
dichloro-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one as a colourless solid (33 
mg, 23%). 
2-Benzyl-4-chloro-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one (272): Rf 0.18 
(pet ether/EtOAc, 6:1); m.p. 183-185 
o
C; υmax 3213 (OH), 2929, 2861 (CH), 1687 
(C=O); δH (400 MHz, CDCl3) 6.76 – 7.81 (10H, m, ArH), 4.84 (1H, d, J = 15.0 Hz, 
NCHaHb), 4.47 (1H, s, CHCl), 4.19 (1H, d, J = 15.0 Hz, NCHaHb), 2.58 (1H, s, OH), 
2.26 (1H, dd, J = 13.5, 2.5 Hz, cy), 1.48 – 1.77 (3H, m, cy), 1.13 – 1.42 (4H, m, cy), 
0.79 – 0.96 (1H, m, cy), 0.69 (1H, td, J = 13.0, 4.0 Hz, cy); δC (100 MHz, CDCl3) 
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172.2 (C=O), 137.5, 136.0 (quarternary), 129.0, 128.7, 128.6, 128.6, 128.2, 127.6 
(ArCH), 98.5 (NC(OH)Ph), 60.4 (CHCl) 48.2 (CH(Cl)CC(OH)), 45.2 (NCH2Ph), 
33.62, 26.45, 24.71, 22.65, 22.41 (cy); m/z (ES
+
) C22H24ClNNaO2 requires 392.1393, 
found: 392.1388 [M+Na]
+
. 
2-Benzyl-4,4-dichloro-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one (273): Rf 
0.21 (pet ether/EtOAc, 6:1); m.p. 178-180 
o
C; υmax 3517 (OH), 2932, 2869 (CH), 
1728 (C=O); δH (400 MHz, CDCl3) 6.86 – 7.86 (10H, m, ArH), 4.82 (1H, d, J = 15.0 
Hz, NCHaHb), 4.03 (1H, d, J = 15.0 Hz, NCHaHb), 2.80 (1H, br s, OH), 1.94 - 2.09 
(1H, m, cy), 1.72 – 1.87 (1H, m, cy), 1.41 – 1.70 (4H, m, cy), 1.23 – 1.41 (1H, m, 
cy), 1.10 – 1.23 (1H, m, cy), 0.91 – 1.10 (1H, m, cy), 0.54 – 0.76 (1H, m, cy); δC 
(100 MHz, CDCl3) 166.7 (C=O), 136.1, 135.7 (quarternary), 128.1, 127.9, 127.5, 
126.8 (ArCH), 95.5 (NC(OH)Ph), 90.8 (CCl2), 52.6 (C(Cl)2CC(OH)), 45.1 
(NCH2Ph), 31.7, 27.5, 23.8, 21.0, 20.6 (cy), (Only four aromatic CH observed, 
overlap of peaks is presumed); m/z (ES
+
) C22H23Cl2NNaO2 requires 426.1004, found: 
426.0998 [M+Na]
+
. 
 
1-Benzyl-3-chloro-5-hydroxy-4,4-dimethyl-5-phenylpyrrolidin-2-one (275) and 
1-Benzyl-3,3-dichloro-5-hydroxy-4,4-dimethyl-5-phenylpyrrolidin-2-one (276) 
        
The general procedure for the cyclisation of trichloroenamides (6.3.1) was applied 
using N-Benzyl-2,2,2-trichloro-N-(2-methyl-1-phenylprop-1-enyl)acetamide (234) 
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(150 mg, 0.39 mmol), CuCl (38.8 mg, 0.39 mmol), TPA (114 mg, 0.39 mmol) and 
toluene (3.5 mL). The crude product was purified by column chromatography (pet 
ether/EtOAc, 10:1) to give 1-benzyl-3-chloro-5-hydroxy-4,4-dimethyl-5-
phenylpyrrolidin-2-one as a colourless solid (17 mg, 13%) and 2-benzyl-4,4-
dichloro-1-hydroxy-1-phenyl-2-azaspiro[4.5]decan-3-one as a colourless solid (68 
mg, 48%). 
1-Benzyl-3-chloro-5-hydroxy-4,4-dimethyl-5-phenylpyrrolidin-2-one (275): Rf 
0.10 (pet ether/EtOAc, 6:1); m.p. 183-185 
o
C; υmax 3376 (OH), 2972, 2935 (CH), 
1677 (C=O); δH (400 MHz, CDCl3) 7.37 – 7.48 (3H, m, ArH), 7.29 – 7.37 (2H, m, 
ArH), 7.17 – 7.28 (3H, m, ArH), 6.96 – 7.04 (2H, m, ArH), 5.16 (1H, d, J = 14.5 Hz, 
NCHaHb), 4.73 (1H, s, CHCl), 4.13 (1H, d, J = 14.5 Hz, NCHaHb), 2.08 (1H, s, OH), 
1.10 (3H, s, CH3), 0.77 (3H, s, CH3); δC (100 MHz, CDCl3) 172.1 (C=O), 137.2, 
136.6 (quarternary), 129.1, 129.0, 128.7, 128.3, 128.0 (ArCH), 95.9 (NC(OH)Ph), 
65.7 (CHCl), 48.3 (C(CH3)2), 44.5 (NCH2Ph), 22.0 (CH3), 19.1(CH3) (Only five 
aromatic CH observed, overlap of peaks is presumed); m/z (ES
+
) C19H21ClNO2 
requires 330.1261, found: 330.1255 [M+H]
+
. 
1-Benzyl-3,3-dichloro-5-hydroxy-4,4-dimethyl-5-phenylpyrrolidin-2-one (276): 
Rf 0.18 (pet ether/EtOAc, 6:1); m.p. 171-172 
o
C; υmax 3520 (OH), 2933, 2866 (CH), 
1676 (C=O); δH (400 MHz, CDCl3) 7.31 – 7.55 (4H, m, ArH), 7.16 – 7.31 (6H, m, 
ArH), 4.96 (1H, d, J = 15.0 Hz, NCHaHb), 4.22 (1H, d, J = 15.0 Hz, NCHaHb), 2.88 
(1H, s, OH), 1.33 (3H, s, CH3), 0.87 (3H, s, CH3); δC (100 MHz, CDCl3) 167.8 
(C=O), 136.7, 136.4 (quarternary), 129.1, 128.9, 128.6, 128.0, 127.9 (ArCH), 96.0 
(NC(OH)Ph), 90.7 (CCl2), 52.6 (C(CH3)2), 46.0 (NCH2Ph), 26.6 (CH3), 18.0 (CH3) 
(Only five aromatic CH observed, overlap of peaks is presumed); m/z (ES
+
) 
C19H19Cl2NNaO2 requires 386.0691, found: 386.0691 [M+Na]
+
. 
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1-Benzyl-3,3,4,4-tetramethyl-5-phenylpyrrolidin-2-one (278), 1-Benzyl-5-
hydroxy-3,3,4,4-tetramethyl-5-phenylpyrrolidin-2-one (279) and 2-Benzyl-4,4,5-
trimethyl-1-phenyl-2-azabicyclo[3.1.0]hexan-3-one (280) 
      
The general procedure for the cyclisation of bromoenamides (6.3.2) was applied 
using N-Benzyl-2-bromo-2-methyl-N-(2-methyl-1-phenylprop-1-enyl)propanamide 
(235) (200 mg, 0.518 mmol), CuBr (44.6 mg, 0.311 mmol), TPA (90.2 mg, 0.311 
mmol) and toluene (5 mL). The crude product was purified by column 
chromatography (6:1, pet ether/EtOAc) to yielding 1-benzyl-5-hydroxy-3,3,4,4-
tetramethyl-5-phenylpyrrolidin-2-one (279) as a white solid (61 mg, 36%) and a 
colourless oil (30 mg) that was found to be a 4:1 mixture of 1-benzyl-3,3,4,4-
tetramethyl-5-phenylpyrrolidin-2-one (278) (15%) and 2-benzyl-4,4,5-trimethyl-1-
phenyl-2-azabicyclo[3.1.0]hexan-3-one (280) (4%). 
1-Benzyl-5-hydroxy-3,3,4,4-tetramethyl-5-phenylpyrrolidin-2-one (279): Rf  0.16 
(pet ether/EtOAc, 6:1); m.p. 117-119 
o
C; υmax 3217 (OH), 2912 (CH), 1666 (C=O); 
δH (400 MHz, CDCl3) 7.14 – 7.48 (8H, m, ArH), 7.01 – 7.14 (2H, m, ArH), 5.20 
(1H, d, J = 15.0 Hz, NCHaHb), 4.03 (1H, d, J = 15.0 Hz, NCHaHb), 1.95 (1H, s, OH), 
1.35 (3H, s, CH3), 1.09 (3H, s, CH3), 0.95 (3H, s, CH3), 0.53 (3H, s, CH3); δC (100 
MHz, CDCl3) 182.1 (C=O), 139.2, 138.5 (quarternary), 128.9, 128.5, 128.3, 128.0, 
127.7 (ArCH), 96.9 (NC(OH)Ph), 46.7 (C(CH3)2), 46.0 (C(CH3)2), 44.0 (NCH2), 
25.4 (CH3), 24.9 (CH3), 20.4 (CH3), 17.0 (CH3), (Only five aromatic CH observed, 
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overlap of peaks is presumed); m/z (ES
+
) C21H25NNaO2 requires 346.1783, found: 
346.1781 [M+Na]
+
. 
1-Benzyl-3,3,4,4-tetramethyl-5-phenylpyrrolidin-2-one (278) and 2-Benzyl-
4,4,5-trimethyl-1-phenyl-2-azabicyclo[3.1.0]hexan-3-one (280) (4:1): Rf 0.19 (pet 
ether/EtOAc, 6:1); δH (400 MHz, CDCl3) 6.87 – 7.44 (10H maj + 10 H min, m, 
ArH), 5.24 (1H maj, d, J = 14.0 Hz, NCHaHb), 4.83 (1H min, d, J = 14.0 Hz, 
NCHaHb), 3.97 (1H maj, s, NCH), 3.72 (1H min, d, J = 14.0 Hz, NCHaHb), 3.66 (1H 
maj, d, J = 14.0 Hz, NCHaHb), 1.32 (3H min, s, COC(CH3)(CH3)), 1.18 (3H min, s, 
COC(CH3)(CH3)), 1.08 (3H maj, s, COC(CH3)(CH3)), 1.00 (1H min, d, J = 6.0 Hz, 
NCCHaHb), 0.96 (3H maj, s, COC(CH3)(CH3)), 0.85 (3H maj, s, CH3), 0.79 (3H 
min, s, CH3), 0.59 (3H maj, s, CH3), 0.30 (1H min, d, J = 6.0 Hz, NCCHaHb); δC 
(150 MHz, CDCl3) 181.2 (C=O maj), 179.5 (C=O min), 137.1 (Ar quaternary min), 
136.3 (Ar quaternary maj), 135.4 (Ar quaternary maj), 134.2 (Ar quaternary min), 
129.5, 129.2, 128.9, 128.5, 128.4, 128.2, 128.1, 127.8, 127.8, 127.5, 127.3 (ArCH), 
68.6 (NCH maj), 51.6 (NC(Ph)CH2), 46.7 (COC(CH3)2 maj), 45.3 (NCH2Ph min), 
45.3 (COC(CH3)2 min), 44.8 (NCH2Ph maj), 42.4 (NCHC(CH3)2 maj), 28.8 
(NC(Ph)C(CH3) min), 25.0 (NCCH2 min), 24.2 (COC(CH3)(CH3) min), 21.6 
(COC(CH3)(CH3) min), 21.3 (NCHC(CH3)(CH3) maj), 21.1 (NCHC(CH3)(CH3) 
maj), 20.7 (COC(CH3)(CH3) maj), 19.2 (COC(CH3)(CH3) maj), 14.1 (NCC(CH3) 
min); m/z (ES
+
) C21H25NNaO requires 330.1834, found: 330.1832 [M+Na]
+
 (278). 
m/z (ES
+
) 306.2 [M+H]
+
, 328.2 [M+Na]
+
 (280). 
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2-Benzyl-1-hydroxy-4,4-dimethyl-1-phenyl-2-azaspiro[4.5]decan-3-one (285), 2-
Benzyl-4,4-dimethyl-1-phenyl-2-azaspiro[4.5]decan-3-one (286) and (287) 
(0.22:1). 
 
The general procedure for the cyclisation of bromoenamides (6.3.2) was applied 
using N-Benzyl-2-bromo-N-(cyclohexylidene(phenyl)methyl)-2-methylpropanamide 
(233) (200 mg, 0.469 mmol), CuBr (40.1 mg, 0.281 mmol), TPA (81.7 mg, 0.281 
mmol) and toluene (5 mL). The crude product was purified by column 
chromatography (9:1:0.2, hexane/diethyl ether/triethylamine) yielding 2-benzyl-1-
hydroxy-4,4-dimethyl-1-phenyl-2-azaspiro[4.5]decan-3-one (285) as a white solid 
(56 mg, 33%) and 0.22:1 mixture (41 mg) of 2-benzyl-4,4-dimethyl-1-phenyl-2-
azaspiro[4.5]decan-3-one (286) (5%) and (287) (21%). 
 
2-Benzyl-1-hydroxy-4,4-dimethyl-1-phenyl-2-azaspiro[4.5]decan-3-one (285): Rf 
0.18 (pet ether/EtOAc, 6:1); m.p. 169-170 
o
C; υmax 3165 (OH), 2919  (CH), 1664 
(C=O); δH (400 MHz, CDCl3) 7.30 – 7.66 (4H, m, ArH), 7.06 – 7.30 (4H, m, ArH),  
6.98 – 7.05 (2H, m, ArH), 5.14 (1H, d, J = 15.0 Hz, NCHaHb), 3.91 (1H, d, J = 15.0 
Hz, NCHaHb), 1.93 (1H, s, OH), 1.78 (1H, dd, J = 13.5, 6.0 Hz, cy), 1.47 – 1.58 (2H, 
m, cy), 1.39 (3H, s, CH3), 1.24 – 1.45 (4H, m, cy), 1.31 (3H, s, CH3), 0.97 – 1.07 
(1H, m, cy), 0.87 – 0.97 (1H, m, cy), 0.77 – 0.87 (1H, m, cy); δC (100 MHz, CDCl3) 
182.1 (C=O), 140.0, 138.4 (quarternary), 128.9, 128.5, 128.4, 127.8 (ArC), 97.3 
(COH), 48.7 (COHC(cy)), 47.1 (C(CH3)2), 44.2 (NCH2), 32.4 (cy), 30.5 (cy), 27.5 
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(cy), 25.5 (cy), 25.2 (CH3), 23.5 (CH3), 22.7 (cy); m/z (ES
+
) C24H39NNaO2 requires 
386.2096, found: 386.2096 [M+Na]
+
. 
2-Benzyl-4,4-dimethyl-1-phenyl-2-azaspiro[4.5]decan-3-one (286) and (287): Rf 
0.21 (pet ether/EtOAc, 6:1); υmax 2933, 2866 (CH), 1676 (C=O); δH (400 MHz, 
CDCl3) 7.16 – 7.39 (8H maj + 8H min, m, ArH), 7.02 – 7.06 (2H maj, m, ArH), 6.99 
– 7.02 (2H min, m, ArH), 5.22 (1H min, d, J = 14.5 Hz, NCHaHb), 4.61 (1H maj, d, J 
= 14.5 Hz, NCHaHb), 4.08 (1H min, s, CH), 3.74 (1H maj, d, J = 14.5 Hz, NCHaHb), 
3.46  (1H min, d, J = 14.5 Hz, NCHaHb), 1.83 – 1.93 (1H maj + 1H min, m, cy), 1.78 
(1H maj, td, J = 14.5, 6.5 Hz, cy), 1.57 – 1.70 (2H maj, m, cy), 1.46 – 1.54 (2H min, 
m, cy), 1.39 (3H maj, s, CH3), 1.34 – 1.41 (3H min, m, cy), 1.15 – 1.30 (3H min, m, 
cy), 1.27 (3H min, s, CH3), 1.23 (3H maj, s, CH3), 1.11 (3H maj, s, CH3), 1.04 – 1.15 
(1H maj + 1H min, m, cy), 0.95 – 1.04 (1H maj, m, cy), 0.85 (1H maj, dd, J = 8.5, 
2.5 Hz, cy), 0.74 – 0.82 (1H maj, m, cy), 0.57 – 0.69 (1H maj, m, cy).; δC (100 MHz, 
CDCl3) 180.1 (C=O min), 178.8 (C=O maj), 137.7 (NCH2C maj), 136.7 (ArCCN 
min), 136.3 (NCH2C min), 132.7 (ArCCN maj), 132.3, 128.7, 128.7, 128.6, 128.4, 
128.2, 128.2, 128.0, 127.9, 127.5, 126.9 (ArCH), 68.5 (NCHPh min), 52.6 
(C(O)NCPh), 47.6, 46.5, 44.9, 44.8 (quarternary), 34.0 (cy), 31.1 (CH maj), 29.7 
(cy), 28.4 (cy), 25.6 (cy), 23.9 (CH3 maj), 23.8 (CH3 min), 23.0 (cy), 22.5 (cy), 21.8 
(CH3 min), 21.6 (cy), 21.2 (cy), 21.2 (CH3 maj), 20.1 (cy); m/z (ES
+
) C24H30NO 
requires 348.2327, found: 348.2323 [M+H]
+ 
(286), C24H28NO requires 346.2171, 
found: 346.2175 [M+H]
+ 
(287). 
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N-benzyl-2,2-dichloro-2-(1,3,3-trimethyl-2-oxocyclohexyl)acetamide (292) and 
N-benzyl-2-chloro-2-(1,3,3-trimethyl-2-oxocyclohexyl)acetamide (293) 
     
The general procedure for the cyclisation of trichloroenamides (6.3.1) was applied 
using N-benzyl-2,2,2-trichloro-N-(2,6,6-trimethylcyclohex-1-enyl)acetamide (236) 
(150 mg, 0.39 mmol), CuCl (38.8 mg, 0.39 mmol), TPA (114 mg, 0.39 mmol) and 
toluene (3.5 mL). The crude product was purified by column chromatography (pet 
ether/EtOAc, 10:1) to give N-benzyl-2,2-dichloro-2-(1,3,3-trimethyl-2-
oxocyclohexyl)acetamide as a colourless oil (23 mg, 12%) and N-benzyl-2-chloro-2-
(1,3,3-trimethyl-2-oxocyclohexyl)acetamide as a colourless solid (65 mg, 38%). 
 
N-benzyl-2,2-dichloro-2-(1,3,3-trimethyl-2-oxocyclohexyl)acetamide (292): Rf 
0.37 (pet ether/EtOAc, 6:1); δH (300 MHz, CDCl3) 7.06 – 7.35 (5H, m, ArH), 6.99 
(1H, br s, NH), 4.41 (2H, qd, J = 15.0, 5.5 Hz, NCH2Ph), 2.28 (1H, dd, J = 15.0, 
10.5 Hz, cy), 1.88 - 2.03 (1H, m, cy), 1.40 - 1.88 (4H, m, cy), 1.51 (3H, s, CH3), 1.06 
(3H, s, CH3), 1.03 (3H, s, CH3); δC (100 MHz, CDCl3) 216.1 (ketone C=O), 166.4 
(amide C=O), 137.3 (Ar quarternary), 128.8, 127.7, 127.6 (ArCH), 94.3 (CCl2), 45.2 
(cy quarternary), 44.6 (cy), 37.8 (cy), 36.8 (cy quarternary), 27.9 (CH3), 27.7 (CH3), 
23.4 (CH3), 18.2 (cy); m/z (ES
+
) C18H24Cl2NO2 requires 356.1184, found: 356.1186 
[M+NH]
+
. 
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N-benzyl-2-chloro-2-(1,3,3-trimethyl-2-oxocyclohexyl)acetamide (293): Rf 0.32 
(pet ether/EtOAc, 6:1); m.p. 129- 131 
o
C; υmax 3356 (NH), 2968, 2924 (CH), 1728 
(C=O), 1672 (C=O); δH (400 MHz, CDCl3) 7.09 – 7.48 (5H, m, ArH), 6.71 (1H, br s, 
NH), 5.12 (1H, s, CHCl), 4.41 (2H, qd, J = 145.0, 5.5 Hz, NCH2Ph), 1.54 – 1.95 
(6H, m, cy), 1.27 (3H, s, CH3), 1.22 (3H, s, CH3), 1.15 (3H, s, CH3); δC (100 MHz, 
CDCl3) 217.7 (Ketone C=O), 167.1 (amide C=O), 136.8 (Ar quaternary), 128.2, 
127.2, 127.1 (ArCH), 68.8 (CHCl), 49.6, 43.8 (cy quarternary), 43.4 (NCH2), 37.2 
(cy), 32.1 (cy), 27.8 (CH3), 27.3 (CH3), 24.7 (CH3), 16.9 (cy); m/z (ES
+
) 
C18H24ClNNaO2 requires 344.1393, found: 344.1379 [M+Na]
+
. 
 
1-Benzyl-3,3,3a-trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-2(9bH)-one (294), 
1-Benzyl-9b-hydroxy-3,3,3a-trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-
2(9bH)-one (295) and (296) 
         
The general procedure for the cyclisation of bromoenamides (6.3.2) was applied 
using N-Benzyl-2-bromo-2-methyl-N-(2-methyl-3,4-dihydronaphthalen-1-
yl)propanamide (237) (132 mg, 0.331 mmol), CuBr (28.5 mg, 0.199 mmol), TPA 
(57.7 mg, 0.199 mmol) and toluene (3.3 mL). The crude product was purified by 
column chromatography (10:1 to 5:1, pet ether/EtOAc) to give the 1-benzyl-3,3,3a-
trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-2(9bH)-one (294) (33 mg, 31%), 1-
benzyl-9b-hydroxy-3,3,3a-trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-2(9bH)-one 
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(295) (21 mg, 19%) and 1-benzyl-[3,9b]cyclopropyl-3,3,3a-trimethyl-3,3a,4,5-
tetrahydro-1H-benzoindol-2(9bH)-one (296) (7 mg, 7%) 
1-Benzyl-3,3,3a-trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-2(9bH)-one (294): 
Rf 0.15 (pet ether/EtOAc, 8:1); δH (600 MHz, CDCl3) 7.30 (2H, t, J = 7.5 Hz, ArH), 
7.21 – 7.28 (2H, m, ArH), 7.15 (1H, d, J = 7.5 Hz, ArH), 7.12 (1H, t, J = 7.5 Hz, 
ArH), 7.09 (1H, d, J = 7.5 Hz, ArH), 6.92 (1H, d, J = 7.5 Hz, ArH), 4.95 (1H, d, J = 
15.5 Hz, NCHaHb), 4.24 (1H, s, NCH), 3.62 (1H, d, J = 15.5 Hz, NCHaHb), 2.79 
(2H, dt, J = 12.0, 6.0 Hz, ArCH2), 1.68 – 1.75 (1H, m, ArCH2CHaHb), 1.54 (1H, m, 
ArCH2CHaHb), 1.24 (3H, s, CH3), 1.13 (3H, s, CH3), 0.94 (3H, s, CH3); δC (600 
MHz, CDCl3) 179.9 (C=O), 137.7 (ArCCH2N), 137.2 (ArCCH2CH2), 132.8 (ArCH), 
130.0 (ArCCH), 129.1, 128.6, 128.5, 127.4, 127.0, 125.4 (ArCH), 61.5 (NCH), 47.0 
(COC(CH3)2), 43.2 (ArCH2N), 41.0 (COC(CH3)2C), 27.3 (ArCH2CH2), 25.8 
(ArCH2CH2), 20.8, 17.2, 14.6 (CH3); m/z (ES
+
) C22H25NNaO requires 342.1834, 
found: 342.1828 [M+Na]
+
. 
1-Benzyl-9b-hydroxy-3,3,3a-trimethyl-3,3a,4,5-tetrahydro-1H-benzoindol-
2(9bH)-one (295): Rf 0.05 (pet ether/EtOAc, 8:1); δH (400 MHz, CDCl3) 7.21 – 7.29 
(1H, m, ArH), 6.59 – 6.91 (8H, m, ArH), 4.30 (1H, d, J = 15.5 Hz, NCHaHb), 3.80 
(1H, d, J = 15.5 Hz, NCHaHb), 2.47 (1H, ddd, J = 17.5, 11.0, 6.5 Hz, ArCHaHbCH2), 
2.27 (1H, dt, J = 17.5, 4.5 Hz, ArCHaHbCH2), 1.95 (1H, s, OH), 1.17 – 1.48 (2H, m, 
ArCH2CH2), 1.14 (3H, s, CH3), 0.77 (3H, s, CH3), 0.72 (3H, s, CH3); δC (100 MHz, 
CDCl3) 180.7 (C=O), 137.9, 136.1, 134.6 (ArC), 128.1, 128.0, 127.6, 127.5, 126.8, 
126.0, 125.6 (ArCH), 90.8 (NCOH), 45.4 (COC(CH3)2), 44.6 (NC(OH)C(CH3)), 
42.5 (NCH2), 30.9 (C(CH3)CH2), 25.1 (ArCH2CH2), 24.8 (COC(CH3)(CH3)), 18.8 
(COC(CH3)(CH3)), 12.3 (NC(OH)C(CH3)); m/z (ES
+
) C22H25NNaO2 requires 
358.1738: found: 358.1778 [M+Na]
+
. 
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1-Benzyl-[3,9b]cyclopropyl-3,3,3a-trimethyl-3,3a,4,5-tetrahydro-1H-
benzoindol-2(9bH)-one (296): Rf 0.26 (pet ether/EtOAc, 8:1); δH (600 MHz, 
CDCl3) 7.08 – 7.54 (7H, m, ArH), 7.00 – 7.07 (2H, m, ArH), 4.92 (1H, d, J = 14.5 
Hz, NCHaHb), 4.30 (1H, d, J = 14.5 Hz, NCHaHb), 2.89 (1H, dd, J = 17.5, 7.5 Hz, 
ArCHaHbCH), 2.54 (1H, d, J = 17.5 Hz, ArCHaHbCH), 1.33 (3H, s, CH3), 1.13 (3H, 
s, CH3), 0.90 (1H, d, J = 7.5 Hz, CH2CH), 0.64 (3H, s, CH3); δC (150 MHz, CDCl3) 
180.1 (C=O), 143.1, 137.3, 137.0 (ArC), 128.8, 128.2, 127.3, 126.7, 126.4, 124.9, 
123.4 (ArCH), 59.3, 52.8 (quarternary), 45.7 (NCH2), 44.4 (quarternary), 32.4 
(CH3), 30.8 (ArCH2), 25.0 (CH3), 21.3 (CH3), 6.5 (CH); m/z (ES
+
) C22H24NO 
requires 318.1858, found: 318.1860 [M+H]
+
. 
 
1-(Benzylamino)-2-methyl-1-oxopropan-2-yl 2-(3-oxobutyl)benzoate (297) 
 
Rf  0.14 (pet ether/EtOAc, 6:1); δH (600 MHz, CDCl3) 7.76 (1H, dd, J = 8.0, 1.5 Hz, 
ArH), 7.40 (1H, td, J = 7.5, 1.5 Hz, ArH), 7.27 – 7.34 (4H, m, ArH), 7.21 – 7.27 
(3H, m, ArH), 6.64 (1H, br t, J = 7.5 Hz, NH), 4.50 (2H, d, J = 7.5 Hz, NCH2), 3.10 
(2H, t, J = 7.5 Hz, CH2CH2), 2.73 (2H, t, J = 7.5 Hz, CH2CH2), 2.04 (3H, s, 
COCH3), 1.77 (6H, s, C(CH3)2); δC (150 MHz, CDCl3) 208.2 (C=O ketone), 172.9 
(C=O amide), 166.1 (C=O ester), 142.8 (ArC), 138.3 (ArC), 132.2, 131.0,  130.3,  
128.6,  127.7, 127.4, 126.2 (ArC), 81.6 (COC(CH3)), 45.1 (CH2CH2CO), 43.5 
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(NCH2), 29.9 (COCH3), 27.9 (ArCH2CH2), 24.9 (C(CH3)); m/z (ES
+
) C22H26NO4 
requires 368.1862, found: 368.1856 [M+H]
+
.  
 
6.4 Compounds Synthesised in Chapter Four 
6.4.1. General Procedure for synthesis of N-bromobenzyl enamides  
Oxime (1 eq.), acetic acid (3 eq.), acetic anhydride (3 eq.) and iron powder (2 eq.) in 
anhydrous toluene were heated to reflux under an inert atmosphere for 6-16 hours. 
The mixture was then filtered through celite, diluted with DCM and washed with 2M 
NaOH and NaCl(aq). The organic phase was then dried over MgSO4, filtered and then 
concentrated in vacuo to give the crude product. The crude enamide (1 eq.) was 
added to sodium hydride (5 eq., 60% w/w dispersion in mineral oil) in anhydrous 
THF and cooled to 0 
o
C. 2-Bromobenzyl bromide (1.05 eq.) was then added and the 
reaction heated to reflux under an inert atmosphere for 10-16 hours. The reaction 
mixture was then added to water and extracted with ethyl acetate. The combined 
organic layers were then dried over MgSO4, filtered and then concentrated in vacuo 
to give the crude product. Products were purified by column chromatography or 
recrystallisation as stated below. 
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N-(2-Bromobenzyl)-N-cyclohexenylacetamide (320) 
 
Cyclohexanone oxime (4 g, 35.3 mmol), copper iodide (0.673 g, 3.53 mmol), acetic 
anhydride (6.67 mL, 70.7 mmol) and sodium bisulfite (11.1 g, 106 mmol) in DCE 
(156 mL) were heated to 120 
o
C for 16 hours. The reaction mixture was then cooled, 
diluted with EtOAc (100 mL), washed with NaOH (2 M, 2 x 200 mL), dried over 
MgSO4 and concentrated in vacuo to give a brown oil (3.73 g). The oil was added to 
sodium hydride (5.36 g, 134 mmol) in THF (250 mL) at 0 
o
C, and the reaction then 
heated to reflux for 18 hours. After cooling, water (150 mL) was added and the 
mixture was extracted with EtOAc (3 x 150 mL) and the combined organic layers 
were dried over MgSO4, filtered, and concentrated in vacuo to give the crude product 
as a brown oil (9.25 g). The crude product was purified by column chromatography 
(pet ether/ EtOAc, 6:1) to give the product as a pale yellow oil (3.71 g, 34%). Rf 0.15 
(pet ether/EtOAc, 6:1); υmax 2931 (CH), 1651 (C=O); δH (400 MHz, CDCl3) 7.50 
(1H, dd, J = 8.0, 1.0 Hz, ArH), 7.38 (1H, dd, J = 7.5, 1.5 Hz, ArH), 7.22 – 7.28 (1H, 
m, ArH), 7.09 (1H, td, J = 7.5, 1.5 Hz, ArH), 5.40 – 5.45 (1H, m, C=CH), 4.78 (2H, 
s, NCH2), 2.10 (3H, s, CH3), 1.96 – 2.06 (4H, m, cy), 1.63 – 1.71 (2H, m, cy), 1.49 – 
1.57 (2H, m, cy); δC (100 MHz, CDCl3) 170.2 (C=O), 138.7 (C=CN), 137.2 (ArC), 
132.5 (ArCH), 130.4 (C=CH), 128.7 (ArCH), 128.2 (ArCH), 127.5 (ArCH), 124.0 
(ArCBr), 48.8 (NCH2), 28.0, 24.8, 22.7, 21.6 (cy), 21.4 (COCH3); m/z (ES
+
) 
C15H18BrNONa requires 330.0472, found 330.0464 [M+Na]
+
. 
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1-(Spiro[cyclohexane-1,1'-isoindoline]-2'-yl)ethanone (326), cis-1-
(1,2,3,4,4a,10b-Hexahydrophenanthridin-5(6H)-yl)ethanone (327a) and trans-1-
(1,2,3,4,4a,10b-Hexahydrophenanthridin-5(6H)-yl)ethanone (327b) 
 
N-(2-Bromobenzyl)-N-cyclohexenylacetamide (1 g, 3.24 mmol) was dissolved in 
toluene (225 mL) and heated to reflux. A mixture of Bu3SnH (1.31 mL, 4.87 mmol) 
and ACN (159 mg, 0.649  mmol) in toluene (225 mL) was added by syringe pump 
over 7 hours and the reaction heated at reflux for a further 10 hours before cooling to 
room temperature. The reaction mixture was then concentrated in vacuo to give a 
yellow oil which was taken up in acetonitirile (100 mL) and washed with hexane (3 
x 100 mL). The acetonitrile phase was then concentrated in vacuo to give the crude 
product as a yellow oil (813 mg). The mixture was purified by column 
chromatography (14:1 to 6:1 pet ether/EtOAc) which led to the isolation of 1-
(spiro[cyclohexane-1,1'-isoindoline]-2'-yl)ethanone (81 mg, 11%), cis-1-
(1,2,3,4,4a,10b-hexahydrophenanthridin-5(6H)-yl)ethanone (209 mg, 28%) and 
trans-1-(1,2,3,4,4a,10b-hexahydrophenanthridin-5(6H)-yl)ethanone (153 mg, 21%) 
1-(Spiro[cyclohexane-1,1'-isoindoline]-2'-yl)ethanone (326): υmax 2925 (CH), 
1644 (C=O); δH (400 MHz, CDCl3) 7.64 (1H, dd, J = 15.0, 12.5 Hz, ArH), 6.82 – 
7.42 (3Hz, m, ArH), 4.76 (2H, s, NCH2), 3.08 (2H, td, J = 13.0, 5.5 Hz, 1H), 2.13 
(3H, s, COCH3), 1.67 – 1.87 (4H, m, cy), 1.43 – 1.61 (4H, m, cy); δC (100 MHz, 
CDCl3) 169.4 (C=O), 147.0, 134.0 (ArC), 127.3, 127.2, 124.0, 122.4 (ArCH), 70.7 
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(NC quarternary), 53.8 (NCH2), 32.1, 27.8 (cy), 25.3 (CH3), 24.3, 22.4 (cy); m/z 
(ES
+
) requires 252.1364, found 252.1359 [M+H]
+
. 
cis-1-(1,2,3,4,4a,10b-Hexahydrophenanthridin-5(6H)-yl)ethanone (327a) (1:0.7 
ratio of amide rotamers): δH (400 MHz, CDCl3) 7.36 (1H maj + 1H min, dd, J = 
16.5, 7.5 Hz, ArH), 7.06 – 7.31 (3H maj + 3H min, m, ArH), 5.03 (1H maj, d, J = 
18.0 Hz, NCHaHb), 4.82 (1H min, dt, J = 12.0, 4.5 Hz, NCH), 4.65 (1H min, d, J = 
16.5 Hz, NCHaHb), 4.55 (1H, d, J = 16.5 Hz, NCHaHb), 4.34 (1H, d, J = 18.0 Hz, 
NCHaHb), 3.95 (1H maj, dt, J = 11.5, 4.5 Hz, NCH), 3.24 (1H maj, br s, NCHCH), 
3.12 (1H min, br s, NCHCH), 2.58 (1H maj, ddt, J = 14.0, 5.5, 3.0 Hz, cy), 2.45 – 
2.54 (1H min, m, cy), 2.21 (3H maj, s, CH3), 2.17 (3H min, s, CH3), 1.08 – 1.84 (5H 
maj + 5H min, m, cy); δC (100 MHz, CDCl3) 169.4 (C=O maj), 169.3 (C=O min), 
135.9, 134.4, 133.2, 132.5 (ArC, quarternary), 127.2, 126.8, 126.7, 126.4, 126.2, 
126.1, 126.0, 125.9 (ArCH), 55.7 (NCH maj), 49.9 (NCH min), 45.9 (NCH2 min), 
42.6 (NCH2 maj), 37.2 (NCHCH maj), 36.4 (NCHCH min), 27.6, 27.3, 27.2, 25.7, 
25.6, 25.4 (cy), 22.4, 21.7 (COCH3), 19.8, 19.5 (cy); m/z (ES
+
) requires 252.1364, 
found 252.1351 [M+H]
+
. 
 
Trans-1-(1,2,3,4,4a,10b-Hexahydrophenanthridin-5(6H)-yl)ethanone (327b) 
(1:1.7 ratio of amide rotamers): υmax 2931 (CH), 1625 (C=O); δH (400 MHz, 
CDCl3) 7.04 – 7.38 (4H maj + 4H min, m, ArH), 5.55 (1H min, d, J = 13.5 Hz, 
NCHaHb), 4.44 (1H maj, d, J = 14.5 Hz, NCHaHb), 4.27 (1H maj, d, J = 14.5 Hz, 
NCHaHb), 3.73 (1H, d, J = 13.5 Hz, 1H), 3.36 (1H maj, t, J = 12.5 Hz, NCH), 3.08 
(1H min, td, J = 12.0, 5.5 Hz, NCH), 1.28 - 2.69 (9H maj + 9H min, m, cy), 2.13 
(3H, s, CH3), 2.03 (3H, s, CH3); δC (100 MHz, CDCl3) 170.6 (C=O min), 169.8 
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(C=O maj), 139.9, 139.2, 137.7, 136.3 (ArC quarternary), 127.9, 127.5, 126.3, 126.2, 
125.6, 124.4, 123.1, 122.6 (ArCH), 60.2, 58.3 (NCH min), 53.8 (NCH maj), 47.1 
(NCH min), 43.2 (NCH2 maj), 42.1 (NCH2 maj), 41.8 (NCHCH), 33.9, 31.0, 27.8, 
26.0, 25.8, 25.3, 25.2 (cy), 22.9 (CH3), 22.5, 22.4 (cy), 21.8 (CH3); m/z (ES
+
) 
requires 252.1364, found 252.1359 [M+H]
+
. 
 
1,3-Dibromo-2-(bromomethyl)benzene
202
 (339) 
 
2,6-Dibromotoluene (1 g, 4.00 mmol), N-bromosuccinimide (783 mg, 4.40 mmol) 
and benzoyl peroxide (64.6 mg, 0.2 mmol) in CCl4 (10 mL) were heated to reflux for 
16 hours. The reaction mixture was then cooled, diluted with DCM (30 mL) and 
washed with water (3 x 50 mL). The organic phase was then dried over MgSO4, 
filtered and concentrated in vacuo to give the crude product as a brown solid. The 
product was recrystallised from 10:1, hexane/EtOAc to give a brown crystalline 
solid (1.152 g, 87%). Rf 0.59 (pet ether/EtOAc, 6:1); υmax 2930 (CH); δH (400 MHz, 
CDCl3) 7.25 (2H, d, J = 8.0 Hz, ArH), 6.72 (1H, t, J = 8.0 Hz, ArH), 4.54 (2H, s, 
CH2); δC (100 MHz, CDCl3) 135.7 (ArC), 132.1 (ArCH), 130.2 (ArCH), 125.1 
(ArC), 33.4 (CH2). ; m/z (ES
+
) 326.8 [M+H]
+
. 
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N-Cyclohexenyl-N-(2,6-dibromobenzyl)acetamide (340) 
 
N-Cyclohexenylacetamide (253 mg, 1.82 mmol) in THF (10 mL) was added to 
sodium hydride (367 mg, 9.09 mmol) in THF (15 mL) and the reaction mixture was 
cooled to 0 
o
C. 2,6-dibromobenzyl bromide (627 mg, 1.91 mmol) was then added 
and the reaction heated to reflux for 12 hours. The reaction mixture was then cooled 
and added to water (30 mL) and extracted with ethyl acetate (3 x 50 mL). The 
combined organic layers were then dried over MgSO4, filtered and then concentrated 
in vacuo to give the crude product. The crude product was purified by column 
chromatography (pet ether/ EtOAc, 9:1) to give the product as a pale yellow oil (353 
mg, 50%). Rf 0.15 (pet ether/EtOAc, 6:1); υmax 2928 (CH), 1649 (C=O) ; δH (400 
MHz, CDCl3) 7.52 (2H, d, J = 8.0 Hz, ArH), 6.98 (1H, t, J = 8.0 Hz, ArH), 5.26 – 
5.50 (1H, m, C=CH), 5.10 (2H, s, CH2), 2.05 (3H, s, CH3), 1.80 – 2.00 (4H, m, 5.0 
Hz, C=CCH2), 1.50 – 1.64 (2H, m, CH2), 1.32 – 1.50 (2H, m, CH2); δC (100 MHz, 
CDCl3) 169.6 (C=O), 137.3 (C=CN), 135.7 (ArC), 132.4 (ArCH), 130.1 (ArCH), 
129.4 (C=CH), 127.0 (ArCBr), 48.7 (NCH2), 28.6, 24.8, 22.7, 21.4 (cy), 21.3 
(COCH3); m/z (ES
+
) C15H17Br2NNaO requires 407.9569, found 407.9569 [M+Na]
+
. 
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N-(2-Bromobenzyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide (342) 
 
The general procedure for the synthesis of N-bromobenzyl enamides (6.2.1) was 
applied using 2-methyl-1-phenylpropan-1-one oxime (2 g, 12.2 mmol), acetic acid 
(2.10 mL, 36.8 mmol), acetic anhydride (3.47 mL, 36.8 mmol) and iron powder 
(1.37 g, 24.5 mmol) in toluene (50 mL) to give the crude enamide as an yellow oil 
(1.82 g). This was reacted with sodium hydride (1.92 g, 48.1 mmol) and 2-
bromobenzyl bromide (2.52 g, 10.1 mmol) in anhydrous THF (140 mL) to give the 
crude product as a yellow oil (3.82 g). The crude product was purified by column 
chromatography (pet ether/ EtOAc, 4:1) to give the product as a pale yellow 
crystalline solid (1.88 g, 55%). Rf 0.43 (pet ether/EtOAc, 4:1); m.p. 92-94 
o
C; υmax 
2922 (CH), 1640 (C=O); δH (400MHz, CDCl3) 7.53 (1H, d, J = 7.5 Hz, ArC(Br)CH), 
7.46 (1H, d, J = 8.0 Hz, ArC(CH2)CH), 7.25 – 7.40 (5H, m, 5 x Ar), 7.21 (1H, t, J = 
7.5 Hz, ArC(Br)CHCH), 7.08 (1H, t, J = 7.5 Hz, ArC(CH2)CHCH), 5.22 (1H, d, J = 
14.5 Hz, ArCHaHbN), 4.13 (1H, d, J = 14.5 Hz, ArCHaHbN), 2.21 (3H, s, C=OCH3), 
1.82 (3H, s, C=C(CH3)(CH3)), 1.51 (3H, s, C=C(CH3)(CH3)); δC (100MHz, CDCl3) 
171.2 (C=O), 137.0 (ArCCH2N), 136.4, 134.1, 134.1 (quaternary), 132.5 (ArCH), 
132.5 (ArCH), 129.3 (ArCH), 128.9 (ArCH), 128.1 (ArCH), 127.7 (ArCH), 127.2 
(ArCH), 124.3 (ArCBr), 48.6 (ArCH2N), 21.4 (CH3), 21.4 (CH3), 21.0 (C=CCH3); 
m/z (ES
+
) C19H21BrNO requires 358.0801, found: 358.0800 [M+H]
+
. 
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N-(2-Bromobenzyl)-N-(cyclohexylidene(phenyl)methyl)acetamide (343) 
 
The general procedure for the synthesis of N-bromobenzyl enamides (6.2.1) was 
applied using cyclohexyl(phenyl)methanone oxime (2 g, 9.84 mmol), acetic acid 
(1.69 mL, 29.5 mmol), acetic anhydride (2.78 mL, 29.5 mmol) and iron powder 
(1.10 g, 19.7 mmol) in toluene (40 mL) to give the crude enamide as an 
orange/brown solid (2.2 g). This was reacted with sodium hydride (1.92 g, 47.9 
mmol) and 2-bromobenzyl bromide (2.52 g, 10.1 mmol) in anhydrous THF (140 
mL) to give the crude product as a brown solid (2.72 g). The crude product was 
purified by recrystallisation from hexane to give the product as an orange/brown 
solid (1.76 g, 46%). Rf 0.5 (pet ether/EtOAc, 4:1); m.p. 116-118 
o
C; υmax 2936 (CH), 
1641 (C=O); δH (400MHz, CDCl3) δ 7.53 (1H, d, J = 7.5 Hz, ArCBrCHCH), 7.49 
(1H, d, J = 7.5 Hz, ArC(CH2)CHCH), 7.30 – 7.41 (3H, m, ArH), 7.28 (2H, d, J = 7.0 
Hz, ArH), 7.24 (1H, t, J = 7.5 Hz, Br-ArH), 7.11 (1H, t, J = 7.5 Hz, Br-ArH), 5.36 
(1H, d, J = 14.0 Hz, ArCHaHbN), 3.98 (1H, d, J = 14.0 Hz, ArCHaHbN), 2.54 (1H, 
dd, J = 14.0, 5.0 Hz, C=C(CHaHb)(CHaHb)), 2.22 (3H, s, CH3), 2.08 (1H, dt, J = 9.0, 
4.5 Hz, C=C(CHaHb)(CHaHb)),  1.97 (1H, ddd, J = 14.0, 10.5, 4.0 Hz, 
C=C(CHaHb)(CHaHb)),  1.81 (1H, ddd, J = 13.5, 10.5, 4.0 Hz, 
C=C(CHaHb)(CHaHb)),  1.65 – 1.73 (1H, m, cyH), 1.54 – 1.62 (1H, m, cyH), 1.36 – 
1.54 (3H, m, cyH), 0.69 – 0.85 (1H, m, C=CCH2CHaHb); δC (100MHz, CDCl3) δ 
171.1 (C=O), 141.2 (C=C(CH2)2), 137.1 (ArCCH2N), 136.2 (ArCC=C), 132.7 
(ArCH), 132.6 (ArCH), 131.1 (NC=C(CH2)2), 129.3 (ArCH), 129.0 (ArCH), 128.2 
(ArCH), 127.8 (ArCH), 127.2 (ArCH), 124.5 (ArCBr), 48.0 (ArCH2N), 31.4 
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(C=C(CH2)(CH2), 31.4 (C=C(CH2)(CH2), 27.8 (CH2CH2CH2), 27.0 (CH2CH2CH2), 
26.4 (CH2CH2CH2), 21.4 (CH3); m/z (ES
+
) C22H24BrNNaO requires 420.0933, 
found: 420.0936 [M+Na]
+
. 
 
N-(2-Bromobenzyl)-N-(2-phenylcyclohex-1-enyl)acetamide (344) 
 
The general procedure for the synthesis of N-bromobenzyl enamides (6.2.1) was 
applied using 2-phenylcyclohexanone oxime (800 mg, 4.23 mmol), acetic acid (0.73 
mL, 12.7 mmol), acetic anhydride (1.20 mL, 12.7 mmol) and iron powder (472 mg, 
8.45 mmol) in toluene (20 mL) to give the crude enamide as an orange solid (880 
mg). This was reacted with sodium hydride (817 mg, 20.4 mmol) and 2-
bromobenzyl bromide (1.07 g, 4.29 mmol) in anhydrous THF (60 mL) to give the 
crude product as a brown solid (2.72 g). The crude product was purified by column 
chromatography (pet ether/EtOAc 4:1) to give the product as a yellow oil (690 mg, 
43%). Rf 0.36 (pet ether/EtOAc, 4:1); υmax 2930 (CH), 1638 (C=O); δH (400MHz, 
CDCl3) δ 7.48 (1H, dd, J = 8.0, 1.5 Hz, ArH), 7.02 – 7.37 (9H, m, ArH), 5.02 (1H, d, 
J = 15.0 Hz, ArCHaHbN), 3.94 (1H, d, J = 15.0 Hz, ArCHaHbN), 2.30 – 2.50 (2H, m, 
C=CCH2), 2.13 (3H, s, C=OCH3), 1.99 – 2.10 (2H, m, C=CCH2), 1.59 – 1.75 (4H, 
m, CH2CH2CH2); δC (100MHz, CDCl3) δ 170.3 (C=O), 140.5 (ArCC=C), 137.3 
(ArCCH2N), 136.7 (NC=CPh), 135.2 (NC=CPh), 132.5 (ArCH), 130.8 (ArCH), 
128.7 (ArCH), 128.5 (ArCH), 127.5 (ArCH), 127.2 (ArCH), 126.9 (ArCH), 123.7 
(ArCBr), 50.2 (NCH2Ar), 31.8 (C=CCH2), 30.8 (C=CCH2), 23.0 (CH2CH2CH2), 
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22.5 (CH2CH2CH2), 21.8 (CH3); m/z (ES
+
) C21H22BrNNaO requires 406.06777, 
found: 406.0771 [M+Na]
+
. 
 
N-(2-bromobenzyl)-N-(2-methyl-3,4-dihydronaphthalen-1-yl)acetamide (345) 
 
Methytetralone oxime (1 g, 5.71 mmol), copper iodide (109 mg, 0.571 mmol), acetic 
anhydride (1.08 mL, 11.4 mmol) and sodium bisulfite (1.79 g, 17.1 mmol) were 
heated to rflux in DCE (29 mL) fro 4 hours. The reaction mixture was then cooled 
and diluted with EtOAc (30 mL) before washing with NaOH (2M, 2 x 70 mL) an 
dbrine (70 mL). The organic phase was then dried over MgSO4, filtered and 
concentrated in vacuo to give an orange solid (366 mg). The solid was added to 
sodium hydride (497 mg, 12.4 mmol) in THF (25 mL). The reaction mixture was 
then cooled to 0 
o
C and 2-bromobenzyl bromide (652 mg, 2.6 mmol) followed by 
heating to reflux for 14 hours. Water (40 mL) was then added and the mixture and 
extracted with ethyl acetate (3 x 50 mL). The combined organic layers were then 
dried over MgSO4, filtered and then concentrated in vacuo to give the crude product. 
The crude product was purified by recrystallisation from hexane to give the product 
as an pale yellow crystalline solid (1.76 g, 46%). Rf 0.46 (3:1, pet ether/EtOAc); υmax 
2927, 2881, 2824 (CH), 1654 (C=O); δH 7.59 (1H, dd, J = 7.5, 1.5 Hz, ArH), 7.43 
(1H, dd, J = 8.0, 1.0 Hz, ArH), 7.11 – 7.25 (3H, m, ArH), 7.04 – 7.11 (1H, m, ArH), 
6.91 – 6.98 (1H, m, ArH), 5.52 (1H, d, J = 14.0 Hz, NCHaHb), 4.29 (1H, d, J = 14.0 
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Hz, NCHaHb), 2.88 (1H, td, J = 15.0, 7.0 Hz, CHaHbCH2), 2.70 (1H, ddd, J = 15.5, 
6.5, 4.0 Hz, CHaHbCH2), 2.35 (1H, tdd, J = 15.0, 6.5, 1.0 Hz, CH2CHaHb), 2.15 (1H, 
ddd, J = 16.5, 7.0, 7.0 Hz, CH2CHaHb), 1.92 (3H, s, COCH3), 1.35 (3H, s, C=CCH3); 
δC (100 MHz CDCl3) 171.6, 137.0, 136.5, 136.2, 133.1, 132.5, 132.4, 132.0, 129.1, 
127.6, 127.4, 127.1, 126.8, 125.0, 121.6, 48.1, 29.5, 27.2, 21.1, 18.8; m/z (ES
+
) 
C20H20BrNNaO requires 392.0626, found: 392.0627 [M+Na]
+
. 
 
1-(2-Phenylspiro[cyclohexane-1,1'-isoindoline]-2'-yl)ethanone (347) 
 
N-(2-Bromobenzyl)-N-(2-phenylcyclohex-1-enyl)acetamide (344) (670 mg, 1.74 
mmol), Bu3SnH (0.703 mL, 2.62 mmol) and ACN (85.2 mg, 0.349 mmol) in toluene 
(87.2 mL) were heated to reflux for 26 hours. The reaction mixture was then cooled 
and concentrated in vacuo. The residue was then partitioned between acetonitrile (50 
mL) and hexane (50 mL), and the acetonitrile phase concentrated in vacuo to give 
the crude product as a brown oil (561 mg). The crude product was purified by 
column chromatography (9:1, pet ether/EtOAC) to give 1-(2-
phenylspiro[cyclohexane-1,1'-isoindoline]-2'-yl)ethanone (111 mg, 21%). Rf 0.17 
(6:1 pet ether/EtOAC); δH (400 MHz) 7.33 – 7.44 (2H, m, ArH), 7.17 – 7.23 (1H, m, 
ArH), 6.98 – 7.10 (3H, m, ArH), 6.87 (1H, d, J = 7.5 Hz, ArH), 6.64 – 6.70 (2H, m, 
ArH), 4.30 (1H, d, J = 13.5 Hz, NCHaHb), 3.21 (1H, d, J = 13.5 Hz, NCHaHb), 2.82 
– 3.02 (2H, m, cy), 2.63 – 2.78 (1H, m, cy), 2.41 – 2.51 (1H, m, cy), 2.16 – 2.27 (1H, 
m, cy), 2.07 – 2.16 (1H, m, cy), 1.98 (3H, s, CH3), 1.47 – 1.83 (3H, m, cy); δC (100 
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MHz, CDCl3)170.3 (C=O), 147.8, 141.9, 135.3 (ArC), 128.5, 127.7, 127.5, 127.3, 
126.2, 123.0, 121.1 (ArCH), 74.1 (NC quarternary), 56.4 (CH), 55.1 (NCH2), 38.7, 
28.2, 25.8 (cy), 25.1 (COCH3), 22.8(cy); m/z (ES
+
) C21H23NNaO requires 328.2677, 
found: 328.1673 [M+Na]
+
. 
 
6.5 Compounds Synthesised in Chapter Five 
N-Butyl-3-methylaniline
249
 (392) 
 
Sodium hydride (1.87 g, 46.6 mmol) was added to 3-methylaniline (5.00 g, 46.6 
mmol) in DMF (35 mL) and the mixture was stirred for 1 h. Iodobutane (5.31 mL, 
46.6 mmol) was then added and the reaction stirred at room temperature for 14 h. the 
reaction was then quenched with ethanol (25 mL) followed by saturated ammonium 
chloride (40 mL). Diethyl ether (100 mL) was then added and the organic layer was 
washed with water (2 x 100 mL) and brine (2 x 100 mL). The organic phase was 
then dried over MgSO4, filtered, and concentrated in vacuo to give the crude product 
as an orange oil (6.79 g). The crude product was purified by column chromatography 
(16:1 pet ether/EtOAC) to give the product as a yellow oil (1.96 g, 26%). Rf 0.35 
(16:1 pet ether/EtOAC); υmax 3403 (NH), 2955, 2926, 2860 (CH); δH (300 MHz) 7.10 
– 7.02 (1H, m, ArH), 6.51 (1H, d, J = 7.5 Hz, ArH), 6.45 – 6.39 (2H, m, 2 x ArH), 
3.52 (1H, br s, NH), 3.10 (2H, t, J = 7.0 Hz, NHCH2CH2), 2.28 (3H, s, ArCH3), 1.66 
– 1.52 (2H, m, NHCH2CH2), 1.43 (2H, sextuplet, J = 7.0 Hz, CH2CH2CH3), 0.96 
(3H, t, J = 7.0 Hz, CH2CH3); δC 148.7 (ArCN), 139.0 (ArC), 129.1, 118.1, 113.5, 
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109.9 (ArCH), 43.7 (NCH2), 31.8 (CH2CH2CH2), 21.7 (Ar-CH3), 20.4 (CH2CH3), 
14.0 (CH2CH3); m/z (ES
+
) 164.1 [M+H]
+
. 
 
2-Bromo-N-butyl-2-methyl-N-m-tolylpropanamide
223
 (394) 
 
N-Butyl-3-methylaniline was dissolved in diethyl ether and the solution cooled to 0 
o
C. Triethylamine (1.02 mL, 7.35 mmol) was then added followed by the dropwise 
addition of 2-bromoisobutyryl bromide (0.909 mL, 7.35 mmol). The reaction was 
then allowed to warm to room temperature and stirred for 24 h. The reaction was 
then quenched by the addition of water and the phases separated. The organic phase 
was washed with 2M HCl, dried over MgSO4, filtered and concentrated in vacuo to 
give the product as an orange oil (1.67 g, 85%). Rf 0.44 (pet ether/EtOAC, 6:1); υmax 
2965 (C-H), 1719 (C=O), 833 (C-Br); δH (300 MHz) 7.28 (1H, t, J = 7.5 Hz, ArH), 
7.21 – 7.10 (3H, m, 3 x ArH), 3.65 (2H, t, J =  7.5 Hz, NCH2), 2.38 (3H, s, ArCH3), 
1.71 (6H, s, C(CH3)2Br), 1.56 (2H, quintet, J = 7.5 Hz, NCH2CH2), 1.31 (2H, 
sextuplet, J = 7.5 Hz, CH2CH3), 0.90 (3H, t, J = 7.5 Hz, CH2CH3); δC (75 MHz) 
169.7 (C=O), 142.6 (ArC-N), 139.0, 132.3 (ArC), 130.2, 128.9, 128.8, 126.6 
(ArCH), 58.6 (C(CH3)2Br), 53.4 (NCH2), 33.4 (C(CH3)2Br), 29.2 (NCH2CH2), 21.4 
(Ar-CH3), 20.1 (CH2CH3), 14.9 (CH2CH3); m/z (ES
+
) 312.0 [M+H]
+
. 
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1-Butyl-3,3,4-trimethylindolin-2-one
223
 (395) and 1-butyl-3,3,6-trimethylindolin-
2-one
223
 (396) 
 
Intramolecular Friedel-Crafts Method. 
2-Bromo-N-butyl-2-methyl-N-m-tolylpropanamide (500 mg, 1.60 mmol) was added 
to anhydrous aluminium chloride (5.34 mg, 4.00 mmol) under nitrogen and the 
mixture heated to 50 
o
C for 10 min and then 160 
o
C for 1 h. Upon cooling a 
purple/brown solid was obtained. This was taken up in diethyl ether (50 mL) and 
washed with water (3 x 50 mL). The organic phase was then dried over MgSO4, 
filtered and concentrated in vacuo to give the crude product as a yellow oil (351 mg). 
Bu3SnH / AIBN Radical Cyclisation Method 
A solution of Bu3SnH (0.948 mL, 3.52 mmol) and AIBN (97.8 mg, 0.400 mmol) in 
toluene (30 mL) was added  over 2 hours via syringe pump to a refluxing solution of 
2-bromo-N-butyl-2-methyl-N-m-tolylpropanamide (500 mg, 1.60 mmol) in toluene 
(50 mL). The reaction mixture was then heated a reflux for a further 14 hours. The 
reaction was then concentrated in vacuo and the residue taken up in acetonitrile (50 
mL) and washed with hexane (5 x 30 mL). The acetonitrile phase was then 
concentrated in vacuo to give the crude product as a yellow oil (535 mg). 
Copper Mediated Radical Cyclisation Method 
2-Bromo-N-butyl-2-methyl-N-m-tolylpropanamide (500 mg, 1.60 mL), CuBr (68.9 
mg, 0.48 mmol) and TPA (139 mg, 0.48 mmol) were dissolved in methanol (13.3 
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mL) and the mixture stirred for 5 mins. KBH4 (259 mg, 4.80 mmol) was then added 
and the reaction stirred at 50 
o
C for 24 h. The reaction mixture was then cooled and 
filtered through a silica plug with DCM (50 mL). The solvent was then evaporated 
and the residue was taken up in diethyl ether (50 mL) and washed with water (3 x 50 
mL). The organic phase was then dried over MgSO4, filtered and concentrated in 
vacuo to give the crude product as a yellow oil (347 mg). 
In all three reactions 1-butyl-3,3,4-trimethylindolin-2-one (395) and 1-butyl-3,3,6-
trimethylindolin-2-one (396) were identified in the crude 
1
H NMR by comparison 
with previous literature data.
223
 
1-Butyl-3,3,4-trimethylindolin-2-one (395) 
δH (400 MHz) 7.14 (1H, t, J  = 8.0 Hz, ArH), 6.81 (1H, d, J  = 8.0 MHz, ArH), 6.71 
(1H, d, J = 8.0 MHz, ArH), 3.70 (2H, t, J = 7.5 Hz, NCH2), 2.40 (3H, s, Ar-CH3), 
1.65 (2H, quintet, J = 7.5 Hz, NCH2CH2), 1.45 (6H, s, C(CH3)2), 1.38 – 1.34 (2H, m, 
CH2CH3), 0.95 (3H, t, J = 7.5 Hz, CH2CH3).  
1-Butyl-3,3,6-trimethylindolin-2-one (396) 
δH (400 MHz) 7.08 (1H, d, J = 7.5 Hz, ArH), 6.86 (1H, d, J = 7.5 Hz, ArH), 6.68 
(1H, s, ArH), 3.69 (2H, t, J = 7.5 Hz, NCH2), 2.38 (3H, s, Ar-CH3), 1.65 (2H, 
quintet, J = 7.5 Hz, NCH2CH2), 1.38 – 1.34 (2H, m, CH2CH3), 1.34 (6H, s, 
C(CH3)2), 0.95 (3H, t, J = 7.5 Hz, CH2CH3). 
 
6.5.1 General Procedure of the Synthesis of Anilides 
Amine (1.0 eq.) was dissolved in toluene (0.5 M) and the solution cooled to 0 
o
C. 
Triethylamine (1.2 eq.) was then added, followed by the dropwise addition of 2-
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bromoisobutyryl bromide (1.1 eq.). The reaction was then allowed to warm to room 
temperature and stirred for 24 h. The reaction was then quenched by the addition of 
water and the phases separated. The organic phase was then washed with 2 M HCl, 
dried over MgSO4 and filtered before being concentrated in vacuo to give the 
product. No further purification was required. 
 
2-Bromo-N-isopropyl-2-methyl-N-phenylpropanamide
223
 (397b) 
 
The general procedure for the synthesis of anilides (6.5.1) was applied using N-
isopropylaniline (370 mg, 2.74 mmol), triethylamine (0.456 mL, 3.28 mmol), 2-
bromoisobutyryl bromide (0.372 mL, 3.01 mmol) and toluene (5.50 mL). The 
product was obtained as a pale yellow crystalline solid (490 mg, 67%). Rf 0.39 (pet 
ether/EtOAC, 6:1); m.p. 58-60 
o
C; υmax 2976 (C-H), 1629 (C=O), 708 (C-Br); δH 
(400 MHz, CDCl3) 7.42 – 7.36 (3H, m, ArH), 7.32 – 7.24 (2H, br m, ArH), 4.98 (1H, 
septuplet, J = 6.5 MHz, CH(CH3)2), 1.69 (6H, br s, C(CH3)2Br), 1.06 (6H, d, J = 6.5 
Hz, CH(CH3)2); δC (400 MHz, CDCl3) 169.5 (C=O), 137.8 (ArN), 131.9 (Ar), 128.5 
(Ar), 128.3 (Ar), 59.3 (C(CH3)2Br), 49.3 (CH(CH3)2), 33.5 (C(CH3)2Br), 20.6 
(CH(CH3)2); m/z (ES
+
) C13H19BrNO requires 284.0645, found: 284.0646 [M+H]
+
. 
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 2-Bromo-N-(4-methoxyphenyl)-N,2-dimethylpropanamide
223
 (397e) 
 
The general procedure for the synthesis of anilides (6.5.1) was applied using 4-
methoxy-N-methylaniline (1.00 g, 7.29 mmol), triethylamine (1.21 mL, 8.75 mmol), 
2-bromoisobutyryl bromide (0.991 mL, 8.02 mmol) and toluene (14.5 mL). The 
product was obtained as a yellow crystalline solid (1.95 g, 93%). Rf 0.19 (pet 
ether/EtOAC, 6:1); υmax 2973 (C-H), 1737 (C=O), 662 (C-Br); δH (400 MHz, CDCl3) 
7.28 (2H, d, J = 9.0 Hz, 2 x ArH), 6.91 (2H, d, J = 9.0 Hz, 2 x ArH), 3.83 (3H, s, 
OCH3), 3.30 (3H, s, NCH3), 1.75 (6H, s, C(CH3)2Br); δC (400 MHz, CDCl3) 170.5 
(C=O), 159.0 (ArOCH3), 137.0 (ArN), 129.7 (2 x Ar), 114.2 (2 x Ar), 58.0 
(C(CH3)2Br), 55.5 (OCH3), 42.0 (NCH3), 33.4 (C(CH3)2Br); m/z (ES
+
) C12H17BrNO2 
requires 286.0437, found: 286.0440 [M+H]
+
. 
 
2-Bromo-N,2-dimethyl-N-(4-nitrophenyl)propanamide (397f) 
 
The general procedure for the synthesis of anilides (6.5.1) was applied using N-
methyl-4-nitroaniline (1.00 g, 6.57 mmol), triethylamine (1.09 mL, 7.89 mmol), 2-
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bromoisobutyryl bromide (0.894 mL, 7.23 mmol) and toluene (13.0 mL). The 
product was obtained as a bright yellow solid (1.87 g, 94%). Rf 0.11 (pet 
ether/EtOAC, 6:1); m.p. 70-71 
o
C; υmax  2971 (C-H), 1637 (C=O), 837 (C-Br); δH 
(400 MHz, CDCl3) 8.28 (2H, d, J = 9.0 Hz, ArH), 7.54 (2H, d, J = 9.0 Hz, ArH), 
3.51 (3H, s, NCH3), 1.91 (6H, s, C(CH3)2Br); δC (100 MHz, CDCl3) 170.4 (C=O), 
150.4 (ArNO2), 146.5 (ArN), 128.8, 126.4, 124.7 (Ar), 57.0 (C(CH3)2Br), 41.4 
(NCH3), 32.9 (C(CH3)2Br); m/z (ES
+
) C11H14BrN2O3 requires 301.0182, found: 
301.0183 [M+H]
+
.  
 
6.5.2 General Procedure for Cu(TPA)Br and KBH4 Mediated Synthesis of 
Oxindoles 
Anilide (1 eq.), CuSO4.5H2O (0.2 eq.) and TPA (0.2 eq.) were dissolved in methanol 
(0.12 M) and stirred for 5 mins. KBH4 (2 eq.) was then  added portionwise and the 
reaction mixture heated to 50 
o
C for 24 h. The reaction mixture was then cooled and 
filtered through a silica plug with DCM (25 mL). The filtrate was then washed with 
water (30 mL), dried over MgSO4, filtered and concentrated in vacuo to give the 
crude product. 
6.5.3 General Procedure for Cu(TPA)Br Mediated Synthesis of Oxindoles in 
Methanol 
Anilide (1 eq.), CuBr (1 eq.) and TPA (1 eq.) were dissolved in methanol (0.1 M) 
under nitrogen and the reaction mixture heated to 50 
o
C for 24 h. The reaction 
mixture was then cooled and filtered through a silica plug with EtOAC (50 mL) and 
the filtrate was concentrated in vacuo to give the crude product. 
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6.5.4 General Procedure for Cu(TPA)Br Mediated Synthesis of Oxindoles in 
Toluene 
Anilide (1 eq.), CuBr (1 eq.) and TPA (1 eq.) were dissolved in toluene (0.1 M) 
under nitrogen and the reaction mixture heated to 110 
o
C for 24 h. The reaction 
mixture was then cooled and filtered through a silica plug with EtOAC (50 mL) and 
the filtrate was concentrated in vacuo to give the crude product. 
 
1,3,3-Trimethylindolin-2-one
223
 (399a) 
 
Rf 0.28 (6:1, pet ether/EtOAc); mpt ; υmax 2968 (C-H), 1703 (C=O); δH (400 MHz, 
CDCl3) 7.26 (1H, t, J = 7.5 Hz, ArH), 7.20 (1H, d, J = 7.5 Hz, ArH), 7.06 (1H, t, J = 
7.5 Hz, ArH), 6.84 (1H, d, J = 7.5 Hz, ArH), 3.21 (3H, s, NCH3), 1.37 (6H, s, 
C(CH3)2); δC (400 MHz) 181.4 (C=O), 142.6 (Ar-N), 135.8 (Ar), 127.7 (ArH), 122.5 
(ArH), 122.3 (ArH), 108.0 (ArH), 44.2 (C(CH3)2), 26.2 (NCH3), 24.4 (C(CH3)2); m/z 
(ES
+
) 176.1 [M+H]
+
. 
1-Isopropyl-3,3-dimethylindolin-2-one
223
 (399b) 
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Rf 0.35 (6:1, pet ether/EtOAc); υmax 3053, 2970 (CH), 1692 (C=O); δH (400MHz, 
CDCl3) 7.22 (1H, t, J = 8.0 Hz, ArH), 7.21 (1H, d, J = 8.0 Hz, ArH), 7.04 (1H, d, J = 
8.0 Hz, ArH), 7.02 (1H, d, J = 8.0 Hz, ArH), 4.65 (1H, septuplet, J = 7.0 Hz, 
CH(CH3)2), 1.48 (6H, d, J = 7.0 Hz, CH(CH3)2), 1.31 (6H, s, C(CH3)2); δC (100MHz, 
CDCl3) 181.0 (C=O), 141.2 (ArCN), 136.4 (ArC), 127.3, 122.5, 121.9, 109.9 
(ArCH), 43.8 (C(CH3)2), 43.4 (CH(CH3)2), 24.5 (C(CH3)2), 19.4 (CH(CH3)2); m/z 
(ES
+
) 204.1 [M+H]
+
. 
 
1-Benzyl-3,3-dimethylindolin-2-one
250
 (399c) 
 
Rf 0.29 (6:1, pet ether/EtOAc); υmax 2970 (C-H), 1708 (C=O); δH (400MHz, CDCl3) 
7.24 – 7.28 (5H, m, ArH), 7.20 (1H, d, J = 7.5 Hz, ArH), 7.12 (1H, td, J = 7.5, 1.0 Hz, 
ArH), 7.01 (1H, t, J =7.5 Hz, ArH), 6.72 (1H, d, J = 7.5 Hz, ArH), 4.91 (2H, s, 
NCH2), 1.43 (6H, s, (C(CH3)2); δC (100MHz, CDCl3) 181.0 (C=O), 141.7 (ArCN), 
136.1 (ArC), 135.8 (ArC), 128.8, 127.6, 127.5, 127.2, 122.5, 122.4, 109.1 (ArCH), 
44.2 (C(CH3)2), 43.6 (NCH2), 24.8 (C(CH3)2); m/z (ES
+
) 252.1 [M+H]
+
. 
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5-Chloro-1,3,3-trimethylindolin-2-one
251
 (399d) 
 
Rf 0.18 (6:1, pet ether/EtOAc); υmax 2977 (C-H), 1706 (C=O), 813 (CCl); δH 
(400MHz, CDCl3) 7.16 (1H, dd, J = 8.0, 2.0 Hz, ArH), 7.10 (1H, d, J = 2.0 Hz, ArH), 
6.69 (1H, d, J = 8.0 Hz, ArH), 3.13 (3H, s, NCH3),1.30 (6H, s, C(CH3)2); δC 
(100MHz, CDCl3) 180.8 (C=O), 141.2 (ArCN), 137.5 (ArC), 127.9 (ArCCl), 127.6, 
122.9 , 108.9 (ArCH), 44.5 (C(CH3)2), 26.3 (NCH3), 24.3 (C(CH3)2); m/z (ES
+
) 232 
[M+Na]
+
. 
  
5-Methoxy-1,3,3-trimethylindolin-2-one
250
 (399e) 
 
Rf 0.10 (6:1, pet ether/EtOAc); υmax 2968 (CH), 1699 (C=O); δH (400MHz, CDCl3) 
6.81 (1H, d, J = 2.5 Hz, ArH), 6.77 (1H, dd, J = 8.5, 2.5 Hz, ArH), 6.72 (1H, d, J = 8.5 
Hz, ArH), 3.78 (3H, s, OCH3), 3.17 (3H, s, NCH3), 1.34 (6H, s, (C(CH3)2); δC 
(100MHz, CDCl3) 181.1 (C=O, quaternary), 156.1 (ArC-OCH3), 137.3 (ArCN), 
136.2 (ArC), 111.6, 110.1, 108.2 (ArCH), 55.3 (OCH3), 44.6 (C(CH3)2), 26.3 
(NCH3), 24.4 (C(CH3)2); m/z (ES
+
) 206.1 [M+H]
+
. 
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1,3,3-Trimethyl-5-nitroindolin-2-one
252
 (399f) 
 
Rf 0.08 (6:1, pet ether/EtOAc); υmax 2976 (CH), 1721 (C=O); δH (400MHz, CDCl3) 
8.26 (1H, dd, J = 8.5, 2.5 Hz, ArH), 8.10 (1H, d, J = 2.5 Hz, ArH), 6.94 (1H, d, J = 8.5 
Hz, ArH), 3.30 (3H, s, NCH3), 1.40 (6H, s, C(CH3)2); δC (100MHz, CDCl3) 181.3 
(C=O), 148.4 (ArC-N), 145.0 (ArCNO2), 136.5 (ArC), 125.2, 118.3, 107.6 (ArCH), 
44.2 (C(CH3)2), 26.6 (NCH3), 24.2 (C(CH3)2); m/z (ES
+
) 221.1 [M+H]
+
. 
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